congress information

Transcription

TABLE OF CONTENTS
Table of Contents ........................................................................................................2
Acknowledgements .....................................................................................................3
Welcome Message ......................................................................................................4
Presidential Message ..................................................................................................5
Boards and Committees ..............................................................................................6
ESAO Boards and Committees ....................................................................................7
Awards ........................................................................................................................8
Congress Information ..................................................................................................9
Registration Fee and Payment Regulations ..............................................................10
Other Regulations .....................................................................................................11
General Information ..................................................................................................12
Arrivals and Departures ............................................................................................13
Congress Map ............................................................................................................14
Social Events – Opening Ceremony and Welcome Reception ..................................15
Social Events – Networking Reception ......................................................................16
Social Events – Gala Dinner .......................................................................................17
yESAO Researchers Initiative ....................................................................................18
Scientific Program – Overview .................................................................................19
Floor Plan of the Congress Venue .............................................................................23
Plenary Lectures, Special Symposia and Oral Sessions ............................................24
Poster Sessions ..........................................................................................................43
Authors Index ............................................................................................................54
2
ACKNOWLEDGEMENTS
We would like to thank the following institutions and organizations for they support
Platinum Sponsor
Gold Sponsors
Silver Sponsors
Sponsors
Endorsing Institutions
3
WELCOME MESSAGE
Dear colleagues and friends,
On behalf of the Local Organizing Committee, it is our great pleasure to welcome you to the
XLIII Annual Congress of the European Society for Artificial Organs, to be held at the Nalecz
Institute of Biocybernetics and Biomedical Engineering (IBBE PAS), and the International
th
th
Centre of Biocybernetics, Polish Academy of Sciences, Warsaw (Poland) from 14 to 17
of September 2016.
The program of the Congress includes four plenary lectures on support of the diseased
heart, biocompatibility, tissue engineering and technologies facilitating diabetes treatment,
which will be delivered by the world-class experts: Prof. Piotr Suwalski, Prof. Jörg Vienken,
Prof. Rui L. Reis and Prof. David C. Klonoff, in the consecutive days of the Congress. Eight keynote speakers and over
75 invited speakers will report on the latest significant findings and developments in the broad field of artificial organs
during 16 special symposia, the IFAO symposium, 3 ESAO Working Group symposia and ESAO Corporate Members
symposium. The Program Committee of the Congress selected 120 oral and 140 poster presentations, giving scientists,
clinicians, industrial partners and students from 33 countries the opportunity to present and discuss results of their work.
It is worth mentioning that two of the special symposia are organized in memory of Prof. Dieter Falkenhagen
and Prof. Jan M. Wojcicki, ESAO Presidents who passed away in the recent years.
The scenery of the Congress venue and the rich scientific
program will create a unique atmosphere stimulating
discussions and inspiring an exchange of creative ideas,
bringing us closer “Towards Effective, Seamlessly
integrated and Affordable Artificial Organs”, which is
the theme motto of the XLIII Annual ESAO Congress.
These three features of artificial organ therapy, such as
the ability to effectively replace, substitute or
regenerate the natural organ’s function, the seamless
integration with the human body and affordability are
altogether at the sharpest edge of the bioengineering
revolution.
In 2016, the Annual ESAO Congress is hosted in Warsaw, the capital of Poland, for the third time. However, the city has
been changing and developing very fast since the last ESAO Congress in Warsaw in 2004. Therefore, Poland´s capital has a
lot to offer even to those who visited the city in the past. We are sure that you will find it very interesting and exciting to
discover the new face of this bustling metropolis, experience its unique atmosphere and get to know the extraordinary
history of the capital of Poland. The official tourist website of the city claims that “there are countless reasons to fall in
love with Warsaw”. We hope that after staying in Warsaw on the occasion of the XLIII ESAO Congress, you will realize that
it is not just an empty slogan but the real truth.
We look forward to meeting you in Warsaw to explore the fascinating area of artificial organs and to spend a good time
together.
Prof. Piotr Ladyzynski
Congress President
Prof. Marek Darowski
Honorary Congress President
4
PRESIDENTIAL MESSAGE
Dear colleagues and friends,
I am very glad to invite you to join the XLIII Congress of the European Society for Artificial
Organs organized by Prof. Piotr Ladyzynski and his team from Nalecz Institute of
Biocybernetics and Biomedical Engineering, and the International Centre of Biocybernetics,
Polish Academy of Sciences in Warsaw, Poland from September 14–17, 2016.
This year´s motto of the Congress “Towards Effective, Seamlessly Integrated and Affordable
Artificial Organs” represents a wide scale of activities, reaching from new biomaterials with
improved functionality, cardiac assist, hemodialysis, apheresis, ECMO, liver support devices
to the engineering of tissues and organs including fundamental studies, preclinical and
clinical investigations. In this way, the Congress will cover activities in research and development on tissue and organ
support and replacements, reaching from bench to bed site.
The Congress organizers could attract the interest of people from many different countries in Europe and far beyond,
collecting about 300 abstracts for oral and poster presentations. A special feature of this year´s Congress are the 19
special symposia that are organized by ESAO Working Group chairmen and other invited chair persons. Here not only
themes from all areas of artificial organ support will be discussed but also emerging topics like implantable biosensors,
biomimetic devices, bioartificial organs and many others.
I am also very proud to announce that the Congress organizers invited top-class speakers for keynote lectures that will
certainly bring interesting new views and insights into different topics related to biocompatibility, cardiac assist devices
and surgery, technologies for detecting hypoglycemia and the area of regenerative medicine.
The pre yESAO Congress that will start on September 13 provides a platform for young researchers to meet each other
and to discuss their latest research also with more experienced scientists who will contribute with two tutorial lectures.
The ESAO Congress in Warsaw will also provide plenty of opportunities to discuss research results of fundamental and
clinical studies with colleagues from biomedical industry, which is an important prerequisite for translating research into
clinical application. In this regard, I am also looking forward to our ESAO Corporate Members Symposium where members
from biomedical companies will present the latest developments in medical devices.
Those of you who do not belong to the European Society of Artificial Organs yet, are cordially invited to become a
member of our society and join our activities on development of artificial organ technology, tissue engineering and
regenerative medicine. We also invite all participants to submit their research results as presented during this Congress to
the flagship of our society, The International Journal of Artificial Organs.
Warsaw – the capital of Poland - is a lively town with a lot of interesting and exiting sites. It is a city of many faces
blending historical and socrealist buildings with post-modern skyscrapers, and has plenty more to offer like interesting
museums, nice cafes and restaurants.
Finally, the hospitality of Polish people is exceptional and well known. Piotr Ladyzynski and his team have planned an
exciting social program that will certainly be very pleasurable for all of us.
These are many reasons to attend the XLIII Congress of the European Society for Artificial Organs. I hope to see you there!
A warm welcome
Prof. Thomas Groth
ESAO President
5
BOARDS AND COMMITTEES
Honorary Congress President
Marek Darowski
Congress President
Piotr Ladyzynski
Congress Organizer
Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences
International Centre of Biocybernetics, Polish Academy of Sciences
Local Organizing Committee
Piotr Foltynski – Chairman
Marta Baranowska
Anna Ciechanowska
Joanna Kinasiewicz
Dorota Lewinska
Krzysztof J. Palko
Stanislawa Sabalinska
Anna Stecka
Barbara Wolff
Krzysztof Zielinski
International Scientific Committee
Klaus Affeld (DE)
Angel Argilés (FR)
Steven Ash (US)
Pedro Baptista (ES)
Ulrich Baurmeister (DE)
Andrea Buscaroli (IT)
Gerardo Catapano (IT)
Anna Ciechanowska (PL)
Peter Czermak (DE)
Marek Darowski (PL)
Juan F. del Cañizo (ES)
Arianna Di Molfetta (IT)
Sunny Eloot (BE)
Giuseppe Faggian (IT)
Gianfranco Ferrari (IT)
Piotr Foltynski (PL)
Birgit Glasmacher (DE)
Ludomira Granicka (PL)
Thomas Groth (DE)
Joachim Jankowski (DE)
Erik A. Johannessen (NO)
Tim A.S. Kaufmann (DE)
Ulrich Kertzscher (DE)
Petar Kes (HR)
Ashraf W. Khir (UK)
Jon B. Klein (US)
Horst Klinkmann (DE)
David C. Klonoff (US)
Piotr Ladyzynski (PL)
Cecile Legallais (FR)
Dorota Lewinska (PL)
Adam Liebert (PL)
Bengt Lindholm (SE)
Roman Maniewski (PL)
Joao F. Mano (PT)
Ares K. Menon (DE)
Bart Meyns (BE)
Francesco Moscato (AT)
Khosrow Mottaghy (DE)
Zbigniew Nawrat (PL)
Nuno M. Neves (PT)
Dorota G. Pijanowska (PL)
Rui L. Reis (PT)
Andrea Remuzzi (IT)
Jacek Rozga (PL)
Igor M. Sauer (DE)
Heinrich Schima (AT)
Thomas Schlöglhofer (AT)
Aleksandar Sikole (MK)
Simon J. Sonntag (DE)
Dimitrios Stamatialis (NL)
Bernd G. Stegmayr (SE)
Gustav Steinhoff (DE)
Ulrich Steinseifer (DE)
Maria Giovanna Trivella (IT)
Wladyslaw Torbicz (PL)
Markus Storr (DE)
Tom Verbelen (BE)
Jörg Vienken (DE)
Beat Walpoth (CH)
Jacek Waniewski (PL)
Viktoria Weber (AT)
6
ESAO BOARDS AND COMMITTEES
ESAO Board
President:
President Elect:
Past President:
Honorary President:
Treasurer:
General Secretary:
Honorary Board Member:
Co-opted Board Member:
Thomas Groth (DE)
Cecile Legallais (FR)
Bernd G. Stegmayr (SE)
Horst Klinkmann (DE)
Ulrich Kertzscher (DE)
Sunny Eloot (BE)
Sergio Stefoni (IT)
Birgit Glasmacher (DE)
Rui L. Reis (PT)
Heinrich Schima (AT)
ESAO Governors
Gerardo Catapano (IT)
Marek Darowski (PL)
Arianna Di Molfetta (IT)
Giuseppe Faggian (IT)
Joachim Jankowski (DE)
Tim A. S. Kaufmann (DE)
Ashraf W. Khir (UK)
Bengt Lindholm (SE)
Francesco Moscato (AT)
Maria Giovanna Trivella (IT)
ESAO Working Groups
Apheresis and Adsorption
Chairman: Bernd G Stegmayr (SE), [email protected]
Bioartificial Organs
Chairman: Dimitrios Stamatialis (NL), [email protected]
Education
Chairman: Aleksandar Sikole (MK), [email protected]
Co-Chairman: Rafael Ponikvar (SI), [email protected]
Heart Support
Chairman: Ulrich Steinseifer (DE), [email protected]
Liver Support
Chairman: Igor Sauer (DE), [email protected]
Tissue Engineering
Chairman: Nuno Neves (PT), [email protected]
Uremic toxins
Chairman: Àngel Argilés (FR), [email protected]
Co-Chairman: Joachim Jankowski (DE), [email protected]
ESAO Corporate Members
Chairmen: Markus Storr (DE) and Ares K. Menon (DE)
yESAO
Chairman: Tom Verbelen (BE)
Co-Chairman: Simon Sonntag (DE)
Webpage: http://www.yesao.org
7
AWARDS
ESAO-Wichting Research Award
The Annual ESAO-Wichtig Awards is the most important award for the ESAO to acknowledge the scientific achievements
of young scientists. The award is given to the best peer-reviewed publication of scientists younger than 38 years working
in the field of artificial organ research. A call for submission of candidate publications and authors has been issued in the
ESAO web-site and in the International Journal for Artificial Organs (IJAO). A committee of scientist members of the ESAO
will rate the submitted and will select the winner. The winner will receive a check of 2,500 Euro and a certificate during
the Opening Ceremony of the Congress, and will be given the possibility to briefly present the work done during the
Congress. The ESAO is thankful to Wichtig International for sponsoring this award.
ESAO Poster Awards
Three Poster Awards (500, 300 and 200 Euro respectively) will acknowledge the authors of the best posters. An ESAO
Committee will select the awardees based on poster scientific content and graphic presentation. The Awards will be
notified during the Closing Ceremony the Congress.
ESAO Innovation Award
The ESAO innovation award (500 Euro) will acknowledge the most innovative abstract presented. The winner will be
selected by an ESAO Committee, based on the abstract content and presentation. The Award will be notified during the
Closing Ceremony of the Congress.
ESAO PhD Award
This ESAO award is meant for young researches who recently finalized their PhD. The award mainly aims at encouraging
PhD students to make their work visible on an international level, already from the start of their PhD. Hence, next to the
appreciation of the finalized PhD book by a committee of ESAO board members, also the international impact of the
applicant’s CV will be rated. Awardees will be handed in a “Certificate of Recognition of Excellence” during the Opening
Ceremony of the Congress and will be given the opportunity to briefly present their PhD work in a special session.
yESAO Exchange Program Award
This yESAO award gives students possibility to experience research in different European research Laboratories, offering a
grant of 500 Euro for each participating research. This year, the yESAO Exchange Program Award will be handed in during
the Opening Ceremony of the Congress to the following winners:
Indra Müller (Department of Cardiovascular Engineering, RWTH Aachen, Germany) and Philipp Aigner (Center for
Medical Physics and Biomedical Engineering, Medical University of Vienna, Austria) for research on “Comparison
and iImprovement of cardiac and vascular mock-up components for flow visualization”,
Michela Bozzetto (IRCSS - Istituto di Ricerche Farmacologiche “Mario Negri”, Italy) and Floris Vanommeslaeghe
(Ghent University Hospital, Belgium) for research on “Computational modeling for surgical planning of
arteriovenous fistula for hemodialysis”,
Alejandro Garcia Garcia (BioMechanics and BioEngineering laboratory, Université de Technologie de Compiègne
(UTC), France) and Fedaa Al Halabi (Institute for Multiphase Processes, Leibniz Universitaet Hannover, Germany)
for research on “Coaxially electrospun and directional solidified scaffolds for bone and vascular tissue engineering”.
The awardees will be given the opportunity to briefly report on their experience in a special session.
8
CONGRESS INFORMATION
Congress Secretariat
Prof. Piotr Ladyzynski
Nalecz Institute of Biocybernetics and Biomedical Engineering
4, Trojdena Str., 02-109 Warsaw, Poland.
Phone: +48 22 5925942, fax: +48 22 6597030
e-mail: [email protected]
Congress Venue
The Congress will be held at the premises of the Nalecz Institute of Biocybernetics and Biomedical Engineering and
International Centre of Biocybernetics, Polish Academy of Sciences, 4 Księcia Trojdena Street, Warsaw, Poland.
The Institute is located at the corner of Księcia Trojdena Street and Pawińskiego Street. The main entrance to the Institute
is located at Pawińskiego Street and the entrance to the paid parking is located at Księcia Trojdena Street (behind the
barrier). The GPS coordinates of the Congress Venue are as follows: N 52° 12’ 24’’ E 20° 58’ 42’’
Official Language
English will be the official language of the Congress.
No parallel translation will be provided.
Registration and Information During the Congress
Delegates are kindly requested to register at the Central Reception located in the Congress venue at the Nalecz Institute
of Biocybernetics and Biomedical Engineering Polish Academy of Sciences, at the beginning of the Congress. Participants
will be able to collect their badge and Congress documentation. Central Reception will be open at the following hours:
th
Wednesday, September 14 , 12:00 - 17:00
th
Thursday, September 15 , 08:00 - 18:00
th
Friday, September 16 , 08:00 - 18:00
th
Saturday, September 17 , 08:00 - 15:00
9
REGISTRATION FEE AND PAYMENT REGULATIONS
Registration Fee
Different categories of registration fee have been available for Congress participants.
Category
ESAO member
ESAO member (reduced fee*)
Senior ESAO member
ESAO non-member
ESAO non-member (reduced fee*)
MSc Student and PhD student**
One-day registration
Accompanying person
Early Bird Fee
th
(before June 15 , 2016)
EURO
350
250
150
400
350
150
150
100
Regular Fee
th
(after June 15 , 2016)
EURO
400
300
200
450
400
200
200
150
50
50
Gala Dinner
*
for participants from Central and Eastern Europe and from low and lower-middle income countries (Gross National Income
per capita less than 4 125 USD),
**
a certificate from university should be provided
Payment Regulations
Payments can be made by bank transfer or by payment card.
Payments are available for registered users only.
Registration can be made using Registration on-line at http://esao2016.ibib.waw.pl
Bank transfer
Bank transfer payment should be made to the following account:
Account owner:
Instytut Biocybernetyki i Inzynierii Biomedycznej im. Macieja Nalecza
Polskiej Akademii Nauk, ul. Ks. Trojdena 4, 02-109 Warszawa, POLAND
Bank:
BGK
IBAN / Account No:
PL07113010170020144708200027
SWIFT:
GOSKPLPW
While paying by bank transfer, please:
ensure that all the bank charges are paid by the participant, make sure that your name appears on the payment,
send the copy of bank transfer receipt to the Congress Secretariat either by e-mail or by fax.
Card payment
Card payment is available using the following Payment Cards: Visa, VisaElectron, Master Card, Master Card Electronic, Maestro.
Online transaction are supported by eCard S.A.
10
OTHER REGULATIONS
Registration fee for participants includes:
Congress Bag, Abstract Book, Congress Badge,
Opening Ceremony and Welcome Reception on September 14 th,
Networking Reception on September 15th,
Admission to all plenary sessions, symposia, poster sessions and exhibition,
Lunches on September 15th and 16th, and Farewell Lunch on September 17th and refreshments during breaks.
Registration fee for accompanying persons includes:
Congress Badge and Admission to the Congress venue,
Opening Ceremony and Welcome Reception on September 14 th,
Networking Reception on September 15th,
th
Lunches on September 15 and 16th, and Farewell Lunch on September 17th and refreshments during breaks.
Receipts and VAT Invoices
Fees listed in the fee table above are inclusive of tax and include VAT where applicable. The Organizer will issue a VAT invoice
for the Buyers, provided that all information of the Buyer needed for issuing of the VAT invoice will be given by the participants
before making the payment (using 'Registration on-line').
Cancellation
Notification of cancellation must be made in writing to the Congress Secretariat.
Cancellation before July 20th, 2016 - a refund of 90% will be made.
Cancellation before August 10th, 2016 - a refund of 50% will be made.
Cancellation after August 20th, 2016 - no refund will be made.
All refunds will be made after the Congress. In case of bank transfer payment, the reimbursement will be transferred directly to
the account that was used to make the payment. In case of card payment, the reimbursement will be transferred directly to the
card payment account.
Returns
RETURNS ARE NOT ACCEPTED due to the nature of the services ordered by the participants.
Processing of the Personal Data
Personal data of participants will be processed by the Nalecz Institute of Biocybernetics and Biomedical Engineering Polish
Academy of Sciences (the Organizers) with its seat in Warsaw (Poland), 02-109, at 4 Księcia Trojdena Street for the purpose of
their participation in XLIII Annual Congress of the European Society for Artificial Organs, including processing of payment of the
registration fees.
Participants acknowledge that they have the right to access and rectify abovementioned personal data, as defined in the Act of
August 29, 1997 on the Protection of Personal Data (Journal of Laws of 2014, item 1182, with amendments).
Submitting personal data is voluntary, but necessary to accomplish participation in the abovementioned Congress.
Warranty Disclaimer
All the best endeavors will be made by Organizers to implement the program of the ESAO 2016 Congress as it will be announced
here. However, no warranty is given whatsoever that the final program will be in full agreement with the announced one. The
Organizers reserve the right to alter or cancel, without prior notice, any of the arrangements, timetables, plans or other items
relating directly or indirectly to the Congress, for any reasons beyond their reasonable control.
11
GENERAL INFORMATION
Passports and Visas
Foreign visitors from outside the European Union must possess a passport valid for at least the next 6 months. Some congress
participants may require visa in order to enter Poland. Please check with your local Polish Consulate or Embassy for details
regarding visa and entry requirements.
Liability
The Congress Secretariat and Organizers cannot accept liability for personal accidents, loss of belongings or damage to private
property of participants, students and accompanying persons, either during or directly arising from the ESAO 2016 Congress.
Participants should make their own arrangements with respect to health, travel and property insurance before they depart from
their country.
Currency and Credit Cards
The currency unit in Poland is the Polish Złoty (zł or PLN) which is subdivided into 100 grosze (gr). The current exchange rate to
Euro and US Dollar can be checked at http://www.oanda.com/converter/classic (choose PLN as the Polish currency code). In
August 2016 it was about 4.35 PLN for 1 EUR. Delegates may change foreign currency and travelers checks at several banks
located in the city center as well as in many exchange bureaus, at the railway station, at the airport or in many others places.
International credit cards are widely accepted in hotels, restaurants, cash machines and shops.
Electricity
Electricity supply is 230 V / 50 Hz.
Climate and Clothing
The weather in September in Warsaw is usually warm and pleasant, however the evenings might be sometimes quite cold. The
average daytime temperature varies from 15 degrees to 18 degrees of Celsius. There is a possibility of rain, so an umbrella, light
raincoat and comfortable shoes are advisable.
Shopping
Most shops (except for food stores) are open from 11:00 until 19:00. Some department stores may open earlier or close later on
weekdays as well as on Saturdays and Sundays.
Polish craftwork is fascinating. Polish souvenirs include glass, hand-woven baskets, paper cut-outs and crystal. One of the most
popular souvenirs is amber from the Baltic Sea. Each individual piece can be fashioned into a pendant, ring, bracelet, or earrings.
Most highly prized is amber with a prehistoric insect preserved inside, though it is a rare find. Poland is also known for its silver
jewellery, which is sometimes combined with amber to create uniquely Polish pieces.
Food
Poles are known for their hospitality and love of food. Polish meals offer a wide selection ranging from fresh game in season to
Baltic herring. Red beet soup or borsch, is well-known, as are Polish sausages (kielbasa) and stuffed cabbage (gołąbki).
Dumplings (pierogi) come stuffed with meat, potatoes, blueberries, or sauerkraut and mushrooms. Bigos is a stew of meat and
sauerkraut, while roast duck comes stuffed with apples. For dessert, try pastries with poppy seeds, or perhaps a Polish donut
filled with preserved fruit (pączek). In the late summer, you can try delectable strawberries, blueberries and cherries.
12
ARRIVALS AND DEPARTURES
By Air
Congress Venue is 5 km away from Warsaw Chopin Airport “Okęcie”. It can be reached from Warsaw Chopin Airport by
taxi (cost 20-40 Polish Złoty) or by bus no. 175 (the bus stop is located in front of the arrivals hall). A bus ticket for 20 min
costs 3.40 Polish Złoty and for 75 min – 4.40 Polish Złoty.
It is advisable to buy a ticket before getting to a bus
because ticket machines are not present in all the buses.
Usually the 20 min ticket is enough if there is no heavy
traffic. You should get off the bus at UNIWERSYTET
MEDYCZNY 02 stop, cross Żwirki i Wigury Street and
walk 600 m to the West along Księcia Trojdena Street.
Congress Venue is the last group of buildings on the
right just at the corner of of Księcia Trojdena Street and
Adolfa Pawińskiego Street.
Bus no. 175 can be also used to get to the center of the
city (75 min ticket is necessary). There is also a railway
connection from Warsaw Chopin Airport “Okęcie” to
Photo: http:// www.lotnisko-chopina.pl
Warsaw Central Railway Station (Warszawa Centralna).
By Rail
Warsaw Central Railway Station (Warszawa
Centralna) is located in the city center at 54
Jerozolimskie Avenue (Aleje Jerozolimskie).
Congress Venue can be reached from Warsaw
Central Railway Station by taxi (cost 2030 Polish Złoty) or by tram no. 9 or 7 in the
West direction to the Ochota district. The tram
stop located in the middle of Aleje
Jerozolimskie can be reached using underpass.
A tram ticket for 20 min costs 3.40 Polish Złoty
Photo: Radek Kołakowski, http://pl.wikipedia.org
and for 75 min – 4.40 Polish Złoty. It is
advisable to buy a ticket before getting to a tram because ticket machines are not present in all the trams. Usually the
20 min ticket is enough if there is no heavy traffic. You should get off the tram at HALE BANACHA 02 stop at the Grójecka
Street and then walk 300 m to the East to the Congress Venue.
By Road
For those traveling from the West, North or South, Warsaw can be
reached by car using A2 highway and then S2 Warsaw beltway. You
should head to the South (towards Kraków), take Aleja Krakowska exit,
turn left onto Krakowska Avenue (Aleja Krakowska) towards city center,
after 5 km turn right onto Dickensa Street, after 300 m turn left onto
Pawińskiego Street, after 300 m turn right onto Księcia Trojdena Street
and then after 100 m turn left into the first gate to the paid parking lot
in front of the Congress Venue.
Photo: Łukasz Jóźwiak, Ministry of Transport,
Construction and Marine Economy
13
CONGRESS MAP
The interactive map is available at: http://esao2016.ibib.waw.pl/index.php?id=17
Congress Venue
OC
NR
Opening Ceremony and Welcome Reception,
September 14th, 19:00 - 22:00
Networking Reception,
September 15th, 18:15-21:00
Gala Dinner,
September 16th, 19:45-22:00
1
The Westin *****
2
Radisson Blu Sobieski Hotel, Warsaw
3
Novotel Warszawa Centrum ****
4
Polonia Palace ****
5
Mercure Warszawa Grand ****
6
Novotel Warszawa Airport ****
7
Ibis Warszawa Reduta ***
8
MDM City Centre ***
9
Metropol ***
10
Campanile**
14
SOCIAL EVENTS
Opening Ceremony and Welcome Reception
Wednesday, September 14th, 2016, 19:00-22:00
Technicians’ Association House of the Head Technical Organization (Warszawski Dom Technika NOT),
3/5 Czackiego Street
The Opening Ceremony and Welcome Reception will take place in the Technicians’ Association House of the Head
Technical Organization. The Technicians’ Association was founded in Warsaw in 1898, and the construction of its
Czackiego Street office started in 1903, and was designed
by Jan Fijałkowski. The neo-baroque building was given its appearance
partly due to the facade sculptures by Zygmund Otto. The figures are
of Daedalus, Icarus and Archimedes, and a woman of radium rays, who
symbolizes the past and the future. Perched on a cartouche, she is
supported by seated figures of women, bearing the inscription ‘Artibus
Technicis MXMIV’. Inside the stairwell there was an ornate ceiling,
showing people going
through the fire of
revolution and headed
toward a better future.
Text and photos: http://www.warsawtour.pl
Between 1913-1914 a wing
was added to the building, and during World War I, the main halls were
opened for use by the hospital. As a result of World War II, Tech House
was burned; though the bearing walls were preserved and part of the main
staircase survived, the rich interior and stucco did not survive the war. The
restored building was opened in 1949.
Currently, it houses many groups, and acts as the headquarters for
Text and photos: http://www.warsawtour.pl
the Head Technical Organization.
The scientific program of the Opening Ceremony is outlined in the Congress Program – Overview. To make the beginning
of the Congress more attractive and memorable the scientific content of the ceremony will be complemented with
the artistic one.
During the Opening Ceremony, Agnieszka Flis (Agnes Violin) will perform .
Agnieszka Flis (Agnes Violin) is a violinist, precursor and performer of spectacular music
shows, where she plays the diamond violin. Keeping abreast of the times Agnes Violin has
focused on fusion of her classical skills as a violinist and the latest world trends of creating
artistic sensations. After graduating from the Academy of Music in Łódź she was linked
to the Łódź Philharmonic and a few ensembles. However, continuously searching for
possibilities of new music interpretation she had chosen a solo carrier. Agnes Violin has
played concerts in United States, Canada, Japan, China and many other countries gaining
rich stage experience. In Poland, she has partnered a few well known artists.
Agnes Violin is a versatile musician, who can perform different musical styles, starting with
classical music, through jazz, folk and ending with improvisation and club music. Show on the
Diamond Electric Violin is composed of very dynamic, original, masterly and diversified
arrangements of pop, musical and movie tunes.
Photo: http://agnes-violin.muzzo.pl
15
SOCIAL EVENTS
Networking Reception
Thursday, September 15th, 2016, 18:15-20:30
Exhibition Hall at the Congress Venue, 4 Księcia Trojdena Street
After the completion of the scientific sessions of the first
day of the Congress all participants are invited to gather in
the Exhibition Hall (Lunch Area). During the Networking
Reception you will have the possibility to mingle with other
congress participants, meet old friends and make new
contacts in an informal atmosphere.
Snacks and drinks will be served to make the evening more
enjoyable and to facilitate the exchange of views. Among
other delicacies, you will have the opportunity to taste
famous Polish potato pancakes, which will be prepared right
before your eyes, and to try different types of Polish beers.
This event is free of charge for all registered congress participants and accompanying persons.
16
SOCIAL EVENTS
Gala Dinner
Friday, September 16th, 2016, 19:45-22:00
Lecture Hall at the Central Agricultural Library (Centralna Biblioteka Rolnicza),
66 Krakowskie Przedmieście Street
The building of the Central Agricultural Library is located in
the heart of Warsaw, just 100 m from the Royal Castle. It was
founded in 1454 as a monastery. During the "Swedish
Deluge" a monastery was burned. After the expulsion of the
Swedes monastery was rebuilt and decorated in the baroque
style. Secular functions monastery building dates back to the
first years after the partition of Poland in 1772. First, the
Prussians dedicate part of the monastery at the guardhouse.
During the stay of Napoleon monastery served as a military
hospital. The monastery was then close to ruin. Once again
became a place of public events during the January Uprising
Text and photo: http://www.cbr.edu.pl
in 1863 that gave rise to the liquidation of the monastery
in 1865. The owner of the buildings post-monastery has become the Museum of Industry and Agriculture, which was
founded in Warsaw in 1875.
After the First World War, the museum lost some
importance but it has been developing further. In 1939,
during the bombing of Warsaw Museum building, along
with the collection was destroyed. Rebuilt after the war,
in 1955, it was intended for the Central Agricultural
Library. It is a scientific library of the Ministry of
Agriculture and Rural Development. It collects literature
in the field of agricultural science, horticulture, animal
husbandry, fisheries, veterinary medicine, food industry,
agricultural technology, environmental protection,
forestry, politics and economics of agriculture and related
sciences. Book Library - has about 380 thousand ox.
Photo: http://cateringamfitrion.blogspot.com
th
Publications. In 2005, the Library celebrated its 50
anniversary.
During the Gala Dinner a show of a Polish Folk Song and
Dance Ensemble Polski Łan will take place. Polski Łan was
formed by Zbigniew Jasiński in 2005 with professional
dancers and musicians who have contributing to the high
artistic quality of the ensemble and its continuous
development.
Polski Łan has in its repertoire brilliantly executed Polish
national dances: krakowiak, mazurek, oberek, polonaise,
kujawiak as well as folk dances and songs from different
regions of the country. Original and beautiful costumes and a
music band playing traditional folk instruments emphasize
the character of the performed songs and dances.
Choreography and music arrangements result from
Text and photo: http://www.polskilan.pl
collaboration with renowned artists who have been
associated with this genre of art for a long time.
Dancing, singing, games and competitions with the audience will carry the spectators into a colorful and joyful world
of Polish folklore.
17
The event is co-sponsored by the International Centre of Biocybernetics
18
SCIENTIFIC PROGRAM – OVERVIEW
19
20
21
22
FLOOR PLAN OF THE CONGRESS VENUE
3
1
5
7
4
2
6
Exhibition Legend
1.
3.
5.
7.
HeartWare
Fresenius Medical Care
Berlin Heart
Wichtig
2.
4.
6.
Infomed
em-tec
3M
23
PLENARY LECTURES, SPECIAL SYMPOSIA
AND ORAL SESSIONS
WEDNESDAY, September 14th
THURSDAY, September 15th
Plenary Lecture 1
Opening Ceremony Hall
Oral Session OS1
Blood Pump Development
O1-O6
Chairmen:
Lecture Hall A
Thomas GROTH, Halle, Germany,
Piotr LADYZYNSKI, Warsaw, Poland
19:30 PL1 IN THE SEARCH OF SUPPORT OF DISEASED HEART
Suwalski P
Clinic of Cardiac Surgery, Central Clinical Hospital
of the Ministry of Interior and Administration in Warsaw,
Warsaw, Poland
Chairmen:
Graham FOSTER, Swansea, UK,
Ulrich STEINSEIFER, Aachen, Germany
8:30 O1
MINIATURIZATION AND OPTIMIZATION OF A
VENTRICULAR ASSIST DEVICE
Hallier S1, Torner B1, Wisniewski A2, Müller J2, Peter N2,
Wurm F1
1
Institute of Turbomachines, University of Rostock,
Rostock, Germany; 2 Berlin Heart GmbH, Berlin, Germany
8:45 O2
DESIGN CHANGES OF THE VENTRICULAR ASSIST DEVICE
SPUTNIK
Selishchev S, Telyshev D
Biomedical systems, National Research University
of Electronic Technology, Moscow, Russian Federation
9:00 O3
CURRENT AND SPEED RESPONSE OF THE HVAD IN SINGLE
AND DUAL STATOR CONFIGURATION
Maw M1, Aigner P2, Schima H3, Moscato F1
1
Center for Medical Physics and Biomedical Engineering,
Medical University of Vienna, Vienna, Austria; 2 LudwigBoltzmann-Cluster for Cardiovascular Research, Vienna,
Austria; 3 Department of Cardiac Surgery, Medical
University of Vienna, Vienna, Austria
9:15 O4
INVESTIGATION OF THE PERMANENT MAGNETIC
BEARINGS FOR RELIGA HEART ROT CENTRIFUGAL BLOOD
PUMP
Altyntsev I, Kurtyka P, Darłak M, Kustosz R
Artificial Heart Laboratory, Zbigniew Religa Foundation for
Cardiac Surgery Development, Zabrze, Poland
9:30 O5
BENCHMARK OF CENTRIFUGAL IMPELLER DESIGNS USING
COMPUTATIONAL FLUID DYNAMICS: CLINICAL VAD VS.
INDUSTRIAL PUMP
Boës S1, Wiegmann L2, Ochsner G1, de Zélicourt D2,
Meboldt M1, Kurtcuoglu V2,3, Schmid Daners M1
1
Product Development Group Zurich, Department
of Mechanical and Process Engineering, ETH Zurich, Zurich,
Switzerland; 2 The Interface Group, Institute of Physiology,
University of Zurich, Zurich, Switzerland; 3 Zurich Center for
Integrative Human Physiology, University of Zurich, Zurich,
Switzerland
9:45 O6
TIME RESOLVED 3D-VELOCITY MEASUREMENTS IN A
SCALED UP HEARTMATE II BLOOD PUMP MODEL
Schuele C, Menzen C, Affeld K, Kertzscher U
Biofluid Mechanics Laboratory, Charite Universitaetsmedizin Berlin, Berlin, Germany
24
Plenary Lectures, Special Symposia and Oral Sessions
Thursday, September 15
Oral Session OS2
Vascular Access and New Perspectives
O7-O12
Oral Session OS3
Biomaterials Synthesis and Characterization
O13-O18
Lecture Hall B
Lecture Hall C
Chairmen:
Chairman:
Andrea REMUZZI, Milan, Italy,
Krzysztof JOZWIK, Lodz, Poland
8:30 O7
COMPUTER SIMULATION OF THE ARTERIOVENOUS
FISTULA MATURATION
Jodko D, Obidowski D, Reorowicz P, Jozwik K
Institute of Turbomachinery, Lodz University
of Technology, Lodz, Poland
8:45 O8
INFLUENCE OF THE ARTERIAL NEEDLE DIRECTION ON
ACCESS FLOW MEASUREMENT
Lopot F, Vermirovska J, Svara F, Polakovic V
Department of Medicine, General University Hospital,
Praha, Czech Republic
9:00 O9
CLINICAL USE OF AVF.SIM SYSTEM FOR SURGICAL
PLANNING OF ARTERIOVENOUS FISTULA FOR
HEMODIALYSIS
Bozzetto M1, Rota S2, Vigo V3, Casucci F3, Lomonte C3,
Morale W4, Senatore M5, Tazza L6, Lodi M7, Remuzzi G2,
Remuzzi A1
1
Bioengineering Department, IRCSS - Istituto di Ricerche
Farmacologiche Mario Negri, Bergamo, Italy; 2 Unit of
Nephrology and Dialysis, ASST Papa Giovanni XXIII,
Bergamo, Italy; 3 Unit of Nephrology and Dialysis, Ente
Ecclesiastico Ospedale F. Miulli, Acquaviva delle Fonti (BA),
Fonti, Italy; 4 Unit of Nephrology and Dialysis, A.O.
Cannizzaro, Catania, Italy; 5 Unit of Nephrology and
Dialysis, Ospedale Annunziata, Cosenza, Italy; 6
Department of Urology and Nephrology, Catholic
University, Rome, Italy; 7 Unit of Nephrology and Dialysis,
Ospedale Santo Spirito, Pescara, Italy
9:15 O10 HEALTH RELATED QUALITY OF LIFE IN HEMODIALYSIS
PATIENTS WITH DIFFERENT NUMBER OF PREVIOUS
ARTERIO-VENOUS FISTULA THROMBOSIS
Gelev S, Gerasimovska V, Dejanov P, Selim G, Dzekova P,
Trajceska L, Sikole A
Department of Nephrology, University Clinic, Skopje,
The Former Yugoslav Republic of Macedonia
9:30 O11 CHANGING PERSPECTIVES IN EXTRACORPOREAL
TREATMENTS – FROM PASSIVE MACHINE MONITORING
TO ACTIVE PHYSIOLOGIC PATIENT DATA
Kleinekofort W
Department of Engineering, RheinMain University
of Applied Sciences, Wiesbaden, Germany
9:45 O12 CHALLENGE TO THE NEXT STAGE OF ARTIFICIAL KIDNEY
Matsuda K1, Moriguchi T1, Yamane T2, Kokubo K3,
Yamamoto K4
1
Emergency and Critical Care Medicine, University
of Yamanashi School of Medicine, Yamanashi, Japan;
2
Mechanical Engineering, School of Engineering, Kobe
University, Kobe, Japan; 3 Medical Engineering and
Technology, Kitasato University School of Allied Health
Sciences, Kanagawa, Japan; 4 Medical Engineering,
Kawasaki University of Medical Welfare, Kurashiki, Japan
th
Gloria GALLEGO-FERRER, Valencia, Spain,
Andrzej CHWOJNOWSKI, Warsaw, Poland
8:30 O13 DIAMOND-LIKE-CARBON COATING FOR EXTENDED
POLYTETRAFLUOROEHYLENE: POTENTIAL FOR
EXPANSINO OF APPLICATION TO THE MEDICAL FIELD.
Fujii Y1, Oozawa S1, Osaka D1, Nakatani T2, Uchida H3,
Sano S1
1
Cardiovascular Surgery, Okayama University Graduate
School of Medicine, Dentistry, and Pharmaceutical
Sciences, Okayama, Japan; 2 Research Institute
of Technology, Okayama University of Science, Okayama,
Japan; 3 Department of Chronic Kidney Disease and
Cardiovascular Disease, Okayama University Graduate
School of Medicine, Dentistry, and Pharmaceutical
Sciences, Okayama, Japan
8:45 O14 CARDIOVASCULAR SCAFFOLDS FABRICATED FROM
BLOOD PROTEIN SOLUTIONS VIA ELECTROSPINNING
Mueller M1, Dreyer L1, Repanas A1, Krolitzki B1, Knigge S1,
Wang I2, Pfeiffer D2, Glasmacher B1
1
Institute for Multiphase Processes, Leibniz Universität
Hannover, Hannover, Germany; 2 Institute for Cell Biology,
Histology and Embryology, Medical University Graz, Graz,
Austria
9:00 O15 REDUCING WATER TRANSMISSION OF DYNAMICALLY
LOADED POLYURETHANE BY MULTILAYER BARRIER
COATINGS APPLIED BY PLASMA-ENHANCED CHEMICAL
VAPOR DEPOSITION (PECVD)
Lierath C
Deptartment of Cardiovascular Engineering, Institute of
Applied Medical Engineering, RWTH Aachen University,
Aachen, Germany
9:15 O16 LIFETIME PREDICTION FOR THE DESIGN OF A NEW
POLYMERIC HEART VALVE PROSTHESIS
Serrani M1, Brubert J1, Stasiak J1, De Gaetano F2,
Costantino M2, Moggridge G1
1
Department of Chemical Engineering and Biotechnology,
University of Cambridge, Cambridge, UK; 2 Department of
Chemistry, Materials and Chemical Engineering,
Politecnico di Milano, Milano, Italy
9:30 O17 CLOSER LOOK INTO EXPERIMENTAL SET-UPS OF THE
HIGHLY COMPLEX MAGNESIUM DEGRADATION
Knigge S, Evertz F, Glasmacher B
Hannover, Hannover, Germany
9:45 O18 IN VIVO BIOCOMATIBILITY STUDY OF AN INNOVATIVE
ELASTOMER FOR LONG TERM IMPLANTS APPLICATION
Zawidlak-Węgrzyńska B1, Ścigała P2, Janiczak K1,
Gawlikowski M1, Cieśla P1, Kustosz R1, Gonsior M1,
El Fray M3, Piegat A3
1
Artificial Heart Laboratory, Zbigniew Religa Foundation
for Cardiac Surgery Development, Zabrze, Poland;
2
Emergency and Specialty Animal Medical Center, Piekary
Slaskie, Poland; 3 Polymer Institute, Biomaterials and
Microbiology Technologies Dept., West Pomerania
University of Technology, Szczecin, Poland
25
Oral Session OS4
Tissue Engineering. Bone and cartilage, O19-O24
Lecture Hall D
Chairmen:
Dorota LEWINSKA, Warsaw, Poland,
Gerardo CATAPANO, Rende, Italy
th
Plenary Lecture 2
Lecture Hall A
Chairman:
Horst KLINKMANN, Rostock, Germany
10:10 PL2 LESSONS LEARNT FROM THREE DECADES OF
BIOCOMPATIBILITY RESEARCH
8:30 O19 2D TRANSPORT MODEL OF rPBBs FOR BONE TE PREDICTS
THAT RADIAL FLUX UNIFORMITY CONTROLS O2
DISTRIBUTION IN CELL ACTIVITY-DEPENDENT FASHION
Donato D1, Falvo D'Urso Labate G2, Debbaut C1, Segers P1,
Catapano G2
1
IbiTech-BioMMeda, Ghent University, Ghent, Belgium;
2
Department of Environmental and Chemical Engineering,
University of Calabria, Rende, Cosenza, Italy
Vienken J
Usingen, Germany
8:45 O20 TIME EVOLUTION OF OXYGEN CONCENTRATION PROFILES
AS CELLS GROW AND DIFFERENTIATE IN rPBBs FOR BONE
TE FROM A 3D TRANSIENT TRANSPORT MODEL
Falvo DUrso Labate G1, Torchia F1, Debbaut C2, Segers P2,
Catapano G1
1
University of Calabria, Rende, Cosenza, Italy; 2 IbiTech BioMMeda, Ghent University, Ghent, Belgium
9:00 O21 OSTEOGENIC DIFFERENTIATION OF RAT BONE MARROW
STROMAL CELLS ENCAPSULATED INTO
PHOTOCROSSLINKED COLLAGEN-LIKE POLYPEPTIDE
HYDROGELS
Nurlidar F, Yamane K, Kobayashi M, Terada K, Ando T,
Tanihara M
Materials Science, Nara Institute of Science
and Technology, Nara, Japan
9:15 O22 BONE TISSUE ENGINEERING WITH
POLYCAPROLACTONE/HYDROXYAPATITE BIOMIMETIC
SCAFFOLDS
Garcia Garcia A1, Schlatter G2, Anne H2, Egles C1, Bedou F3,
Legallais C1
1
BMBI UMR 7338, Université de Technologie
de Compiègne, Compiègne, France; 2 UMR 7515 ICEPEES,
Université de Strasbourg, Strasbourg, France; 3 UMR 7337
Laboratoire Roberval, Université de Technologie
de Compiègne, Compiègne, France
9:30 O23 MACROPOROUS PLA CONSTRUCT SUPPORTING THE
OSTEOINDUCTIVE POROUS CHITOSAN-HYDROXYAPATITE
HYDROGEL FOR BONE TISSUE ENGINEERING
Rogina A1, Pribolšan L2, Gómez-Estrada L3, Gallego
Ferrer G4, Marijanović I2, Ivanković M1, Ivanković H1
1
Faculty of Chemical Engineering and Technology,
University of Zagreb, Zagreb, Croatia; 2 Faculty of Science,
University of Zagreb, Zagreb, Croatia; 3 Ikasia Technologies
SL, c/Zamora 2, 46100 Burjassot, Valencia, Spain; 4 Center
for Biomaterials and Tissue Engineering (CBIT), Universitat
Politècnica de València, Valencia, Spain
9:45 O24 BIODEGRADABLE MICROSPHERES FOR ARTICULAR
CARTILAGE REGENERATION
Sancho-Tello M1, Milián L1, Zurriaga J2, Forriol F3, Martín de
Llano J1, Mínguez M4, Carda C1
1
Departamento Patología, Universidad de Valencia;
INCLIVA, Instituto Investigación Sanitaria Hospital Clínico
Universitario de Valencia, Valencia, Spain; 2 Servicio
Traumatología, Hospital Clínico Universitario de Valencia,
Valencia, Spain; 3 Servicio Traumatología, Hospital Clínico
Universitario de Valencia; ERESA, Valencia, Spain; 4 Servicio
Traumatología, Hospital Clínico Universitario de Valencia;
Universitario de Valencia, Valencia, Spain
Oral Session OS5
Blood Trauma in VADs
O25-O30
Lecture Hall A
Chairmen:
Heinrich SCHIMA, Vienna, Austria,
Leonid GOUBERGRITS, Berlin, Germany
11:00 O25 CHARACTERIZATION OF BLOOD DAMAGE UNDER
DYNAMIC AND STATIC CONDITIONS USING MULTIPLE
HEMOLYSIS MARKERS
Wiegmann L1, de Zélicourt D1, Speer O2, Kurtcuoglu V3
1
The Interface Group, Institute of Physiology, University
of Zurich, Zurich, Switzerland; 2 Erythrocyte laboratory,
University Children's Hospital Zurich, Zurich, Switzerland;
3
The Interface Group, Institute of Physiology and Zurich
Center for Integrative Human Physiology, University
of Zurich, Zurich, Switzerland
11:15 O26 THE INFLUENCE OF OPERATING CONDITIONS ON THE
FLOW FIELD IN A ROTARY BLOOD PUMP
Thamsen B, Gaebler J, Affeld K, Kertzscher U
11:30 O27 ABILITIES OF ULTRASONIC METHODS APPLICATION TO
MICRO-EMBOLUS DETECTION IN MECHANICAL HEART
SUPPORTING SYSTEMS
Gawlikowski M1, Lewandowski M2, Jaworek M1
1
2
Institute of Fundamental Technological Research,
Polish Academy of Sciences, Warsaw, Poland
11:45 O28 INFLUENCE OF A THROTTLE IN HEMOLYSIS TESTS OF
ROTARY BLOOD PUMPS
Affeld K, Lommel M, Rekus M, Thamsen B, Kertzscher U
26
12:00 O29 INCIDENCE AND RISK FACTOR OF GI BLEEDING AMONG
PATIENTS SUPPORTED WITH CONTINUOUS FLOW LEFT
VENTRICULAR ASSIST DEVICE (CF-LVAD)
Miyamoto T, Nishinaka T, Umehara N, Ichihara Y,
Tateishi M, Komagamine M, Katsube T, Saito S,
Yamazak K
Cardiovascular surgery, Tokyo Womens Medical
University, Tokyo, Japan
12:15 O30 INCIDENCE OF NON-SURGICAL BLEEDINGS DECREASES
OVER TIME AFTER CONTINUOUS FLOW LVAD
IMPLANTATION
Jacobs S, Rega F, Meyns B
Cardiac Surgery, KU Leuven, Leuven, Belgium
Special Symposium SP1
BIOART Initial Training Network: Training Network
for Developing Innovative (Bio)artificial Devices
for Treatment of Kidney and Liver Disease
IL1-IL6
Lecture Hall B
Organizer & Chairman: Dimitrios STAMATIALIS, Twente,
The Netherlands
11:00 IL1
Introduction of the BIOART Initial Training Network
Stamatialis D
Department of Biomaterials Science and Technology,
University of Twente, Enschede, The Netherlands
11:05 IL2
Novel membranes for blood puritification
Stamatialis D
University of Twente, Enschede, The Netherlands
11:20 IL3
Microencapsulation of hepatic spheroids for bioartificial
liver application
Legallais C
BMBI UMR 7338, Université de Technologie
de Compiègne, Compiègne, France
11:35 IL4
11:50 IL5
12:05 IL6
12:20
The immunogenic response of conditionally immortalized
renal proximal tubule epithelial cells for use in
bioartificial kidney
Mihajlovic M
Utrecht University, Utrecht, The Netherlands
MASS AND MOMENTUM TRANSPORT IN PERFUSION
BIOREACTORS FOR 3D LIVER CELL CULTURES: A
MODELING APPROACH
Khakpour S
Institute on Membrane Technology, National Research
Council of Italy,Rende, Italy
AN INNOVATIVE WAY OF USING PLURIPOTENT STEM
CELLS AS SOURCE FOR FUNCTIONAL HUMAN
HEPATOCYTE LIKE CELLS: FIRST STEP TOWARDS A LIVER
MODEL
Strusi V
eXcorLab GmbH, Obernburg, Germany
QUESTIONS & ANSWERS – Plenary discussion with all
speakers
th
Biodegradable Polymeric Scaffolds for Advanced Tissue
Engineering Concepts
KL1, IL7-IL9
Lecture Hall C
Organizer & Chairman: Nuno M. NEVES, Guimarães, Portugal
11:00 KL1
FUNCTIONAL NANOFIBROUS SCAFFOLDS COMBINED
(O31) WITH STEM CELLS FOR ADVANCED BIOMEDICAL
DEVICES AND THERAPIES
Neves NM
1,2
1
3B’s Research Group - Biomaterials, Biodegradables and
Biomimetics, University of Minho, Headquarters of the
European Institute of Excellence on Tissue Engineering
and Regenerative Medicine, Guimarães, Portugal;
2
ICVS/3B’s, PT Government, Guimarães, Portugal
11:30 IL7
BIO-INSPIRED INJECTABLE HYDROGELS AS IN SITU
(O32) FORMING BIODEGRABLE SCAFFOLDS
Gallego-Ferrer G
Centre for Biomaterials and Tissue Engineering,
Universitat Politecnica de Valencia, Valencia, Spain
11:50 IL8
SILK FIBROIN-BASED HYDROGELS AS INSTRUCTIVE
(O33) BIOLOGICAL MILIEU
Motta A1,2
1
Department of Industrial Engineering and BIOtech
Research Centre, University of Trento, Trento, Italy;
2
European Institute of Excellence on Tissue Engineering
and Regenerative Medicine, Trento, Italy
12:10 IL9
BIOMIMETIC SURFACE MODIFICATIONS FOR TISSUE
(O34) ENGINEERING APPLICATIONS
Groth T, Koewitsch A, Zhao M, Yang Y, Esmaeilzadeh P
Biomedical Materials Group, Institute of Pharmacy,
Martin Luther University Halle-Wittenberg, Halle (Saale),
Germany
Artificial Support of the Failing Liver: What’s Next?
KL2, IL10-IL13
Lecture Hall D
Organizer & Chairman: Jacek ROZGA, Warsaw, Poland
11:00 KL2 LIVER SUPPORT WITH THE MARS SYSTEM – CURRENT
STATUS
Mitzner S
Department of Nephrology, University of Rostock, Rostock,
Germany
11:30 IL10 HUMANIZED SPHEROID RESERVOIR BIOARTIFICIAL LIVER
Nyberg S
William J. von Liebeg Center for Transplantation and
Clinical Regeneration, Mayo Clinic,Rochester, USA
11:50 IL11 SLOWING DOWN MULTIORGAN FAILURE COMBINED
WITH ACCELERATION OF LIVER REGENERATION IS KEY TO
LIVER SUPPORT
Stange J
Department of Internal Medicine, University of Rostock,
Rostock, Germany
27
12:10 IL12 OPAL: A NEW OPTION FOR ALBUMIN DIALYSIS
Schmidt H
Department for Transplantation Medicine, University
Hospital Münster, Münster,Germany
12:30 IL13 ALBUMIN APHERESIS – A NOVEL APPROACH TO BLOOD
PURIFICATION AND TREATMENT OF SYSTEMIC
INFLAMMATION
Rozga J
Department of Surgical and Transplantation Nursing,
Warsaw Medical University, Warsaw, Poland
12:50
DISCUSSION
IFAO Meeting
IF1-IF3
th
14:20 IL15 CONTINUOUS NONINVASIVE MONITORING OF THE
CARDIOVASCULAR PERFORMANCE IN DAILY ROUTINE
AND EXERCISE
Moscato F
Medical University Vienna, Vienna, Austria
14:40 IL16 SURGICAL APPROACHES WITH THE HVAD PUMP
Zimpfer D
Department for Cardiothoracic Surgery, Medical University
Vienna, Vienna, Austria
15:00 IL17 EXPERIENCE WITH CONTINUOS FLOW PUMPS AS
A TREATMENT FOR END STAGE HEART FAILURE PATIENTS
Pacholewicz J
Silesian Center for Heart Diseases, Zabrze, Poland
15:20
DISCUSSION
Lecture Hall A
Chairman: Bernd STEGMAYR, Umea, Sweden
13:15 IF1
13:30 IF2
13:45 IF3
DEVELOPMENT OF VARIOUS AUTOLOGOUS
BIOPROSTHETIC GRAFTS WITH A UNIQUE IN-BODY TISSUE
ENGINEERING
Takewa Y
National Cerebral and Cardiovascular Center, Osaka, Japan
WHY IS SURVIVAL ON HEMODIALYSIS DIFFERENT IN
JAPAN, EUROPE AND USA? PLAUSIBLE OPTIONS
Stegmayr B
Internal Medicine, Div. Nephrology, Medicine Centre,
University Hospital of Northern Sweden, Umea, Sweden
HEMODIALYSIS IN JAPAN
Matsuda K
University Yamanashi School of Medicine, Yamanashi,
Japan
Kick-off Meeting of Bioartificial Organs
ESAO Working Group
Lecture Hall B
Chairman:
Dimitrios STAMATIALIS, Twente, The Netherlands
12:30 - 13:15 PROGRAM TBA DURING THE CONGRESS
Larger Uremic Toxins: Clinical Relevance and Dialytic Strategies
for Removal, KL3, IL18-IL20
Lecture Hall B
Organizer & Chairman: Bengt LINDHOLM, Stockholm, Sweden
14:00 KL3 TARGETING LARGE UREMIC TOXINS
Eloot S
Nephrology, Ghent University Hospital, Ghent, Belgium
14:30 IL18 HIGH CUT OFF MEMBRANES FOR HEMODIALYSIS
Girndt M
Department of Internal Medicine II, Martin-LutherUniversity Halle-Wittenberg, Halle, Germany
14:45 IL19 LARGE SOLUTE REMOVAL WITH HEMODIAFILTRATION
AND HEMOFILTRATION
Argiles A
RD - Néphrologie, Montpellier, France
15:00 IL20 REMOVAL OF LARGE SOLUTES BY PERITONEAL DIALYSIS
Waniewski J
Nalecz Institute of Biocybernetics and Biomedical
Engineering, Polish Academy of Sciences, Warsaw, Poland
15:15
DISCUSSION
10 years HeartWare HVAD: “What we Learned, What We Plan”
Symposium sponsored by HeartWare
IL14-IL17
Biomimetic Devices for Tissue and Organ Regeneration
Lecture Hall A
Lecture Hall C
Chairmen:
Organizers & Chairmen:
Heinrich SCHIMA, Vienna, Austria
14:00 IL14 HVAD - ITS ASSETS AND FURTHER ENHANCEMENTS
Brown M
HeartWare Inc, Miami, USA
Symposium Co-sponsored by the Internatinal Centre of Biocybernetics
KL4, IL21, IL22, O38, O39
João F. MANO, Aveiro, Portugal,
Thomas GROTH, Halle, Germany
14:00 KL4
OPEN AND CLOSED POLYMERIC THREE-DIMENSIONAL
(O35) STRUCTURES FOR TISSUE ENGINEERING
Mano JF
Department of Chemistry. CICECO, University of Aveiro,
Aveiro, Portugal
28
14:25 IL21 LIVING BIOINTERFACES BASED ON NON-PATHOGENIC
(O36) BACTERIA TO HARNESS STEM CELL BEHAVIOUR
Salmeron-Sanchez M
Division of Biomedical Engineering, School
of Engineering, University of Glasgow, Glasgow, UK
Presentations IL21 (O36) and O39 will be delivered as one
lecture by Dr. Marco Cantini from Biomedical Engineering
Research Division School of Engineering,
University of Glasgow.
14:40 O39
MATERIAL-DRIVEN FIBRONECTIN NANONETWORKS
PROMOTE MAINTENANCE OF MESENCHYMAL STEM
CELL PHENOTYPES
Rico P1, Mnatsakanyan H2, Salmerón-Sánchez M3
1
Centre for Biomaterials and Tissue Engineering,
Universidad Politecnica de Valencia. Biomedical Research
Networking Center in Bioengineering, Biomaterials and
Nanomedicine, Valencia, Spain; 2 Centre for Biomaterials
and Tissue Engineering, Universitat Politècnica de
València, Valencia, Spain; 3 Division of Biomedical
Engineering, School of Engineering, University of
Glasgow, Glasgow, UK
14:55 IL22 FAST-DEGRADATION HYDROPHILIC-HYDROPHOBIC
(O37) ENVIRONMENTS FOR CELL TRANSPLANTATION
Gámiz-González MA1, Guldris P1, Antolinos Turpín CM2,
Ródenas Rochina J1, Vidaurrea A2, Gómez Ribelles JL1
1
Center for Biomaterials and Tissue Engineering (CBIT),
Universitat Politècnica de València, Cno. de Vera s/n,
46022, Valencia, Spain; 2 Networking Research Center on
Bioengineering, Biomaterials and Nanomedicine (CIBERBBN), Valencia, Spain
15:15 O38
ENHANCEMENT OF ENDOTHELIAL CELL ADHESION ON
EPTFE SUBSTRATE BY THE IMMOBILIZATION OF
FIBRONECTIN-DERIVED PEPTIDE VIA SINGLE-STEP TYR
OXIDATION
Kakinoki S1, Suzuki S1, Nishioka S1, Yamaoka T2, Hirano Y1
1
Faculty of Chemistry, Materials and Bioengineering,
Department of Chemistry and Materials Engineering,
Kansai University, Osaka, Japan; 2 Department of
Biomedical Engineering, National Cerebral and
Cardiovascular Center Research Institute, Osaka, Japan
ALBUMIN - an Old Molecule with New Insights
IL23-IL26
Lecture Hall D
Organizers and Chairmen:
Ulrich BAURMEISTER, Wuppertal,
Jörg VIENKEN, Usingen, Germany
14:00 IL23 PROPERTIES AND ANALYSIS OF FUNCTIONAL
(O40) CHARACTERISTICS OF HUMAN SERUM ALBUMIN
Schnurr K, Waterstradt K
MedInnovation GmbH, Berlin, Germany
14:20 IL24 MEASURING DEVICE FOR THE NON-INVASIVE
(O41) DETERMINATION OF BILIRUBIN DURING
EXTRACORPOREAL LIVER SUPPORT THERAPY
Preussiger M1, Tyczynski B2, Kribben A2, Jost U3,
Jungmann H1
1
MBR Optical Systems GmbH & Co. KG, Wuppertal,
Germany; 2 Universität Duisburg-Essen, Wuppertal, Klinik
für Nephrologie, Essen, Germany; 3 HepaNet GmbH,
Hannover, Germany
th
14:40 IL25 THE ALBUMIN BINDING CAPACITY (ABIC): BIOMARKER
(O42) OR THERAPEUTIC TARGET?
Mitzner S1,2, Stange J1, Klammt S2,3
1
Division of Nephrology, Department of Medicine,
University of Rostock, Rostock, Germany; 2 Fraunhofer
Project Group EXIM, Rostock, Germany; 3 Charité
Research Organisation (CRO), Berlin, Germany
15:00 IL26 ALBUMIN IS HERE TO STAY...OR TO BE REMOVED: STILL
(O43) OPEN QUESTIONS
Vienken J1, Baurmeister U2
1
Usingen, Germany; 2 Wuppertal, Germany
15:20
DISCUSSION
Oral Session OS6
Cardiovascular Implants for Children
O44-O48
Lecture Hall A
Chairmen:
Bart MEYNS, Leuven, Belgium,
Daniel ZIMPFER, Vienna, Austria
16:30 O44 THE NEW POLISH PEDIATRIC VAD FAMILY DEVELOPMENT
AND PRE-CLINICAL STUDIES
Kustosz R1, Gonsior M1, Ścigała P2, Czingon M3, Kapis A1,
Pacholewicz J4, Kubacki K4, Gawlikowski M1, Bujok W1,
Głowacki M1, Janiczak K1, Cieśla P1, ZawidlakWęgrzyńska B1
1
for Cardiac Surgery Development, Zabrze, Poland; 2 Clinic
for Animals Piotr Ścigała, Piekary Slaskie, Poland; 3 Clinic
for Animals Michał Czingon, Zabrze, Poland; 4 Silesian
Center for Heart Diseases, Zabrze, Poland
16:45 O45 A NOVEL TEST BENCH TO SIMULATE THE INTERACTION OF
VAD WITH THE FAILING SUPERIOR CAVO-PULMONARY
CONNECTION
De Gaetano F1, Griselli M2, Soos P3, Costantino M1
1
Department of Chemistry, Materials and Chemical
Engineering, Politecnico di Milano, Milano, Italy;
2
Department of Cardiac Surgery, King Faisal Specialist
Hospital and Research Centre, Riyadh, Saudi Arabia;
3
Berlin Heart GmbH, Berlin, Germany
17:00 O46 OFF-LABEL USE OF STRETCHABLE
POLYTETRAFLUOROETHYLENE: OVEREXPANSION OF
SYNTHETIC SHUNTS
Verbelen T1, Famaey N2, Gewillig M3, Rega F1, Meyns B1
1
Cardiac Surgery, University Hospitals Leuven, Leuven,
Belgium; 2 Mechanical Engineering, KU Leuven, Leuven,
Belgium; 3 Pediatric Cardiology, University Hospitals
Leuven, Leuven, Belgium
17:15 O47 OBSTRUCTED MECHANICAL VALVE IN MITRAL POSITION
IN SMALL CHILDREN : PROSTHETIC MANAGEMENT
STRATEGIES
Chan-Dominy A1, Krupickova S2, Ghez O3, Michielon G3,
Burmester M1, Casanueva L1, Fraisse A2
1
Paediatric Intensive Care Unit, Royal Brompton &
Harefield NHS Foundation Trust, London, UK; 2 Paediatric
Cardiology, Royal Brompton & Harefield NHS Foundation
Trust, London, UK; 3 Paediatric and Congenital Heart
Surgery, Royal Brompton & Harefield NHS Foundation
Trust, London, UK
29
17:30 O48 TREND OF ECHOCARDIOGRAPHIC AND ENERGETIC
PARAMETERS IN LVAD PEDIATRIC PATIENTS
Di Molfetta A1, Iacobelli R2, Ferrari G3, Filippelli S1, Trivella
M4, Amodeo A1
1
Department of Pediatric Cardiology and Cardiac Surgery,
Pediatric Hospital Bambino Gesu, Rome, Italy; 2 Medical
and Surgical Department of Pediatric Cardiology, Pediatric
Hospital Bambino Gesu, Rome, Italy; 3 Section of Rome,
Cardiovascular engineering, CNR - Institute of clinical
Physiology, Rome, Italy; 4 CNR - Institute of Clinical
Physiology, Pisa, Italy
Oral Session OS7
Clinical Aspects of Hemodialysis
O49-O54
Lecture Hall B
Chairmen:
Sunny ELOOT, Gent, Belgium,
Jacek WANIEWSKI, Warsaw, Poland
16:30 O49 CARDIAC FUNCTION AND SOME OTHER RISK FACTORS
RELATED TO VITAMIN D DEFICIENCY IN PATIENTS WITH
CHRONIC RENAL FAILURE(CRF) ON HEMODIALYSIS (HD)
Yonova D, Georgiev M, Antonov S
Medical Faculty, Medical University, Sofia, University
Dialysis Center, Sofia, Bulgaria
16:45 O50 CHANGES IN PULSE WAVE THROUGHOUT HEMODIALYSIS
SESSION
Dębowska M1, Wójcik-Załuska A2, Dąbrowski W3,
Poleszczuk J1, Książek A4, Załuska W4, Waniewski J1
1
Engineering, Polish Academy of Sciences, Warsaw, Poland;
2
Department of Physical Therapy and Rehabilitation,
Medical University of Lublin, Lublin, Poland; 3 Department
of Anesthesiology and Intensive Therapy, Medical
University of Lublin, Lublin, Poland; 4 Department of
Nephrology, Medical University of Lublin, Lublin, Poland
17:00 O51 INFLUENCE OF CLINICAL PARAMETER VARIATION ON IDH
ONSET DURING THE FIRST MINUTES OF THE HD
TREATMENT
Vito D, Casagrande G, Bianchi C, Costantino M
Engineering, Politecnico di Milano, Milano, Italy
17:15 O52 CORRELATES OF CIRCULATING INTERFERON-λ3 (IFN-λ3)
IN HEMODIALYSIS (HD) PATIENTS
Grzegorzewska A1, Świderska M2, Warchoł W3
1
Department of Nephrology, Transplantology and Internal
Medicine, Poznan University of Medical Sciences, Poznan,
Poland; 2 Student Nephrology Research Group, Poznan
University of Medical Sciences, Poznan, Poland;
3
Department of Biophysics, Poznan University of Medical
Sciences, Poznan, Poland
17:30 O53 CARDIOPULMONARY BYPASS: ASSESSING THE RISK OF
RENAL INJURY.
Abbasciano R, Mancini A, San Biagio L, Lucarelli C,
Franzese I, Piani D, Onorati F, Tessari M, Menon T,
Faggian G
Department of Cardiac Surgery, University of Verona,
Verona, Italy
th
17:45 O54 GLUCOSE-FREE DIALYSATE REDUCED SKIN
AUTOFLUORESCENCE AS A MARKER FOR
CARDIOVASCULAR DISEASES
Stegmayr B1, Ramsauer B1, Engels G2, Graaff R3, Sikole A4,
Arsov S5, Hadimeri H6
1
Public Health and Clinical Medicine, Umea University,
Umea, Sweden; 2 Groningen, Haemoscan BV, Groningen,
The Netherlands; 3 UMC Staff and Department of
Endocrinology, University Medical Center Groningen,
University of Groningen, Groningen,nd the Netherland,
Groningen, The Netherlands; 4 University Sts Cyril and
Methodius, Hospital of Nephrology, Skopje, The Former
Yugoslav Republic of Macedonia; 5 Skopje, PZU DiamedMakedonija, Skopje, The Former Yugoslav Republic
of Macedonia; 6 Nephrology, Skaraborgs Hospital,
Skövde, Sweden
Oral Session OS8
Mechanisms of Blood Trauma
O55-O59
Lecture Hall C
Chairmen:
Ulrich KERTZSCHER, Berlin, Germany,
Simon J. SONNTAG, Aachen, Germany
16:30 O55 ON THE SIGNIFICANCE OF EXPOSURE TIME IN
COMPUTATIONAL BLOOD DAMAGE ESTIMATION
Pauli L, Haßler S, Behr M
Chair for Computational Analysis of Technical Systems,
RWTH Aachen University, Aachen, Germany
16:45 O56 THE IMPACT OF ARTIFICIAL SHEAR STRESS ON
LEUKOCYTES AT A BIOMATERIAL INTERFACE
Radley G1, Pieper I2, Chan C2, Moriarty C2, Foster G2,
Hawkins K1, Thornton C1
1
Medical School, Swansea University, Swansea, UK; 2
Calon Cardio-Technology Ltd, Swansea, UK
17:00 O57 ENERGY DISSIPATION RATE AS ALTERNATIVE HEMOLYSIS
METRIC IN STRESS-BASED MODELS
Engel S, Janiga G, Thévenin D
Laboratory of Fluid Dynamics & Technical Flows, Otto-vonGuericke-University Magdeburg, Magdeburg, Germany
17:15 O58 COMPARISON OF HEAT TRANSFER DYNAMICS IN A
MODEL OF THE ARTERIAL SYSTEM DURING CONTINUOUS
OR PULSATILE EXTRACORPOREAL CIRCULATION
Casagrande G, Costantino M
17:30 O59 LONG TERM EVALUATION OF A NOVEL VERSATILE
BIOPROSTHETIC VALVE MADE BY AUTOLOGOUS TISSUES
Takewa Y1, Nakayama Y2, Sumikura H1, Iizuka K1, Katagiri
N1, Takeshita D1, Tatsumi E1
1
Department of Artificial Organs, National Cerebral and
Cardiovascular Center, Osaka, Japan; 2 Medical Engineering
and Materials, National Cerebral and Cardiovascular
Center, Osaka, Japan
30
Oral Session OS9
Cells and Polymers for Tissue Engineering
O60-O64
Lecture Hall D
Chairmen:
Dorota G. PIJANOWSKA, Warsaw, Poland,
Pedro M. BAPTISTA, Zaragoza, Spain
16:30 O60 A NOVEL PERFUSION BIOREACTOR FOR MAMMALIAN
CELL CULTURE
Wawro B, Kruk J, Dudziński K, Kazimierczak B,
Zakrzewska K, Samluk A, Kowalska A, Pijanowska D,
Torbicz W
16:45 O61 ESTABLISHMENT AND CHARACTERIZATION OF HUMAN
RENAL PRIMARY CULTURES TO USE IN MICROFLUIDIC
DEVICES
Sánchez-Romero N, Giménez I
Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain
17:00 O62 FIBRIN GEL AS NATURAL SCAFFOLD FOR HUMAN STEM
CELLS (WJ-MSC AND HIPSC-NPS) IN
NEURODEGENERATIVE DISEASES TREATMENT
Zychowicz M, Figiel- Dąbrowska A, Lech W, Obtułowicz P,
Winiarska H, Domańska-Janik K, Bużańska L
Stem Cell Bioengineering Unit, Mossakowski Medical
Research Centre Polish Academy of Sciences, Warsaw,
Poland
th
17:15 O63 USE OF DECELLULARIZED TRACHEAS FOR AIRWAY
ENGINEERING
Sancho-Tello M1, Milián L1, Carda C1, Garzón I2,
Foschinni G3, Galán G3, Mata M4
1
Universitario de Valencia, Valencia, Spain; 2 Histology
department, Universidad de Granada, Granada, Spain;
3
Thoracic Surgery Unit, Hospital Clínico Universitario de
Valencia; INCLIVA, Instituto Investigación Sanitaria Hospital
Clínico Universitario de Valencia, Valencia, Spain;
4
Universitario de Valencia; Centro de Investigaciones en
Red de Enfermedades Respiratorias (CIBERES), Valencia,
Spain
17:30 O64 POLYMERS WITH MICRO- AND NANOSTRUCTURED
SURFACE FOR IMPLANTS AND FOR TISSUE ENGINEERING
Thormann A1, Rudolph M2, Heilmann A1
1
Biological and Macromolecular Materials, Fraunhofer
IMWS, Halle, Germany; 2 Electrotechnics and Maschine
Builiding, Anhalt University of Applied Sciences, Bernburg,
Germany
31
th
FRIDAY, September 16th
Oral Session OS10
From Bench to Bedside
O65-O70
Lecture Hall A
Chairmen:
Maria Giovanna TRIVELLA, Rome, Italy,
Klaus AFFELD, Berlin, Germany
8:30 O65 THE INNOVATIVE MATERIAL TECHNOLOGIES
APPLICATION FOR THE IMPLANTABLE ROTARY BLOOD
PUMP RELIGA HEART® ROT
Gonsior M1, Darłak M1, Altyntsev I1, Wierzchoń T2,
Antonowicz M1, Kustosz R1
1
for Cardiac Surgery Development, Zabrze, Poland; 2 Faculty
of Materials Science and Engineering, Warsaw University
of Technology, Warsaw, Poland
8:45 O66 THE ABILITY OF REMOTELY MONITORING THE
OPERATION OF PULSATILE VENTRICULAR ASSIST DEVICE
ON THE EXAMPLE OF SET: RH PED – DUO CONTROLLER
Czak M, Gawlikowski M, Kustosz R
Artificial Heart Labolatory, Zbigniew Religa Foundation
for Cardiac Surgery Development, Zabrze, Poland
9:00 O67 INFLUENCE OF AORTIC VALVE REGURGITATION UNDER
LVAD SUPPORT ON HEMODYNAMICS AND CARDIAC
METABOLISM IN ACUTE ANIMAL EXPERIMENTS
Iizuka K, Naito N, Sumikura H, Mizuno T, Tsukiya T,
Takewa Y, Tatsumi E
Department of Artificial Organs, National Cerebral
and Cardiovascular Center, Osaka, Japan
9:15 O68 SINGLE PULMONARY ARTERY SUPPORT FOR THE FAILING
FONTAN CIRCULATION IN SHEEP
Van Puyvelde J1, Rega F1, Nix C2, Hazekamp M3, Rijnberg F3,
Siess T2, Claus P4, Cools B5, Gewillig M5, Meyns B1
1
Belgium; 2 Abiomed Europe GmbH, Aachen, Germany;
3
Department of Cardiothoracic Surgery, Leiden University
Medical Center, Leiden, The Netherlands; 4 Department
of Cardiovascular Imaging and Dynamics, University
Hospitals Leuven, Leuven, Belgium; 5 Department
of Paediatric Cardiology, University Hospitals Leuven,
Leuven, Belgium
9:30 O69 POSTOPERATIVE LEFT VENTRICULAR FUNCTION IN
DIFFERENT TYPES OF PULMONARY HYPERTENSION:
A COMPARATIVE STUDY
Verbelen T1, Van De Bruaene A2, Cools B3, Van
Raemdonck D4, Delcroix M5, Rega F1, Meyns B1
1
Belgium; 2 Cardiology, University Hospitals Leuven, Leuven,
Belgium; 3 Pediatric Cardiology, University Hospitals
Leuven, Leuven, Belgium; 4 Thoracic Surgery, University
Hospitals Leuven, Leuven, Belgium; 5 Pneumology,
University Hospitals Leuven, Leuven, Belgium
Friday, September 16
9:45 O70 HIGH-DOSE ADENOSINE-LIDOCAINE-MAGNESIUM
POLARIZED ARREST IN ELECTIVE CARIDAC SURGERY:
RESULTS OF THE FIRST HUMAN RANDOMIZED
CONTROLLED TRIAL
Abbasciano R1, Onorati F1, San Biagio L1, Lucarelli C1,
Fanti D1, Dobson G2, Menon T1, Gottin L3, Biancari F4,
Tessari M1, Mazzucco A1, Faggian G1
1
Department of Cardiac Surgery, University of Verona,
Verona, Italy; 2 College of Medicine and Dentistry,
Australian Institute of Tropical Health and Medicine
(AITHM), James Cook University, Townsville, Australia;
3
Division of Cardiac Surgery and Postoperative Intensive
Care Unit, University of Verona, Verona, Italy; 4 Division
of Cardiac Surgery, University of Oulu, Oulu, Finland
Oral Session OS11
Adsorption and Uremic Toxins
O71-O76
Lecture Hall B
Chairmen:
Asma ALLAL, Toulouse, France,
Angel ARGILES, Montpellier, France
8:30 O71 POLYETHERSULFONE AND SLIPSKIN BLEND MEMBRANES
FOR DIALYSIS TREATMENT
ter Beek O, Pavlenko D, Suck M, Stamatialis D
Biomaterials Science and Technology, University
of Twente, Enschede, The Netherlands
8:45 O72 CONFORMATION AND DYNAMICS AT A MESOSCOPIC
LEVEL OF BIOMACROMOLECULES ADSOPTION:
A COARSE-GRAINED MOLECULAR SIMULATION
Sabater i Serra R1, Constantino T2, José María M1,
Gómez Ribelles J1, Molina-Mateo J2
1
Networking Research Center on Bioengineering,
Biomaterials and Nanomedicine (CIBER-BBN), Universitat
Politècnica de València/Centre for Biomaterials and Tissue
Engineering, Valencia, Spain; 2 Centre for Biomaterials and
Tissue Engineering, Universitat Politècnica de València,
Valencia, Spain
9:00 O73 STRATEGIES FOR DIALYSATE REGENERATION USING
MIXED MATRIX MEMBRANES
Geremia I, Stamatialis D
Department of Biomaterials Science and Technology Faculty, University of Twente, Enschede, The Netherlands
9:15 O74 SUCCESSFUL TRANSPLANTATION IN ABO- AND HLAINCOMPATIBLE LIVING KIDNEY-TRANSPLANT PATIENTS:
A REPORT ON 12 CASES
Rostaing L1, Karam B2, Congy-Jolivet N3, Hage V2,
Sallusto F4, Esposito L2, Doumerc N4, Debiol B5,
Guilbeau-Frugier C6, Game X4, Allal A2, Kamar N2
1
Faculté de Médecine de Rangueil, Université Toulouse III
Paul Sabatier, Toulouse, France; 2 Department of
Nephrology and Organ Transplantation, CHU Toulouse
Rangueil, Toulouse, France; 3 Department of Immunology,
CHU Toulouse Rangueil, Toulouse, France; 4 Department of
Urology and Organ Transplantation, CHU Toulouse
Rangueil, Toulouse, France; 5 Etablissement Français du
Sang, CHU Toulouse Purpan, Toulouse, France; 6 Service
d'Anatomie et Cytologie Pathologiques, CHU Toulouse
Rangueil, Toulouse, France
32
th
9:30 O75 SPERMATOZOA INITIALLY INCREASE MOTILITY
AS TO ESCAPE UREMIC TOXIN ENVIRONMENT
Vollmer T1, Glorieux G2, Jankowski V3, Jankowski J3,
Stegmayr B1
1
Internal Medicine, Div. Nephrology, Medicine centre,
University Hospital of northern Sweden, Umea, Sweden;
2
Nephrology Section, Department of Internal Medicine,
University of Ghent, Ghent, Belgium; 3 Institute for
Cardiovascular Research, RWTH Aachen University,
Aachen, Germany,
9:45 O76 ESTIMATED GFR POORLY REFLECTS CONCENTRATIONS
OF VARIOUS URAEMIC TOXINS IN PAEDIATRIC CKD
PATIENTS: NEW TOOLS ARE NEEDED TO IMPROVE
DIAGNOSIS
Snauwaert E1, Van Biesen W2, Raes A1, Vande Walle J1,
Eloot S2
1
Paediatric Nephrology, Ghent University Hospital, Ghent,
Belgium; 2 Nephrology, Ghent University Hospital, Ghent,
Belgium
9:15 O80 BIOCOMATIBILITY STUDY OF AN INNOVATIVE
ELASTOMER FOR LONG TERM IMPLANTS APPLICATION
Zawidlak-Węgrzyńska B1, Ścigała P2, Gonsior M1, Janiczak
K1, Gawlikowski M1, Cieśla P1, Kustosz R1, El Fray M3, Piegat
A3
1
for Cardiac Surgery Development, Zabrze, Poland; 2
Emergency and Specialty Animal Medical Center, Piekary
Slaskie, Poland; 3 Polymer Institute, Biomaterials and
Microbiology Technologies Dept., West Pomerania
University of Technology, Szczecin, Poland
9:30 O81 IN VITRO CALCIFICATION: ADVANCING THROUGH THE
DEVELOPMENT OF AN ACCURATE MODEL
D'Alessandro C1, Badria A1, Ratna Tuladhar S2, Gerosa G2,
Korossis S3, Koutsoukos P4, Mavrilas D1
1
Mechanical and Aeronautical, University of Patras,
Patras, Greece; 2 Cardiac Thoracic and Vascular Sciences,
Universitá degli Studi Padova, Padova, Italy; 3
Cardiothoracic, Transplantation and Vascular Surgery,
Hannover Medical School, Hannover, Germany; 4 Chemical
Engineering, University of Patras, Patras, Greece
Oral Session OS12
Implants and Scaffolds
O77-O81
Oral Session OS13
Modelling in silico and in vivo
O82-O87
Lecture Hall C
Lecture Hall D
Chairmen:
Chairmen:
Ludomira GRANICKA, Warsaw, Poland,
Andreas HEILMANN, Halle, Germany
8:30 O77 ELECTROSPUN COLLAGEN NANOFLEECES FOR
APPLICATIONS IN THE FIELD OF REGENERATIVE MEDICINE
Milosevic J1, Kürbitz T2, Heine C1, Hasan S1, Herbst C1,
Meisel H1, Heilmann A3
1
SpinPlant GmbH Leipzig, Leipzig, Germany;
2
Electrotechnics and Maschine Builiding, Anhalt University
of Applied Sciences, Bernburg, Germany; 3 Biological and
Macromolecular Materials, Fraunhofer IMWS, Halle,
Germany
8:45 O78 3D NANOMATERIALS FOR REGENERATION OF
CONNECTIVE TISSUE, SUCH AS CARTILAGE
Gerasimenko A1, Podgaetsky V1, Ichkitidze L1, Telyshev D1,
Eganova E2, Pavlov A2, Selyshchev S1
1
Biomedical systems, National Research University
of Electronic Technology, Moscow, Russian Federation;
2
Department of development and research of micro and
nanosystems, Institute of Nanotechnology
of Microelectronics of the Russian Academy of Sciences,
Moscow, Russian Federation
9:00 O79 DEVELOPMENT OF BIODEGRADABLE INJECTABLE SYSTEM
BASED ON CHITOSAN AND CALCIUM PHOSPHATE
Rogina A1, Matic I2, Ressler A1, Gallego Ferrer G3,
Ivankovic M1, Ivankovic H1
1
Faculty of Chemical Engineering and Technology,
University of Zagreb, Zagreb, Croatia; 2 Faculty of Science,
University of Zagreb, Zagreb, Croatia; 3 Center
for Biomaterials and Tissue Engineering (CBIT), Universitat
Politècnica de València, València, Spain
Gianfranco FERRARI, Rome, Italy
Tim A.S. KAUFMANN, Aachen, Germany
8:30 O82 IMPACT OF ROTARY BLOOD PUMP SPEED STEPS ON
INTRAVENTRICULAR FLOW PATTERNS
Aigner P, Moscato F, Schima H
Medical University of Vienna, Ludwig Boltzmann
Gesellschaft, Vienna, Austria
8:45 O83 IMAGE BASED FITTING OF NEW INFLOW CANNULA FOR
THE EVAHEART LVAS
Sonntag S1, Neidlin M1, Groß-Hardt S2, Benkowski R3,
Motomura T4, Steinseifer U2, Kaufmann T2
1
enmodes GmbH, Aachen, Germany; 2 Department
of Cardiovascular Engineering, RWTH Aachen, Institute
of Applied Medical Engineering, Aachen, Germany;
3
B-Squared Medical Device Solutions LLC, Fort Worth,
USA; 4 Evaheart Medical USA Inc, Houston, USA
9:00 O84 INFLUENCE OF LVAD INFLOW CANNULA POSITIONING ON
VENTRICULAR HEMODYNAMICS WITH A FLUIDSTRUCTURE INTERACTION MODEL
Neidlin M1, Sonntag S1, Groß-Hardt S2, Steinseifer U2,
Kaufmann T2
1
enmodes GmbH, Aachen, Germany; 2 Department
of Cardiovascular Engineering, RWTH Aachen University,
Institute of Applied Medical Engineering, Aachen, Germany
9:15 O85 HEMODYNAMIC CHANGES IN RESPONSE TO IMPROVED
VENTRICULAR CON-TRACTILITY DURING CONTINUOUS
FLOW LVAD SUPPORT: IN-VITRO STUDY
Suciu AM, Khir AW
Brunel Institute for Bioengineering, Brunel University
London, Uxbridge, UK
33
th
9:30 O86 A COMPUTER MODEL OF A HEART MUSCLE - CORONARY
SYSTEM INTERACTION FOR IABP ASSISTANCE HYBRID
SIMULATIONS
Zieliński K1, Kozarski M1, Górczyńska K1, Ferrari G2,
Darowski M1
1
Engineering, Polish Academy of Sciences, Warsaw, Poland;
2
Section of Rome, Cardiovascular Engineering, CNR Institute of Clinical Physiology, Italy
11:20 IL28 HEARTMATE- III: BLACK BOX / BRIGHT FUTURE?
Kaufmann F
Department of Cardiothoracic and Vascular Surgery,
German Heart Institute, Berlin, Germany
9:45 O87 IN-VITRO TESTS RESULTS PROVIDE NEW INSIGHT INTO
PROSTHESIS BEHAVIOR: A HELP FOR CLINICIANS TO
CHOOSE PROSTHESIS AND SIZE IN AORTIC VALVE
REPLACEMENT
Egron S1, Fujita B2, Ensminger S2, Doose C1, Pott D1,
Steinseifer U1
1
Department of Cardiovascular Engineering, Institute
of Applied Medical Engineering, Helmholtz Institute,
RWTH Aachen University, Aachen, Germany; 2 Department
for Thoracic and Cardiovascular Surgery, Heart and
Diabetes Center NRW, Ruhr University Bochum,
Bad Oeynhausen, Germany
12:00 IL30 USE OF SMALL GROUP PROBLEM BASED LEARNING
SCENARIOS AS A METHOD FOR ADVANCED MCS THERAPY
CONTINUING EDUCATION REQUIREMENTS AND
CERTIFICATION
Christensen D
Innovative Program Solutions LLC, Pennsylvania, USA
Plenary Lecture 3
Lecture Hall A
Chairman:
Thomas GROTH, Halle, Germany
10:10 PL3 NEW STRATEGIES FOR THE ENGINEERING OF DIFFERENT
HUMAN TISSUES
Rui L. Reis
3B’s Research Group – Biomaterials, Biodegradables
and Biomimetics, University of Minho, Guimarães, Braga,
Portugal
11:40 IL29 A COMPARISON OF INR TIME IN RANGE PRE AND POST
INITIATION OF A STANDARDIZED PROTOCOL
Thompson M
University of Minnesota Medical Center, Minneapolis, USA
12:15 IL31 PEDIATRIC MECHANICAL CIRCULATORY SUPPORT CHALLENGES AND OPPORTUNITIES
Horvat J
Medical University of Vienna, Vienna, Austria
Changing Perspectives in Extracorporeal Treatment:
from Passive Dialysis Removal to Active Interaction
on the Biology of the Patient
IL32-IL36
Lecture Hall B
Organizer & Chairman: Andrea BUSCAROLI, Ravenna, Italy
11:00 IL32 DOES IT STILL MAKE SENSE TO DEVELOP NEW
MEMBRANES AND HEMODIALYSERS OR
CANNOT WE GO ANY FURTHER?
Catapano G
University of Calabria, Rende, Italy
11:15 IL33 CREATING A FUNCTIONAL BIOARTIFICIAL TUBULE
Stamatialis D
University of Twente, Enchede, The Netherlands
11:30 IL34 THE ROLE OF THE SORPTION IN THE EXTRACORPOREAL
TREATMENT: ONLY TOXINS OR IS THERE MORE?
Mikhalovsky S
School of Pharmacy and Environmental Chemistry,
University of Brighton, Brighton, UK
Special Symposium SP8.1
ICCAC VAD Coordinator Symposium (Session 1)
IL27-IL31
Lecture Hall A
Moderators:
Tonya ELLIOTT, Washington DC, USA,
Thomas SCHLÖGLHOFER, Vienna, Austria
11:00 IL27 FROM BENCH TO BEDSIDE
Kustosz R
of Cardiac Surgery Development, Zabrze, Poland
11:45 IL35 MEDIUM CUT-OFF MEMBRANES - CLOSER TO THE
NATURAL KIDNEY REMOVAL FUNCTION
Krause B
Gambro Dialysatoren GmbH, Hechingen, Germany
12:00 IL36 THE CLINICAL EXPECTATIONS FROM THE NEW BIOACTIVE
TREATMENTS: GREATER WELL-BEING OR LONGER
SURVIVAL?
Argiles A
12:15
DISCUSSION
34
th
Implantable Biosensors
KL5, IL37-IL39
Lecture Hall C
Organizer & Chairman: Erik A. JOHANNESSEN, Borre, Norway
11:00 KL5
CONTINUOUS GLUCOSE MONITORING IN HUMANS
(O88) USING A LONG-TERM IMPLANTED SENSOR/TELEMETRY
SYSTEM
12:00 IL42 EXTRACORPOREAL LIVER PERFUSION MACHINES: THE
(O92) GOOD, THE BAD AND... THE FEASIBLE?
Sanchez Del Arco R, Gutierrez-Gutierrez J, Del Cañizo J
Department of Surgery. Universidad Complutense
de Madrid, Laboratorio de Circulacion Artificial. Hospital
General Universitario Gregorio Maranon, Madrid, Spain
12:15 IL43
1
Gough DA , Routh TL2, Lin JT2, Lucisano JY2
1
Department of Bioengineering, University of California,
CA 92093, San Diego, La Jolla, USA; 2 GlySens
Incorporated, 3931 Sorrento Blvd., Suite 110, CA 92121,
San Diego, USA
11:30 IL37 MONITORING OXYGEN WITH OPTICAL SENSORS IN CELL
(O89) CULTURE, ARTIFICIAL AND NATIVE TISSUE
Meier R, Liebsch G
PreSens Precision Sensing, Regensburg, Germany
11:45 IL38 IMPROVED PLATINUM ANODES FOR THE OPERATION
(O90) OF IMPLANTABLE GLUCOSE FUEL CELLS IN REAL
PHYSIOLOGICAL FLUIDS
Frei M, Bühler M, Erben J, Kerzenmacher S
IMTEK - Department of Microsystems Engineering,
University of Freiburg, Freiburg, Germany
12:00 IL39 ADVANCES IN NANOTECHNOLOGY FOR ORGAN
(O91) REPLACEMENT: A SUMMARY OF 15 YEARS OF
RESEARCH AND COMMERCIALIZATION
Webster TJ
Department of Chemical Engineering, Northeastern
University, Boston, USA
Liver Decellularization: a Second Life for Liver Bioengineering,
Bioartificial Livers and Extracorporeal Liver Perfusion Machines
KL6, IL40-IL44
Lecture Hall D
Chairmen:
Juan F. Del CAÑIZO, Madrid, Spain,
11:00 KL6
LIVER TISSUE ENGINEERING IN VITRO AND IN VIVO
Soto-Gutierrez A
THE NEW EX-VIVO WORLD: MACHINE PERFUSION
WITH A NEW HEMOGLOBIN BASED OXYGEN
CARRIER SOLUTION
Fontes P
Starzl Transplantation Institute, Department of Surgery,
University of Pittsburgh, Pittsburgh, USA
12:30 IL44 LIVER DECELLULARIZATION: A SECOND LIFE FOR LIVER
(O93) BIOENGINEERING, BIOARTIFICIAL LIVERS AND
EXTRACORPOREAL LIVER PERFUSION MACHINES
Baptista P1, Del Cañizo J2
1
Instituto de Investigacion Sanitaria de Aragon,
Saragossa, Spain; 2 Cirugia Experimental, Hospital
Universitario Gregorio Marañon, Madrid, Spain
ESAO Corporate Members Symposium
Beyond Tissue Engeneering - Technical Organ Replacement
Is Still Saving Lives
CM1-CM3
Lecture Hall A
Chairman:
Ares K. Menon, Berlin, Germany
13:00 CM1 BIOCOMPATIBILITY & DIALYZERS: WHAT’S NEXT?
Gebert M
Research & Development, Gambro Dialysatoren GmbH,
Hechingen , Germany
13:15 CM2 VADs AFTER MORE THAN 15 YEARS OF CLINICAL
EXPERIENCE – WHERE ARE THE LIMITS?
Granegger M
Research & Development, Berlin Heart GmbH, Berlin,
Germany
13:30 CM3 TECHNICAL ADVANCEMENTS: SAVING LIVES VERSUS
WILLINGNESS TO PAY
Busink E
Fresenius Medical Care Deutschland GmbH, Bad
Homburg, Germany
Department of Pathology, University of Pittsburgh,
Pittsburgh, USA
11:30 IL40
11:45 IL41
MICROENCAPSULATED HEPATOCYTES AND
BIOARTIFICIAL LIVER : IS HERE A PLACE FOR
EXTRACELLULAR MATRIX?
Legallais C
Université de Technologie de Compiègne, Compiègne,
France
THE CLINICAL DEVELOPMENT OF A BIOARTIFICIAL LIVER:
THE ELAD EXPERIENCE
Ashley R
Vital Therapies, Inc, San Diego, USA
Special Symposium SP8.2
ICCAC VAD Coordinator Symposium (Session 2)
IL45-IL48
Lecture Hall A
Moderators:
Maureen THOMPSON, Minneapolis, USA,
Roman KUSTOSZ, Zabrze, Poland
14:00 IL45 VAD COORDINATOR PERSPECTIVE: CHARACTERISTICS
OF A SUCCESSFUL MCS PROGRAM
Elliott T
MedStar Washington Hospital Center, Washington DC,
USA
35
th
14:30 IL46 REMEDIZER -MONITORING SYSTEM FOR PATIENTS WITH
MCS
Szymanski J
Institute of Cardiology, Warsaw, Poland
14:50 IL47 SWITCH FROM SHORT-TERM TO LONG-TERM
MECHANICAL CIRCULATORY SUPPORT AS A BRIDGE TO
HEART TRANSPLANTATION
Halbe M
Clinic of Cardiac and Vascular Surgery, University Hospital
Zurich, Zurich, Switzerland
15:10 IL48 NON- THERMAL PLASMA APPLICATION FOR VAD
DRIVELINE MANAGEMENT
Bach R
Schuechtermann-Schiller Clinic, Bad Rothenfelde, Germany
15:10 IL56 IGE APHERESIS. A NEW INDICATION FOR ACUTE ALLERGIC
REACTIONS
Valenta R
Department of Pathophysiology and Allergy Research,
Medical University of Vienna, Vienna, Austria
Special Symposium S12
Extracellular Vesicles: Markers of Cellular Activation and
Contributors to Coagulation and Inflammation
Symposium in memory of Prof. Dieter Falkenhagen
KL7, IL57-IL59
Lecture Hall C
Organizer & Chairman: Viktoria WEBER, Krems, Austria
14:00 KL7
Special Symposium WG1
Apheresis Working Group Symposium
IL49-IL56
Lecture Hall B
Chairmen:
Buzas E
Department of Genetics, Cell and Immunobiology,
Semmelweis University, Budapest, Hungary
14:30 IL57
Horst KLINKMANN, Rostock, Germany
Volker WITT, Vienna, Austria
13:30 IL49 OVERVIEW OF MAIN INDICATIONS FOR APHERESIS. WAA
DATA
Stegmayr B
13:40 IL50 OVERVIEW OF APHERESIS TECHNIQUES USED IN CLINICAL
PRACTISE. WAA DATA
Stegmayr B
13:50 IL51 GERMAN LIPID APHERESIS REGISTRY AND DATA
Schettler V
Center of Nephrology Goettingen GbR, Göttingen,
Germany
14:10 IL52 TREATMENT OF SEPSIS BY VARIOUS DEVICES FOR
ADSORPTION TECHNOLOGY
Mitzner S
Department of Medicine, Division of Nephrology,
University of Rostock, Rostock, Germany
14:30 IL53 GRANULOCYTE TRANSFUSIONS IN SEVERE SEPSIS
Witt V
Pediatric Hematology and Oncology, St. Anna Children’s
Hospital, Vienna, Austria
14:45 IL54 GRANULOCYTE BASED BIOREACTOR TREATMENT OF
SEPSIS
Mitzner S
Department of Medicine, Division of Nephrology,
University of Rostock, Rostock, Germany
14:55 IL55 MARGINAL GROUPS FOR APHERESIS. WAA DATA
Witt V
Pediatric Hematology and Oncology, St. Anna Children’s
Hospital, Vienna, Austria
RECENT LESSONS OF EXTRACELLULAR VESICLE
ISOLATION FROM PERIPHERAL BLOOD SAMPLES
HOW TO MEASURE EXTRACELLULAR VESICLES USING
FLOW CYTOMETRY - PITFALLS AND LIMITATIONS
Spittler A
Surgical Research Laboratories, Medical University
of Vienna, Vienna, Austria
14:45 IL58 PRO-COAGULANT POTENTIAL OF PLATELET-DERIVED
(O94) MICROVESICLES
Tripisciano C, Weiss R, Eichhorn T, Weber V
Christian Doppler Laboratory for Innovative Therapy
Approaches in Sepsis - Dep. Health Sciences and
Biomedicine, Danube University Krems, Krems, Austria
15:00 IL59 INFLUENCE OF ANTICOAGULATION ON CELL
(O95) ACTIVATION AND MICROVESICLE GENERATION DURING
LIPID APHERESIS
Weiss R1, Fischer M2, Weber V1
1
Christian Doppler Laboratory for Innovative Therapy
Approach, Danube University Krems, Krems, Austria; 2
Center for Biomedical Technology, Department for
Health Sciences and Biomedicine, Danube University
Krems, Krems, Austria
15:15
DISCUSSION
Oral Session OS14
Liver and Cardiovascular Tissue Engineering
O96-O101
Lecture Hall D
Chairmen:
Cecile LEGALLAIS, Compiegne, France
Krzysztof D. PLUTA, Warsaw, Poland
14:00 O96
HOW TO DETERMINE THE CONCENTRATION OF CELLS
ENCAPSULATED IN ALGINATE-POLYETHERSULFONE
MICROCAPSULES
Lewińska D, Kupikowska-Stobba B, Grzeczkowicz M
36
th
14:15 O97
LIVER TISSUE DECELLULARIZATION AS A TECHNOLOGY
OBTAINING POROUS SCAFFOLD FOR TISSUE
ENGINEERING AND REGENERATIVE MEDICINE
Bobrova M1, Safonova L1, Agapova O2,
Krasheninnikov M3, Shagidulin M2, Agapov I2, Gautier S2
1
Biologocal Faculty, Lomonosov Moscow State
University, Moscow, Russian Federation; 2 Academician
V.I. Shumakov Federal Research Center
of Transplantology and Artificial Organs, Moscow,
Russian Federation; 3 I.M. Sechenov First Moscow State
Medical University, Moscow, Russian Federation
14:30 O98
GENETICALLY MODIFIED FEEDER LAYER CELLS IN
HEPATIC CELLS CULTURE
Zakrzewska K, Samluk A, Kowalska A, Pijanowska D,
Pluta K
14:45 O99
PROCESSING OF HUMAN EXTRACELLULAR MYOCARDIAL
MATRIX PRESERVES ITS CYTOPROTECTIVE EFFECTS
Becker M1, Kappler B1, Ma N1, Falk V2, Stamm C2
1
Berlin Center for Regenerative Therapies, Berlin,
Germany; 2 Deutsches Herzzentrum Berlin, Berlin,
Germany
15:00 O100 IL-6 PRESENT IN HEART FAILURE SERUM FACILITATES
SERUM FACILITATES THE ADAPTATION OF CORD BLOOD
MESENCHYMAL STROMAL CELLS TO HYPOXIC
ENVIRONMENTS
Xu Z1, Nazari-Shafti T2, Bader A2, Falk V2, Stamm C2
1
Berlin Center for Regenerative Therapies, Berlin,
Germany; 2 Deutsches Herzzentrum Berlin, Berlin,
Germany
15:15 O101 CONTRIBUTION OF MESENCHYMAL STEM CELLS TO
FIBROSIS
Fischer F
Health Sciences and Biomedicine, Danube University
Krems, Austria
Vascular Tissue Engineering
KL8, IL60-IL64, O107
16:45 IL61
ENGINEERED VASCULAR TISSUES BY MIMICKING THE
(O103) NATIVE EXTRACELLULAR MATRIX
Zhao Q, Kong D
Key Laboratory of Bioactive Materials (Ministry
of Education), Nankai University, 300071, Tianjin, China
17:00 IL62
MODIFICATION OF POLYMER SURFACE USING RFMS
(O104) TECHNIQUE FOR INCREASED BIOCOMPATIBILITY
Malchikhina A1, Bolbasov E1, Shesterikov E1, Golovkin A2,
Anissimov Y3, Tverdokhlebov S1
1
Institute of Physics and Technology, National Research
Tomsk Polytechnic University, Tomsk, Russian
Federation; 2 Institute of molecular biology and
genetics, Federal Almazov Medical Research Centre,
St. Petersburg, Russian Federation; 3 School
of Biomolecular and Physical Sciences,
Griffith University, Brisbane, Australia
17:15 IL63
DECELLULARIZED SMALL-DIAMETER VASCULAR
(O105) PROSTHESIS FROM HUMAN PLACENTA CHORION
Schneider K1, Enayati M1, Grasl C2, Walter I3, Andreas T4,
Redl H5, Wojta J6, Bergmeister H1
1
Department of Biomedical Research, Medical
University of Vienna, Vienna, Austria; 2 Center for
Medical Physics and Biomedical Engineering, Medical
University of Vienna, Vienna, Austria; 3 Department of
Pathobiology, University of Veterinary Medicine Vienna,
Vienna, Austria; 4 Institute for Biochemical Engineering,
University of Applied Sciences, Technikum Wien,
Vienna, Austria; 5 Ludwig Boltzmann Institute for
Experimental and Clinical Traumatology, Vienna,
Austria; 6 Ludwig Boltzmann Institute of Cardiovascular
Research, Vienna, Austria
17:30 IL64
TAILORING THE FOREIGN BODY RESPONSE FOR IN SITU
(O106) VASCULAR TISSUE ENGINEERING
Rothuizen TC, Damanik FFR, Lavrijsen T, Visser MJT,
Hamming JF, Lalai RA, Duijs JMGJ, van Zonneveld AJ,
Hoefer IE, van Blitterswijk CA, Rabelink TJ, Moroni L,
Rotmans JI
Department of Nephrology, Leiden University Medical
Center, Leiden, The Netherlands
17:45 O107
Lecture Hall A
Organizer:
Chairmen:
16:00 KL8
Beat H. WALPOTH, Geneva, Switzerland
Anna MALASHICHEVA, Saint-Petersburg, Russian
Federation, Giuseppe FAGGIAN, Verona, Italy
IBTA-FABRICATED MICROBIOTUBE VASCULAR GRAFTS
MET 1 YEAR’S PERFECT PATENCY IN A RAT MODEL
Ishii D1, Enmi J2, Iida H2, Kurisu K1, Nakayama Y3
1
Department of Neurosurgery, Hiroshima University
Graduate School of Biomedical and Health Sciences,
Hiroshima, Japan; 2 Department of Investigative
Radiology, National Cerebral and Cardiovascular Center,
Osaka, Japan; 3 Division of Medical Engineering and
Materials, National Cerebral and Cardiovascular Center,
Osaka, Japan
VASCULAR TISSUE ENGINEERING: DREAM OR REALITY?
Walpoth BH
Department of Surgery, Geneva University Hospital,
Geneva, Switzerland
16:30 IL60
ADHESIVE AND CYTOTOXIC PROPERTIES OF
(O102) POLYCAPROLACTONE, LACTIDE AND THEIR
COPOLYMERS
Golovkin A1, Bolbasov E2, Tverdohlebov S2, Sinev A3,
Mishanin A3, Malashicheva A3
1
Institute of Molecular Biology and Genetics, Federal
Almazov Medical Research Centre, St. Petersburg,
Russian Federation; 2 Tomsk Polytechnic University,
Tomsk, Russian Federation; 3 Federal Almazov Medical
Research Centre, St. Petersburg, Russian Federation
Oral Session
ESAO Annual Awards Session
AL1-AL5
Lecture Hall B
Chairman:
16:30
Ashraf W. KHIR, Uxbridge, UK
INTRODUCTION TO THE SESSION
Khir AW
Brunel Institute for Bioengineering, Brunel University
London, Uxbridge, UK
37
th
16:35 AL1
A ROTARY BLOOD PUMP DESIGN TO REDUCE BLOOD
TRAUMA
Thamsen B
17:00 AL2
DESIGN OF CENTRIFUGAL PUMPS FOR PRESSURE
SENSITIVE, EFFICIENT AND BLOOD COMPATIBLE
VENTRICULAR SUPPORT
Graefe R
Helmholtz Institute of Biomedical Engineering,
17:15 AL3
BIOLOGICAL AND MECHANICAL CHARACTERIZATION
OF A BIOHYBRID BONE SUBSTITUTE REBUILT IN
BIOREACTOR FOR MAXILLOFACIAL RECONSTRUCTION
Baudequin T
Université de Technologie de Compiègne,
Compiègne, France
17:30 AL4
TAILORING THE FOREIGN BODY RESPONSE FOR IN SITU
VASCULAR TISSUE ENGINEERING
Müller I1, Aigner P2
1
Department of Cardiovascular Engineering,
RWTH Aachen, Aachen, Germany; 2 Center for Medical
Physics and Biomedical Engineering, Medical University
17:45 AL5
COAXIALLY ELECTROSPUN AND DIRECTIONAL
SOLIDIFIED SCAFFOLDS FOR BONE AND VASCULAR
TISSUE ENGINEERING
Garcia Garcia A1, Al Halabi F2
1
BioMechanics and BioEngineering Laboratory,
Université de Technologie de Compiègne (UTC),
Compiègne, France; 2 Institute for Multiphase Processes,
Leibniz Universitaet Hannover, Germany
Oral Session OS15
Biomaterials in Contact with Blood
O108-O112
Lecture Hall C
Chairmen:
Birgit GLASMACHER, Hannover, Germany,
Maciej GAWLIKOWSKI, Zabrze, Poland
16:30 O108 INSPIRED BY NATURE BILAYERED POLYURETHANE
NANOFIBROUS SCAFFOLDS FOR SMALL DIAMETER
TISSUE ENGINEERED VASCULAR GRAFTS
M. Wojasiński M, Ciach T
Faculty of Chemical and Process Engineering, Warsaw
University of Technology, Warsaw, Poland
16:45 O109 IMMOBILIZATION STRATEGIES FOR
GLYCOSAMINOGLYCANS ON BIOMATERIALS FOR
ANTI-INFLAMMATORY PURPOSES
Al-Khoury H
Biomedical Materials Group Institute of Pharmacy,
Martin Luther University Halle-Wittenberg, Halle,
Germany
17:00 O110 SURFACE THROMBOGENICITY EVALUATION OF NEW
INNOVATIVE BIOMATERIAL
Janiczak K1, Zawidlak-Węgrzyńska B1, Cieśla P1,
Gawlikowski M1, Kościelniak-Ziemniak M1,
El Fray M2, Kustosz R1
1
Artificial Heart Labolatory, Zbigniew Religa Foundation
2
Polymer Institute, West Pomerania University
of Technology, Szczecin, Poland
17:15 O111 A DUAL DRUG DELIVERY SYSTEM (DDS) MADE BY ELECTROSPINNING AGAINST THROMBOSIS IN
CARDIOVASCULAR DISEASES
Repanas A, Mueller M, Al Halabi F, Bode M, Glasmacher B
Hannover, Hannover, Germany
17:30 O112 IN-VITRO EVALUATION OF THE POLISH PAEDIATRIC VAD
RELIGA HEART PED THROMBOGENICITY
Gawlikowski M, Janiczak K, Głowacki M, Cieśla P,
Kustosz R
for Cardiac Surgery Development, Zabrze, Poland
Advances in Regional Citrate-Calcium Anticoagulation
IL65, IL66, O113-O115
Lecture Hall D
Chairmen:
Martin BRANDL, Krems, Austria,
Jens HARTMANN, Krems, Austria
16:30 IL65
CITRATE ANTICOAGULATION IN APHERESIS AND
TANDEM APHERESIS/HEMODIALYSIS PROCEDURES
Buturović-Ponikvar J
Department of Nephrology, University of Ljubljana,
Ljubljana, Slovenia
16:50 IL66
REGIONAL CITRATE ANTICOAGULATION A FUTURE
OF HEMODIALYSIS: A CRITICAL EVALUATION BASED
ON MORE THAN 10 000 CITRATE PROCEDURES PER YEAR
IN A SINGLE CENTER
Ponikvar R
Department of Nephrology, University of Ljubljana,
Ljubljana, Slovenia
17:10 O113 MODELLING AND SIMULATION OF A TARGETORIENTATED ALGORITHM FOR RCA
Brandl M1, Kellner K1, Strobl K2, Hartmann J2
1
Center for Integrated Sensor Systems, Danube
University Krems, Krems, Austria; 2 Center for Biomedical
Technology, Danube University Krems, Krems, Austria
17:25 O114 CITRATE ANTICOAGULATION IMPROVES BLOOD
COMPATIBILITY IN DIALYSIS AND AHPERESIS – DATA
FROM IN VITRO EXPERIMENTS
Harm S, Hartmann J
Center for Biomedical Technology, Danube University
Krems, Krems, Austria
17:40 O115 INFLUENCE OF MAGNESIUM ON COAGULATION DURING
CITRATE ANTICOAGULATION: AN IN-VITRO STUDY
Strobl K, Hartmann J
Department for Health Sciences and Biomedicine,
Danube University Krems, Krems, Austria
38
th
SATURDAY, September 17th
Oral Session OS16
VADs in Daily Activity and Excercise
O116-O121
Lecture Hall A
Chairmen:
Arianna Di MOLFETTA, Rome, Italy,
Francesco MOSCATO, Vienna, Austria
8:30 O116 FULL OR PARTIAL LEFT VENTRICULAR ASSIST DEVICE
SUPPORT: COMPUTATIONAL ASSESSMENT
OF HEMODYNAMICS
Caruso M1, Renzulli A2, Fragomeni G2
1
DIMEG, University of Calabria, Rende, Italy; 2 Medical
and Surgical Science Department, Magna Graecia
University of Catanzaro, Catanzaro, Italy
8:45 O117 EXERCISE PHYSIOLOGY IN HEART FAILURE: A
SIMULATION STUDY
Fresiello L1, Meyns B1, Di Molfetta A2, Ferrari G3
1
Cardiac Surgery, KU Leuven, Leuven, Belgium; 2 Medical
and Surgical Department of Pediatric Cardiology,
Pediatric Hospital Bambino Gesù, Rome, Italy; 3 Institute
of Clinical Physiology, National Research Council,
Rome, Italy
9:00 O118 PRESSURE AND VOLUME UNLOADING DURING RAMP
TESTS IN PATIENTS SUPPORTED WITH A LEFT
VENTRICULAR ASSIST DEVICE: A MODEL STUDY
Moscato F1, Gross C1, Dimitrov K2, Zimpfer D1, Schima H1
1
Medical University of Vienna, Vienna, Austria;
2
Department of Cardiac Surgery, Medical University
9:15 O119 TEMPORARY CARDIAC UNLOADING DURING EVOLVING
MYOCARDIAL INFARCTION DRASTICALLY REDUCES
MORTALITY: PERSPECTIVES FROM A SWINE MODEL
Trivella M1, Piersigilli A2, Bernini F2, Pelosi G1, Burchielli S3,
Puzzuoli S2, Kusmic C1, L’Abbate A2
1
Department of Biomedicine, CNR-Clinical Physiology
Institute, Pisa, Italy; 2 Institute of Life Sciences, Scuola
Superiore Sant’Anna, Pisa, Italy; 3 Fondazione Toscana
Gabriele Monasterio, Pisa, Italy
9:30 O120 WHAT DETERMINES EXERCISE CAPACITY IN LVAD
PATIENTS? A MULTIPLE REGRESSION ANALYSIS STUDY
Fresiello L1, Jacobs S1, Timmermans P2, Meyns B1
1
Clinical Cardiac Surgery Department, KU Leuven,
Leuven, Belgium; 2 Department of Cardiology, University
Hospital of KU Leuven, Leuven, Belgium
9:45 O121 MONITORING OF PHYSICAL ACTIVITY IN PATIENTS WITH
A LEFT VENTRICULAR ASSIST DEVICE IMPLANTED
Gross C1, Haller M1, Zimpfer D2, Schima H1, Moscato F1
1
Medical University of Vienna, Vienna, Austria; 2
Department of Cardiac Surgery, Medical University of
Vienna, Vienna, Austria
Saturday, September 17
Oral Session OS17
Computer Modelling in Hemodialysis
O122-O127
Lecture Hall B
Chairmen:
Detlef H. KRIETER, Wuerzburg, Germany
8:30 O122 FINITE ELEMENT MODELING OF SODIUM EXCHANGE
IN THE HOLLOW FIBER OF A HAEMODIALYZER
Ravagli E1, Perazzini C2, Severi S1
1
Department of Electrical, Electronic and Information
Engineering, University of Bologna, Bologna, Italy;
2
Health Sciences and Technology Interdepartmental
Center for Industrial Research, University of Bologna,
Bologna, Italy
8:45 O123 ANALYSIS OF THE EFFECT OF GEOMETRICAL AND
OPERATIONAL PARAMETERS ON SOLUTE TRANSPORT
IN HOLLOW FIBER DIALYZERS WITH A TWODIMENSIONAL TRANSPORT MODEL
Donato D1, Boschetti-de-Fierro A2, Zweigart C2, Eloot S3,
Storr M2, Krause B2, Leypoldt K4, Segers P1
1
IBiTech − bioMMeda, Department of Electronics and
Information Systems, iMinds Medical IT, Ghent
University, Ghent, Belgium; 2 Research and Development,
Gambro Dialysatoren GmbH, Hechingen, Germany;
3
Nephrology, Dialysis unit 1P8, Ghent University Hospital,
Ghent, Belgium; 4 Baxter Healthcare Corporation,
Deerfield, USA
9:00 O124 INTEGRATED MODEL FOR PHOSPHATE AND CALCIUM
KINETICS DURING WEEKLY CYCLE OF HEMODIALYSIS
Waniewski J, Dębowska M
9:15 O125 IN VIVO CHARACTERIZATION OF FRACTIOPES® 200, A
NEW PLASMA FRACTIONATOR MEMBRANE FOR LIPID
APHERESIS
Krieter D1, Lange F1, Bonn F2, Sauvant C3, Lemke H3,
Wanner C1
1
Division of Nephrology, University Hospital Wuerzburg,
Wuerzburg, Germany; 2 Membranes Business Unit, 3M,
Wuppertal, Germany; 3 R & D, eXcorLab GmbH,
Obernburg, Germany
9:30 O126 DOES THE PERITONEAL FLUID ABSORPTION DEPEND ON
THE TONICITY OF DIALYSATE? – INSIGHTS FROM THE
TWO-PHASE DISTRIBUTED MODELING
Stachowska-Pietka J1, Lindholm B2, Waniewski J1
1
Engineering, Polish Academy of Sciences, Warsaw,
Poland; 2 Divisions of Renal Medicine and Baxter Novum,
Department of Clinical Science, Intervention and
Technology, Karolinska Institutet, Stockholm, Sweden
9:45 O127 A NOVEL ANALYTICAL MODEL PREDICTING THE COURSE
OF HEMATOCRIT ALONG THE LENGTH OF DIALYZER’S
FIBERS
Poorkhalil A1, Mouzakis F1, Amoabediny G2, Kashefi A1,
Mottaghy K1
1
Institute of Physiology, RWTH Aachen University,
Aachen, Germany; 2 Research Center for New
Technologies in Life Science Engineering, University
of Tehran, Tehran, Islamic Republic of Iran
39
th
Oral Session OS18
Artificial Pancreas and Diabetes Treatment
O128-O133
Lecture Hall C
Chairmen:
Joseph KOST, Beer-Sheva, Israel
8:30 O128 NANOTECHNOLOGY FOR TARGETED DRUG AND GENE
THERAPIES
Kost J
Chemical Enginerring, Ben-Gurion University, Beer-Sheva,
Israel
9:00 O129 THE INFLUENCE OF THE VOICEDIAB SYSTEM ON
METABOLIC CONTROL IN PATIENTS WITH TYPE I
DIABETES
Foltyński P1, Ładyżyński P1, Pańkowska E2, Mazurczak K2
1
Poland; 2 Department of Pediatrics, The Institute
of Mother and Child, Warsaw, Poland
9:15 O130 BED SIDE ARTIFICIAL PANCREAS WITH CLOSED-LOOP
SYSTEM AND SURGICAL DIABETES TREATMENT
Hanazaki K1, Munekage M1, Kitagawa H1, Yatabe T2,
Asano T3, Kinoshita Y3, Namikawa T1
1
Surgery 1, Kochi Medical School, Nankoku, Japan;
2
Anesthesiology, Kochi Medical School, Nankoku, Japan;
3
Nikkiso Co LTD, Tokyo, Japan
- O131 WITHDRAWN
9:30 O132 CHALLENGES AND RESULTS FOR THE ARTIFICIAL
PANCREAS: THE CONTROL SYSTEMS PERSPECTIVE
Cusimano V, Palumbo P
CNR - Institute of Systems Analysis and Computer Science
A. Ruberti, Roma, Italy
9:45 O133 WITHDRAWN
9:00 O136 NUMERICAL SIMULATIONS OF THE LUNG AND HEART
DISEASES COMORBIDITY
Zieliński K1, Gólczewski T1, Ferrari G2, Górczyńska K1,
Kozarski M1, Darowski M1
1
Poland; 2 Section of Rome, Cardiovascular Engineering,
CNR - Institute of Clinical Physiology, Rome, Italy
9:15 O137 GEOMETRY FACTOR IN CONTINUOUS INDUCTIVE
POWERING AND INDUCTIVE RECHARGING
OF IMPLANTED MEDICAL DEVICES
Danilov A, Mindubaev E, Selishchev S
Biomedical Engineering Department, National Research
University of Electronic Technology (MIET), Moscow,
Russian Federation
9:30 O138 FINITE ELEMENT ANALYSIS OF MINI-PLATE
STABILIZATION OF MANDIBLE FRACTURE
Wądołowski P1, Krzesiński G1, Gutowski P2
1
The Faculty of Power and Aeronautical Engineering,
Warsaw University of Technology, Warsaw, Poland;
2
Department of Cranio-Maxillo-Facial Surgery, Medical
University of Warsaw, Warsaw, Poland
9:45 O139 SIMULATION OF MASS TRANSPORT DURING
INTRAPERITONEAL CHEMOTHERAPY: A PARAMETRICAL
MODEL OF SINGLE TUMOR NODULES
Steuperaert M1, Falvo D’Urso Labate G2, Debbaut C1,
Ceelen W3, Segers P1
1
IbiTech-BioMMeda, Ghent University, Ghent, Belgium; 2
University of Calabria, Rende, Cosenza, Italy;
3
Department of Surgery, Ghent University, Ghent,
Belgium
Plenary Lecture 4
Lecture Hall A
Chairman:
Oral Session OS19
Computer Modelling in Respiratory System and Others
O134-O139
Lecture Hall D
Chairmen:
10:10 PL4 TECHNOLOGY FOR DETECTING HYPOGLYCEMIA
David C. Klonoff
U.C. San Francisco, School of Medicine, Diabetes Research
Institute Mills-Peninsula Health Services, San Mateo, CA,
USA
Gianfranco FERRARI, Rome, Italy,
Marek DAROWSKI, Warsaw, Poland
8:30 O134 COMPARISON OF AEROSOL ACCESSORIES
PERFORMANCES BY A FLUID DYNAMIC
COMPUTATIONAL APPROACH
Possenti L, Casagrande G, Costantino M
8:45 O135 VIRRESPIR - A VIRTUAL PNEUMONOLOGICAL PATIENT IN
THE FORM OF WEB APPLICATION
Gólczewski T, Zieliński K, Stecka A, Ładyżyński P
40
th
Heart Working Group Symposium
MCS research and regulations
IL77-IL81, KL9
Lecture Hall A
Chairmen:
Part 1
Klaus AFFELD, Berlin, Germany,
Ulrich STEINSEIFER, Aachen, Germany
Update on MCS Research in Europe
11:00 IL77 OPTIMIZING MCS HEMODYNAMICS THROUGH LUMPED
PARAMETER MODELS
Di Molfetta A
Department of Pediatric Cardiology and Cardiac Surgery,
Pediatric Hospital Bambino Gesu, Rome, Italy
11:10 IL78 SMARTER PUMPS: HEMODYNAMIC MONITORING AND
PHYSIOLOGICAL CONTROL
Moscato F
Medical University Vienna, Vienna, Austria
11:20 IL79 BETTER PUMPS: OPTIMIZING PUMP PERFORMANCE
THROUGH FLOW SIMULATION
Kaufmann T
Department of Cardiovascular Engineering, RWTH Aachen,
Institute of Applied Medical Engineering, Aachen,
Germany
11:30 IL80 BLOOD DAMAGE AND THROMBUS FORMATION IN MCS
SYSTEMS
Kertzscher U
11:40 IL81 LIMITATIONS IN EXERCISE CAPACITY IN VAD PATIENTS
Meyns B
Cardiac Surgery, KU Leuven, Leuven, Belgium
Part 2
The Impact of Changing Medical Device
Regulations on MCS Research in Europe
11:50 KL9 NEW MEDICAL DEVICE REGULATIONS AFFECTING MCS
RESEARCH
Schima H
Medical University of Vienna, Ludwig Boltzmann
Gesellschaft, Vienna, Austria
EUTox Working Group Symposium - CME Course
IL67-IL70
Lecture Hall B
Chairman:
11:20 IL68 MINERAL AND BONE DISORDERS IN CHRONIC KIDNEY
DISEASE
Spasovski G1, Rodriguez M2
1
Department of Nephrology, Ss. Cyril and Methodius
University, Skopje, The Former Yugoslav Republic
of Macedonia; 2 Maimonides Institute for Research
in Biomedicine of Cordoba/Reina Sofia University
Hospital/University of Cordoba, Cordoba, Spain
11:40 IL69 NUTRITION IN CHRONIC KIDNEY DISEASE PATIENTS
Vanholder R
Department of Internal Medicine, University Hospital
Ghent, Ghent, Belgium
12:00 IL70 EXTRACELLULAR VOLUME AND BLOOD PRESSURE
IN CHRONIC KIDNEY DISEASE
Argiles A
12:20
DISCUSSION
How to Prevent Hypoglycemia?
Symposium in memory of Prof. Jan. M. Wojcicki
Symposium Co-sponsored by the Internatinal Centre of Biocybernetics
and Diabetes Technology Society
IL71-IL75
Lecture Hall C
Chairmen:
David C. KLONOFF, San Mateo, USA,
11:00 IL71 WELCOMING REMARKS AND MEMORY OF JAN WOJCICKI
Klonoff DC
Diabetes Research Institute Mills-Peninsula Health
Services, San Mateo, USA
11:10 IL72 CONTROVERSIES IN DEFINING HYPOGLYCEMIA
FOR RESEARCH AND CLINICAL PURPOSES
Vigersky R
Walter Reed National Military Medical Center, Washington
DC, USA
11:30 IL73 THE RISKS OF UNDETECTED HYPOGLYCEMIA
Pańkowska E
Warsaw Institute of Diabetology, Warsaw, Poland
11:50 IL74 OPEN LOOP TECHNOLOGY TO PREVENT HYPOGLYCEMIA
Pickup J
King’s College London, London, UK
12:10 IL75 CLOSED LOOP TECHNOLOGY TO PREVENT
HYPOGLYCEMIA
Hovorka R
Institute of Metabolic Science, University of Cambridge,
Cambridge, UK
Joachim JANKOWSKI, Aachen, Germany
11:00 IL67 FUTURE OF ANAEMIA MANAGEMENT IN CHRONIC
KIDNEY DISEASE PATIENTS
Wiecek A
Department of Nephrology, Endocrinology and Metabolic
Diseases, Medical University of Silesia, Katowice, Poland
41
th
Extracorporeal Lung Support and Lung Transplantation
IL76, O140-O144
11:45 O142
SURFACE MODIFICATION OF SILICONE TUBES BY
FUNCTIONAL CARBOXYL AND AMINE, BUT NOT
PEROXIDE GROUPS, AND COLLAGEN IMMOBILIZATION
IMPROVES CELL STABILITY
Salehi-Nik N1, Zandieh-Doulabi B2, Amoabediny G3,
Klein-Nulend J1, Mottaghy K4
1
School of Chemical Engineering, College of Engineering,
University of Tehran, Tehran, Islamic Republic of Iran;
2
Oral Cell Biology, Academic Centre for Dentistry
Amsterdam, University of Amsterdam and VU University
Amsterdam, MOVE Research Institute Amsterdam,
Amsterdam, The Netherlands; 3 Department of
Biomedical Engineering, Research Center for New
Technologies in Life Science Engineering, University of
Tehran, Tehran, Islamic Republic of Iran; 4 Institute of
Physiology, Medical Faculty, RWTH Aachen University,
Aachen, Germany
12:00 O143
DEVELOPMENT OF AN ULTRA COMPACT AND DURABLE
ECMO SYSTEM AND A LONG-TERM EVALUATION
BY CHRONIC ANIMAL EXPERIMENT
Katagiri N, Tatsumi E, Takewa Y, Tsukiya T, Mizuno T,
Taenaka Y
Artificial Organs, National Cerebral and Cardiovascular
Center Research Institute, Osaka, Japan
12:15 O144
WITHDRAWN
Lecture Hall D
Organizer & Chairman: Khosrow MOTTAGHY, Aachen, Germany
11:00 IL76
EXTRACORPOREAL LUNG SUPPORT
TO TRANSPLANTATION?
Spillner J
Department of Cardiac and Thorax Surgery,
11:20 O140
OXYGEN DIFFUSION THROUGH LUNG SURFACTANT
USING FLUOROCARBON IN AN ARTIFICIAL ALVEOLAR
CHAMBER
Khachab A1, Hahn A2, Mottaghy K1
1
Institute of Physiology, RWTH Aachen University,
Aachen, Germany; 2 Federal Institute for Risk
Assessment (BR), Berlin, Germany
11:30 O141
ENDOXY: ENDOTHELIAL CELLS IN BIOHYBRID LUNGS
PROMOTE NOT ONLY HEMOCOMPATIBILITY BUT ALSO
GAS TRANSFER PERFORMANCE
Menzel S1, Jockenhoevel S2, Cornelissen C3
1
Dept. of Tissue Engineering & Textile Implants, Institute
of Applied Medical Engineering, RWTH Aachen
University, Aachen, Germany; 2 Department of Tissue
Engineering & Textile Implants, Institut für Textiltechnik
and Institute of Applied Medical Engineering, RWTH
Aachen University, Aachen, Germany; 3 Department
for Internal Medicine - Section for Pneumology, Medical
Faculty, RWTH Aachen University, Aachen, Germany
42
POSTER SESSIONS
THURSDAY, September 15th
Poster Session I
15:30 – 16:30
Poster Area
Cardiovascular: Pump development (PS1)
P1-P11
Chairmen:
Ashraf W. KHIR, Uxbridge, UK,
Krzysztof ZIELINSKI, Warsaw, Poland
P1
BLOOD FLOW ESTIMATION OF THE POLVAD-MEV VENTRICULAR ASSIST
DEVICE BASED ON STANDARD MEASUREMENTS SIGNALS FROM
SUPPLY UNIT
Siewnicka A, Janiszowski K
Institute of Automatic Control and Robotics, Warsaw University
P2
OPTIMIZATION OF A TRANSCUTANEOUS ENERGY TRANSFER SYSTEM
TOPOLOGY FOR STABLE INDUCTIVE POWERING OF MECHANICAL
CIRCULATORY SUPPORT SYSTEMS
Danilov A, Mindubaev E, Selishchev S
Biomedical Engineering Department, National Research University
of Electronic Technology (MIET), Moscow, Russian Federation
P3
PRECISION MATCHING PULSATILE BLOOD PUMP
Yang M, Zhuang X, Meng F, Xu Z, Ouwen C, Xu L, Li S, Lu C
Instrument Science and Eng., Shanghai Jiaotong University,
Shanghai, China
P4
PROGRESS AND IN VITRO EXPERIENCE OF OUR IMPLANTABLE
PEDIATRIC PUMP
Itkin G, Sysoev A, Dmitrieva O, Nevzorov A, Filatov I, Gotier S
V.I. Shumakov Federal Research Center of transplantology and artificial
organs of the Ministry of Healthcare of the Russian Federation, Moscow,
Russian Federation
P5
DESIGN OF MINIATURE MOTOR FOR CENTRIFUGAL BLOOD PUMP
RELIGA HEART® ROT
Darłak M, Altyntsev I, Kustosz R, Jaworek M
Artificial Heart Laboratory, Zbigniew Religa Foundation for Cardiac
Surgery Development, Zabrze, Poland
P6
DEVELOPMENT OF LVAD SYSTEM BASED ON MECHATRONIC UNIT WITH
UNI-DIRECTIONAL MOTION CONVERTER
Morozov V, Zhdanov A, Belyaev L
Department of Mechanical Engineering, Vladimir State University named
after Alexander and Nikolay Stoletovs, VLSU, Moscow,
Russian Federation
P7
STATIC AND DYNAMIC CHARACTERISTICS OF A MINIMALLY INVASIVE
HEART CATHETER PUMP
Janeczek C1, Karabegovic A1, Hinteregger M1, Willinger R2, Gföhler M1
1
Institute for Engineering Design and Logistics Engineering, Department
of Machine Design and Rehabilitation Engineering, TU Wien, Vienna,
Austria; 2 Institute for Energy Systems and Thermodynamics,
Department of Fluid-Flow Machinery, TU Wien, Vienna, Austria
P8
RESULTS OF IN-VITRO TESTS ON A 1:1 PROTOTYPE
OF A PERCUTANEOUS VENTRICULAR ASSIST DEVICE
Karabegovic A, Janeczek C, Hinteregger M, Gföhler M
Institute for Engineering Design and Logistics Engineering,
Vienna University of Technology, Vienna, Austria
P9
IMPLEMENTATION AND INDUSTRIALIZATION PROCESS OF THE POLISH
PEDIATRIC EXTRACORPOREAL VENTRICULAR ASSIST DEVICE
Gonsior M, Kustosz R, Kapis A, Bujok W, Szuber-Dynia A,
Zawidlak-Węgrzyńska B, Świątek M, Zalewski J
P10
PIV TESTS ON PEDIATRIC VENTRICLE ASSIST DEVICES: EFFECTS
OF THE HEART RATE ON THE VAD OPERATION
Witkowski D
Institute of Turbomachinery, Lodz University of Technology,
Lodz, Poland
P11
THE INNOVATIVE POLISH LONG TERM HEART SUPPORT SYSTEM
DEVELOPMENT
Darłak M, Kustosz R, Altyntsev I, Gonsior M, Gawlikowski M, Głowacki M
Cardiovascular: Hydro- and Hemodynamics
of Cardiac Assist Devices (PS2)
P12-P21
Chairmen:
Steven JACOBS, Leuven, Belgium,
Roman KUSTOSZ, Zabrze, Poland
P12
OPTICAL VALIDATION OF ULTRASONIC MICROOBJECTS DETECTION
Pydziński P, Gawlikowski M
P13
FLOW VISUALIZATION INSIDE THE BLOOD PUMP OF THE 30 CC
PULSATILE PEDIATRIC VENTRICULAR ASSIST DEVICE
Belyaev L, Zhdanov A, Morozov V
Russian Federation
43
th
Poster Sessions
P14
DEVELOPMENT AND ASSESSMENT OF PASSIVE BEATING RIGHT HEART
PLATFORM FOR CARDIOVASCULAR DEVICES TESTING AND REALISTIC
SURGICAL TRAINING
Jaworek M1, Lucherini F1, Gelpi G2, Antona C2, Fiore G1, Vismara R1
1
Department of Electronics, Information and Bioengineering, Politecnico
di Milano, Milan, Italy; 2 Cardiovascular Department, 'Luigi Sacco'
General Hospital, Milan, Italy
P15
REPERFUSION OF PIG HEARTS FROM FOREGOING ANIMAL TRIALS
AFTER EUTHANASIA IN AN ISOLATED HEART APPARATUS
Buesen M1, Ernst L2, Tolba R2, Steinseifer U1
1
Dept. of Cardiovascular Engineering, Institute of Applied Medical
Engineering, RWTH Aachen University, Aachen, Germany; 2 Institute
for Laboratory Animal Science & Experimental Surgery,
RWTH Aachen University Hospital, Aachen, Germany
P16
THE APPLICATION OF SWINE AS AN EXPERIMENTAL MODEL FOR LONG
TERM CARDIAC SUPPORT
Janiczak K1, Kustosz R1, Gonsior M1, Gawlikowski M1, Głowacki M1,
Cieśla P1, Ścigała P2, Czingon M3, Zawidlak-Węgrzyńska B1
1
Surgery Development, Zabrze, Poland; 2 Clinic for Animals, Piekary
Slaskie, Poland; 3 Clinic for Animals, Zabrze, Poland
P17
AORTIC VALVE CLOSING THROUGH APICAL CANNULA DURING
MECHANICAL CIRCULATORY SUPPORT WITH BERLINHEART
EXCOR SYSTEM IN 4-YEAR OLD CHILD
Śliwka J1, Pawlak S1, Przybylski R1, Grzybowski A1, Włoczka G1,
Białkowski J2
1
Department of Cardiac Surgery, Transplantology and Mechanical
Circulatory Support in Children, Silesian Center for Heart Diseases,
Zabrze, Poland; 2 Department of Pediatric Cardiology, Silesian Center
for Heart Diseases, Zabrze, Poland
P18
CONCOMITANT USE OF CONTINUOUS FLOW AND PULSATILE FLOW
VAD IN BIVENTRICULAR AND UNIVENTRICULAR PHYSIOLOGY:
A SIMULATION STUDY
Di Molfetta A1, Ferrari G2, Fresiello L3, Iacobelli R1, Filippelli S1, Amodeo A1
1
Department of Pediatric Cardiology and Cardiac Surgery, Pediatric
Hospital Bambino Gesu, Rome, Italy; 2 Section of Rome, Cardiovascular
engineering, CNR - Institute of clinical Physiology, Rome, Italy;
3
Department of Cardiac Surgery, KU-Leuven, Leuven, Belgium
P19
ACUTE BIVENTRICULAR INTERACTION IN PEDIATRIC PATIENTS
IMPLANTED WITH CONTINUOUS FLOW AND PULSATILE FLOW LVAD:
A SIMULATION STUDY
Di Molfetta A1, Ferrari G2, Iacobelli R1, Filippelli S1, Fresiello L3, Amodeo A1
1
engineering, CNR - Institute of clinical Physiology, Rome, Italy;
3
Department of Cardiac Surgery, KU-Leuven, Leuven, Belgium
P20
EVOLUTION OF MITRAL REGURGITATION IN BERLIN HEART EXCOR
LVAD PATIENTS LESS THAN 10KG
Di Molfetta A1, Iacobelli R1, Ferrari G2, Filippelli S1, Adorisio R1,
Amodeo A1
1
Engineering, CNR - Institute of clinical Physiology, Rome, Italy
P21
CARDIAC AND PLASMA LEVELS OF IL-33/ST2 SYSTEM IN PEDIATRIC
PATIENTS WITH HEART FAILURE UNDERGOING VENTRICULAR
ASSIST DEVICE SUPPORT
Ragusa R1, Di Molfetta A2, Cabiati M3, Pitto L3, Del Ry S3, Amodeo A2,
Trivella M3, Caselli C3
1
Scuola Superiore Sant Anna, Pisa, Italy; 2 Cardiothoracic surgery,
Ospedale Bambin Gesu di Roma, Rome, Italy; 3 Laboratory
of Cardiovascular Biochemistry, CNR Institute of Clinical Physiology,
Pisa, Italy
Cardiovascular: Modelling in silico and in vitro (PS3)
P22-P30
Chairmen:
Libera FRESIELLO, Leuven, Belgium,
Marek DAROWSKI, Warsaw, Poland
P22
COMPUTATIONAL FLUID DYNAMICS ANALYSIS OF HYDRODYNAMIC
BEARINGS UNDER PULSING FLOW CONDITIONS IN BLOOD PUMP
Han Q, Li H
School of Mechanical Engineering, University of Jinan, Jinan, China
P23
SETTING UP A PAEDIATRIC PNEUMATIC VAD: A HYBRID MODEL STUDY
Ferrari G1, Di Molfetta A2, Zieliński K3, Fresiello L4, Górczyńska K3,
Pałko KJ3, Darowski M13, Amodeo A2, Kozarski M3
1
Section of Rome, Cardiovascular engineering, CNR - Institute of clinical
Physiology, Rome, Italy; 2 Department of Pediatric Cardiology and
Cardiac Surgery, Pediatric Hospital Bambino Gesu, Rome, Italy; 3 Nalecz
Institute of Biocybernetics and Biomedical Engineering, Polish Academy
of Sciences, Warsaw, Poland; 4 Clinical Cardiac Surgery Department,
KU Leuven, Leuven, Belgium
P24
INVESTIGATION OF HYDRODYNAMIC BEARING FOR RELIGA HEART®
ROT CENTRIFUGAL BLOOD PUMP
Altyntsev I, Darlak M, Kustosz R
P25
FORCE BALANCE IN RELIGA HEART® ROT CENTRIFUGAL BLOOD PUMP
Altyntsev I, Darlak M, Kustosz R
P26
COMPARISON OF THE FLOW PATTERN OBTAINED WITH NUMERICAL
SIMULATIONS AND PIV MEASUREMENTS
Obidowski D, Reorowicz P, Jodko D, Witkowski D, Jóźwik K
Institute of Turbomachinery, Lodz University of Technology,
Lodz, Poland
P27
BLOOD PARAMETERS INVESTIGATION TO DEFINE BEST NUMERICAL
AND IN VITRO TESTING CONDITIONS TO BENCHMARK VAD
PERFORMANCE
Molteni A, Chan C
Calon Cardio-Technology Ltd, Swansea, UK
P28
MATLAB/ SIMULINK MODELING OF MECHATRONIC LVAD UNIT
WORKING IN CHRONIC HEART FAILURE
Zhdanov A, Shtyh D, Belyaev L, Morozov V
Russian Federation
44
th
Poster Sessions
P29
NUMERICAL INVESTIGATION OF BLOOD FLOW IN A STENOTIC
VASCULAR USING MULTIPHASE MODEL
Gou Z1, Ruan X1, Qian W2, Zou J1, Fu X1
1
State Key Laboratory of Fluid Power & Mechatronic Systems, Zhejiang
University, Hangzhou, China; 2 Cardiothoracic Surgery Department,
Zhejiang Provincial People’s Hospital, Hangzhou, China
P30
FORMAL MODELLING AND ANALYSIS TOOL APPLIED TO DEVELOPMENT
OF VAD SAFETY CONTROL SYSTEM
Cavalheiro A1, Santos Filho D2, Andrade A3, Fonseca J3
1
Engeneer, Fundacao Santo Andre, Sao Paulo, Brazil; 2 Engenharia,
Escola Politecnica da USP, Sao Paulo, Brazil; 3 Bioengeneer, Instituto
Dante Pasanezze de Cardiologia, Sao Paulo, Brazil
Artificial circulation (Lung, ECMO and Liver) (PS4)
P31-P42
Chairmen:
Khosrow MOTTAGHY, Aachen, Germany
P31
COMPARISON OF BLOOD OXYGENATION IN SINGLE AND DUAL
CANNULATION FOR ADULT EXTRACORPOREAL MEMBRANE
OXYGENATION
Togo K1, Takewa Y2, Katagiri N2, Fujii Y2, Tateishi S3, Tatsumi E2
1
Health Medical, Teikyo Heisei University, Tokyo, Japan; 2 Artificial
Organs, National Cerebral and Cardiovascular Center, Osaka, Japan;
3
CA/CP Business Unit, Maquet Japan, K.K., Tokyo, Japan
P32
USING A NEW HYBRID RESPIRATORY SIMULATOR TO STUDY
THE INFLUENCE OF VENTILATION PARAMETERS ON WORK
OF BREATHING IN SMALL CHILDREN
Stankiewicz B, Pałko KJ, Darowski M, Zieliński K, Kozarski M
Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish
Academy of Sciences, Warsaw, Poland
P33
A NEW RESPIRATORY TRAINING SYSTEM WITH A CONTROLLED CO2
ELIMINATION FOR HIGH ALTITUDE TRAINING
Mouzakis F1, Poorkhalil A1, Tabesh H2, Kashefi A1, Mottaghy K1
1
Institute of Physiology, RWTH Aachen University, Aachen, Germany;
2
Department of Life Science Engineering, Faculty of New Sciences and
Technologies, University of Tehran, Tehran, Islamic Republic of Iran
P34
COAGULATION PATTERNS DURING AND AFTER CARDIOPULMONARY
BYPASS DETECTED WITH THROMBELASTOGRAPHY
Hajek R1, Fluger I1, Zezula R1, Maderova K1, Prikrylova K1, Zuscich O1,
Lonsky V1, Ruzickova J2
1
Cardiac Surgery, University Hospital Olomouc, Olomouc,
Czech Republic; 2 Management, Central Moravian Hospital Group,
Prostejov, Czech Republic
P35
NEW BIDIRECTIONAL ARTERIAL PERFUSION DEVICE
Abdel-Sayed S1, Favre J2, Wilhelm M3, Maisano F3, von Segesser L2
1
Surgery, University hospital-CHUV, Lausanne, Switzerland;
2
Department of Musculoskeletal Medicine, University hospital-CHUV,
Lausanne, Switzerland; 3 Department of Cardio-Vascular Surgery,
University Hospital, Zurich, Switzerland
P36
THE PERSPECTIVES FOR APPLICATION OF THE BLOOD
PHOTOBIOMODULATION DURING EXTRACORPOREAL CIRCULATION
Walski T1, Drohomirecka A2, Wąż G3, Trochanowska N1, Gałecka K1,
Czerski A4, Witkiewicz W5, Komorowska M1
1
Department of Biomedical Engineering, Wroclaw University of Science
and Technology, Wroclaw, Poland; 2 Institute of Cardiology, Warsaw,
Poland; 3 Medinet Heart Center Ltd., Wroclaw, Poland; 4 Department
of Animal Physiology and Biostructure, University of Environmental
and Life Sciences, Wroclaw, Poland; 5 Research and Development
Centre, Regional Specialist Hospital in Wroclaw, Wroclaw, Poland
P37
ROLE OF PROSTAGLANDINS IN NORMOTHERMIC LIVER MACHINE
PERFUSION
Rivera A1, Sierra A1, Chuvieco S1, Fernandez-Lopez I1,
Gutierrez-Gutierrez J1, Sanchez del Arco R1, Gullon L2, Asencio J3,
Del Cañizo J2
1
Department of Surgery, Universidad Complutense, Madrid, Spain;
2
Artificial Circulation Laboratory (LCA). Experimental Surgery
Department, Hospital General Universitario Gregorio Marañon, Madrid,
Spain; 3 Department of General Surgery., Hospital General Universitario
Gregorio Marañon, Madrid, Spain
P38
A MULTISCALE FRAMEWORK FOR STUDYING VASCULAR MORPHOLOGY
ALTERATIONS DURING LIVER CIRRHOGENESIS: A FEASIBILITY STUDY
Peeters G1, Debbaut C1, Detrez J2, De Vos W2, Cornillie P3,
Vandecasteele T3, De Schryver T4, Monbaliu D5,
Laleman W5, Segers P1
1
Department of Electronics and Information Systems, Ghent University,
Ghent, Belgium; 2 Department of Veterinary Sciences, University
of Antwerp, Antwerpen, Belgium; 3 Department of Morphology,
Ghent University, Ghent, Belgium; 4 UGCT, Ghent University, Ghent,
Belgium; 5 University Hospitals Leuven, KU Leuven, Leuven, Belgium
P39
THE ROLE OF DEOXYCHOLIC ACID IN LIVER NORMOTHERMIC
PERFUSION
Gutierrez-Gutierrez J1, Sanchez del Arco R1, Gullon L1, Chuvieco S1,
Fernandez I1, Asencio J2, Del Cañizo J1
1
Department of Surgery. Universidad Complutense de Madrid,
Laboratorio de Circulacion Artificial. Hospital General Universitario
Gregorio Maranon, Madrid, Spain; 2 General Surgery Department,
HGUGM, Madrid, Spain
P40
SINGLE COMPARTMENT MODEL FOR KINETICS OF BILE ACIDS DURING
EXTRACORPOREAL LIVER SUPPORT THERAPY
Jung A1, Krisper P2, Korohoda P3, Stadlbauer-Köllner V2,
Stauber R2, Schneditz D4
1
Department of Medical Physics and Biophysics, AGH University
of Science and Technology, Cracow, Poland; 2 Department of Internal
Medicine, Medical University of Graz, Graz, Austria; 3 Department
of Electronics, AGH University of Science and Technology, Cracow,
Poland; 4 Institute of Physiology, Medical University of Graz,
Graz, Austria
P41
LASER-BASED MEASUREMENTS OF AIRBORNE PARTICLES GENERATED
BY NEBULIZERS
D'Avenio G, Daniele C, Grigioni M
Technolgy and Health, Istituto Superiore di Sanità, Rome, Italy
P42
WITHDRAWN
45
th
Poster Sessions
Organ Tissue Engineering (PS5)
P43-P53
Chairmen:
Cecile LEGALLAIS, Compiegne, France,
Nuno M. NEVES, Guimarães, Portugal
P43
TRANSCRIPTIONAL SELECTION AND MAINTENANCE OF INDUCED
CARDIOMYOCYTE PRECURSOR CELLS CREATED BY DIRECT
REPROGRAMMING
Bachamanda Somesh D1, Klose K1, Protze S2, Kunkel D1, Gossen M1,
Falk V3, Stamm C3
1
Berlin Center for Regenerative Therapies, Berlin, Germany; 2 McEwen
Center for Regenerative Medicine, Toronto, Canada; 3 Deutsches
Herzzentrum Berlin, Berlin, Germany
P44
ONE RESULT ABOUT GROWTH ADAPTATION OF A BIOTUBE VASCULAR
GRAFT IN A RAT MODEL
Ishii D1, Enmi J2, Iida H2, Kurisu K1, Nakayama Y3
1
Department of Neurosurgery, Hiroshima University Graduate School
of Biomedical and Health Sciences, Hiroshima, Japan; 2 Department
of Investigative Radiology, National Cerebral and Cardiovascular Center,
Suita, Japan; 3 Division of Medical Engineering and Materials, National
Cerebral and Cardiovascular Center, Suita, Japan
P45
THE OXYGENE PARTIAL PRESSURE IN THE CULTURE OF HUVECS
PERFORMED IN THE CAPILLARY MEMBRANE BIOREACTOR
SIMULATING THE ARTIFICIAL BLOOD VESSEL
Dolata A, Ciechanowska A, Hoser G, Sabalińska S, Kawiak J,
Wojciechowski C, Chwojnowski A, Ładyżyński P
Nalecz Institute of Biocybernetics and Biomedical Engineering,
P49
A BIOARTIFICIAL KIDNEY DEVICE FOR PROTEIN BOUND UREMIC TOXIN
REMOVAL AND IMMUNOGENICITY ANALYSIS
Fedecostante M1, Chevtchik N2, Mihaijlovic M1, Stamatialis D2,
Masereeuw R1
1
Pharmacology Division, Utrecht University, Utrecht, The Netherlands;
2
Biomaterials Science and Technology, University of Twente,
Enschede, The Netherlands
P50
SELECTION OF SYNTHETIC POLYMER SOLUTIONS FOR THE PRODUCTION
OF PARTIALLY BIODEGRADABLE MICROCAPSULES
Kutkowska A, Grzeczkowicz M, Paziewska A, Chwojnowski A, Lewińska D
P51
GENETICALLY MODIFIED HUMAN HEPATOMA CELL LINE – C3A
CHARACTERIZED BY HIGH AMMONIA TOLERANCE AS A SOURCE
OF CELLS FOR BIOARTIFICIAL LIVER SUPPORT
Samluk A, Zakrzewska K, Kowalska A, Pijanowska D1, Pluta K
P52
EFFECT OF DIRECT TENSILE STRAIN ON DIFFERENTIATION
OF MESENCHYMAL STEM CELLS
Campbell Ritchie A1, Moles M2, Colin S1, Sottile V3
1
Faculty of Engineering, University of Nottingham, Nottingham, UK; 2
Wolfson School of Engineering, University of Loughborough,
Loughborough, UK; 3 Faculty of Medicine, University of Nottingham,
Nottingham, UK
P46
AN EFFECT OF THROMBIN ON PROLIFERATION OF HUVECS CULTURED
ON THE FLAT SEMIPERMEABLE POLYSULFONE MEMBRANE
SIMULATING THE BLOOD VESSEL WALL
Hoser G, A. Ciechanowska A, Sabalińska S, Kawiak J, Wojciechowski C,
Chwojnowski A, Ładyżyński P
P53
MICROCOMPUTED TOMOGRAPHY (MCT) STUDY OF HOLLOW FIBER
MEMBRANE (HFM) DISTRIBUTION IN HFM-BIOREACTORS IN SHELLAND-TUBE CONFIGURATION FOR BONE TE
Falvo D’Urso Labate G1, Debbaut C2, Van Hoorebeke L3, De Schryver T3,
Segers P2, Catapano G1
1
Department of Environmental and Chemical Engineer, University
of Calabria, Cosensa, Italy; 2 IBiTech - BioMMeda, Ghent University,
Ghent, Belgium; 3 UGCT-Rad. Phys., Dept. of Physics and Astronomy,
Ghent University, Ghent, Belgium
P47
AN ANALYSIS OF PROLIFERATION AND PRODUCTION OF VWF AND
SICAM-1 BY HUVECS CULTURED IN MEMBRANE BIOREACTOR USED AS
A MODEL OF ARTIFICIAL BLOOD VESSEL
Ciechanowska A, Hoser G, Sabalińska S, Kawiak J, Wojciechowski C,
Chwojnowski A, Ładyżyński P
Methods in Tissue Engineering (PS6)
P54-P62
P48
THE DEVELOPMENT OF XENOGENEIC, SELF-ORGANIZING SMALLDIAMETER VASCULAR GRAFT USING BIOTUBE MATRIX
Yamanami M1, Kawasaki T2, Kami D3, Watanabe T1, Kanda K1, Gojo S3,
Yaku H1
1
Department of Cardiovascular Surgery, Kyoto Prefectural University
of Medicine, Kyoto, Japan; 2 Department of Cardiovascular Medicine,
Kyoto Prefectural University of Medicine, Kyoto, Japan; 3 Department
of Regenerative Medicine, Kyoto Prefectural University of Medicine,
Kyoto, Japan
Chairmen:
Dorota G. PIJANOWSKA, Warsaw, Poland,
Dimitrios STAMATIALIS, Twente, The Netherlands
P54
CHECKERED MICRO CONVEXOCONCAVE PATTERN FOR ORIENTATION
OF CELL CULTURE
Hashimoto S, Takahashi Y, Sugimoto K, Hino H
Mechanical Engineering, Kogakuin University, Tokyo, Japan
P55
ELECTRIC STIMULATION FOR MYOBLAST CULTURE ON MICRO COIL
SPRING
Takahashi Y, Hashimoto S, Hino H, Takeda T, Noda K
46
Poster Sessions
P56
ROLE OF ZINC IN MYOGENIC DIFFERENTIATION
Mnatsakanyan H1, Rico P2, Sabater i Serra R1, Salmeron-Sanchez M3
1
Centre for Biomaterials and Tissue Engineering, Universitat Politècnica
de València, Valencia, Spain; 2 Networking Research Center
on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN),
Zaragoza, Spain; 3 Division of Biomedical Engineering, School
of Engineering, University of Glasgow, Glasgow, UK
th
P64
TRANSCRANIAL CEREBELLAR DIRECT CURRENT STIMULATION IN
PARALYMPIC POWERLIFTERS
Trapp A, Canciglieri Junior O, Alessandro T, Rudek M
Production and Systems Engineering Graduate Program - PPGEPS,
Pontifical Catholic University of Paraná, Curitiba, Brazil
P57
GINSENG FILMS AS MATERIALS FOR WOUND HEALING
Krylova E1, Krylov S1, Kraseninnikov M2, Oganesyan R2, Lyundup A2,
Ivanov I3, Titova M3
1
IRIS, Belgorod, Russian Federation; 2 Sechenov First Moscow Sate
Medical University, Moscow, Russian Federation; 3 Timiryazev Institute
of Plant Physiology RAS, Moscow, Russian Federation
P65
ENSHURING THE INFECTIOUS SAFETY OF ALLOGENEIC TISSUE-DERIVED
BIOMEDICAL PRODUCTS (TBPS) TO USE IN A HOSPITAL AMBULANCE
Khubutia M1, Mironov A2, Khvatov V2, Borovkova N2, Ponomarev I2,
Ponkratova A2, Abramov V1
1
Surgery, Sklifosovsky Research Institution of Emergency Care and
Moscow Institution of Physics and Technology, Moscow, Russian
Federation; 2 Cell and Tissue Technology, Sklifosovsky Research
Institution of Emergency Care, Moscow, Russian Federation
P58
LASER WELDING OF BIOLOGICAL TISSUES OF THE INTERNAL ORGANS
OF THE DIGESTIVE SYSTEM
Savelyev M, Ryabkin D, Rimshan I, Ichkitidze L, Podgaetskiy V, Selishchev
S, Gerasimenko A
Biomedical systems, MIET, Moscow, Russian Federation
P66
CURRENT STATUS IN JAPAN FOR TENDENCY OF INTELLECTUAL
PROPERTY EVALUATION INDEX OF MEDICAL DEVICES
Akagawa E, Tatsumi E
Department of Intellectual Asset Management, National Cerebral
and Cardiovascular Center, Osaka, Japan
P59
COMPARISON THE VIABILITY OF CELLS CULTURED ON POLYMERIC
MEMBRANES PREPARED USING DIFFERENT PORE PRECURSORS
Łukowska E, Kutkowska A, Chwojnowski A, Wojciechowski C
P67
REQUIREMENTS TO SUPORT DESIGN FOR ASSISTIVE TECHNOLOGY DFAT TO OSTOMIZED PRODUCT: SYSTEMATIC REVIEW
Okumura MLM, Canciglieri Junior O
Production and Systems Engineering Graduate Program - PPGEPS,
Pontifical Catholic University of Paraná – PUCPR, Curitiba, Brazil
P60
CONTROLLED INFILTRATION OF CELLS INTO SPHERICAL POLYMERIC
SCAFFOLDS
Suresh S, Gryshkov O, Glasmacher B
Institute for Multiphase Processes, Leibniz Universität Hannover,
Hannover Germany
P68
THE EFFECT ON NERVE REGENERATION FROM INCREASED BLOOD
FLOW IN THE NERVE CONTROL AREA DUE TO STELLATE GANGLION
BLOCKS
Shigeno K, Kaneko M, Wakatsuki M, Shionoya I, Nakada A, Inada Y,
Kanemaru S, Nakamura T
Department of Bio-Artificial Organ, Institute for Frontier Medical
Sciences, Kyoto University, Kyoto, Japan
P61
ACCELERATION OF PROLIFERATION AND DIFFERENTIATION OF CELLS BY
ULTRASONIC VIBRATION
Hino H, Hashimoto S, Nakajima H, Takahashi Y
P62
DEVELOPMENT OF AFFINITY-BASED DELIVERY SYSTEM FOR HEPARINBINDING PROTEINS
Pokholenko I1, Dubey I1, Vozianov S2, Romanenko A2, Pirogov V2,
Bazalytska S2, Nikitaiev S2, Kordium V1
1
Institute of Molecular Biology and Genetics of NAS of Ukraine, Kyiv,
Ukraine; 2 State Institution "Institute of Urology of NAMS of Ukraine",
Kyiv, Ukraine
Innovative Technologies and New Ideas (PS7)
P63-P71
Chairmen:
Jörg VIENKEN, Usingen, Germany,
Paweł KOSTKA, Zabrze, Poland
P63
BIOMIMETIC ARTIFICIAL TONGUE FOR THE MASTICATION
AND THE PERISTALSIS
Yambe T, Shiraishi Y, Inoue Y, Yamada A
PreClinical Research Center, Tohoku University, Sendai, Japan
P69
DIGITAL SCOUT IN PARASPORTS: A CASE STUDY WITH THE MEN 'S
SELECTION OF GOALBALL
Trapp A, Canciglieri Junior O, Okumura M, Tosim A, Rudek M
Production and Systems Engineering Graduate Program, Pontifical
Catholic University of Parana, Curitiba, Brazil
P70
SUPERCONDUCTING FILM MAGNETIC CONCENTRATOR
IN THE COMBINED MAGNETIC FIELD SENSOR
Ichkitidze L, Telishev D, Shichkin N
Department of Biomedical Systems, National Research University
of Electronic Technology, MIET, Moscow, Russian Federation
P71
ANTIBACTERIAL POLY (URETHYANE UREA) BY GELATIN/ALGINATE
IMOMOBIZATION
Shaneh S1, Shokrolahi F1, Shokrollahi P1, Yeganeh H2
1
Biomaterials, Iran Polymer and Petrochemical Institute, Tehran,
Islamic Republic of Iran; 2 Polyurethanes, Iran Polymer and
Petrochemical Institute, Tehran, Islamic Republic of Iran
47
Poster Sessions
FRIDAY, September 16th
Poster Session II
15:30 – 16:30
Poster Area
Hemodialysis I (PS8)
P72-P83
Chairmen:
Bernd STEGMAYR, Umea, Sweden,
Malgorzata DEBOWSKA, Warsaw, Poland
Posters: P88, P75, P89, P93, P81, P80, P92, P90, P91, P79, P78, P77, P76
assigned to Hemodialysis I and Hemodialysis II sessions will be
presented in a form of short oral presentations in Lecture Hall B starting
at 15:30.
P72
WITHDRAWN
P73
OXIDATIVE STRESS IN HEMODIALYSIS PATIENTS (HDP)
WITH OR WITHOUT SEC-HYPERPARATHYROIDISM
Yonova D, Georgieva I, Papazov V, Trendafilov I, Georgiev M, Vazelov E
Medical Faculty, Medical University, University Dialysis Center,
Sofia, Bulgaria
P74
PERITONITIS WAS NOT ASSOCIATED WITH THE SURVIVAL OF PATIENTS
ON PERITONEAL DIALYSIS
Dzekova-Vidimliski P1, Simeonov R2, Sikole A1
1
University Hospital of Nephrology, Skopje, The Former Yugoslav
Republic of Macedonia; 2 University Hospital of Pediatric Surgery,
Skopje, The Former Yugoslav Republic of Macedonia
P75
REMOVAL OF BILE ACIDS IN EXTRACORPOREAL THERAPIES:
AN IN-VITRO STUDY
Hartmann J1, Harm S2
1
Health Sciences & Biomedicine, Danube University Krems, Krems,
Austria; 2 Center for Biomedical Technology, Danube University Krems,
Krems, Austria
P76
RELATIONSHIP BETWEEN CIRCULATING ENDOTHELIAL NITRIC OXIDE
SYNTHASE (ENOS) AND RECEPTOR FOR ADVANCED GLYCATION
END PRODUCTS (RAGE) IN HEMODIALYSIS (HD)
Niepolski L1, Warchoł W2, Grzegorzewska A3
1
Dialysis Center, B.Braun Avitum Poland, Nowy Tomysl, Poland;
2
Department of Biophysics, Poznan University of Medical Sciences,
Poznan, Poland; 3 Department of Nephrology, Transplantology
and Internal Diseases, Poznan University, Poznan, Poland
th
P78
TREATMENT OF LARGE PLASMA VOLUMES USING SPECIFIC
IMMUNOADSORPTION TO DESENSITIZE ABO-INCOMPATIBLE
KIDNEY-TRANSPLANT CANDIDATES
Rostaing L1, Allal A2, Del Bello A2, Salusto F3, Esposito L2, Doumerc N3,
Debiols B4, Delas A5, Game X3, Kamar N2
1
Faculté de Médecine de Rangueil, Université Toulouse III Paul Sabatier,
Toulouse, France; 2 Department of Nephrology and Organ
Transplantation, CHU Toulouse Rangueil, Toulouse, France;
3
Department of Urology and Organ Transplantation, CHU Toulouse
Rangueil, Toulouse, France; 4 Etablissement Français du Sang, CHU
Toulouse Purpan, Toulouse, France; 5 Service d'Anatomie et Cytologie
Pathologiques, CHU Toulouse Rangueil, Toulouse, France
P79
FOUR METHODS TO REDUCE EXPOSURE TO HEPARIN DURING
HEMODIALYSIS
Stegmayr B, Skagerlind M
Public Health and Clinical Medicine, Umea University, Umea, Sweden
P80
REMOVAL OF DRUGS BENEFICIAL TO PATIENTS BY VARIOUS HIGH-FLUX
MEMBRANES
Gebert M, Schmidt C, Hodler J, Voigt M, Boschetti-de-Fierro A, Hulko M,
Krause B
Research and Development, Gambro Dialysatoren GmbH
(a part of Baxter International Inc.), Hechingen, Germany
P81
DETERMINATION OF ALBUMIN REMOVAL DURING HEMODIALYSIS:
INFLUENCE OF THE DIALYSATE SAMPLING METHOD
Boschetti-de-Fierro A1, Voigt M1, Hornung M2, Hulko M1, Storr M1,
Beck W3, Krause B1, Lemke H4, Krieter D5
1
Research and Development, Gambro Dialysatoren GmbH, Hechingen,
Germany; 2 Product Development, Gambro Dialysatoren GmbH,
Hechingen, Germany; 3 Therapeutic Area, Gambro Dialysatoren GmbH,
Hechingen, Germany; 4 eXcorLab GmbH, Obernburg, Germany; 5 Division
of Nephrology, Department of Medicine, University of Würzburg,
Würzburg, Germany
P82
FOLLOW UP OF DIABETIC PATIENTS WITH CENTRAL VENOUS
CATHETERS FOR HEMODIALYSIS
Gerasimovska V1, Gerasimovska Kitanovska B2, Sikole A2
1
Department of Nephrology, University Hospital, Skopje, The Former
Yugoslav Republic of Macedonia; 2 University Clinic of Nephrology,
Skopje, The Former Yugoslav Republic of Macedonia
P83
ASSOCIATION BETWEEN KDIGO SUGGESTED LEVEL ACHIEVEMENT
FOR SERUM CKD-MBD MARKERS AND ARTERIO-VENOUS FISTULA
THROMBOSIS IN OUR HEMODIALYSIS PATIENTS
Gelev S, Gerasimovska V, Selim G, Trajceska L, Dzekova P, Sikole A
Department of Nephrology, University Hospital, Skopje,
The Former Yugoslav Republic of Macedonia
P77
EFFICACY OF LIVER SUPPORTS IN ACUTE-ON-CHRONIC LIVER FAILURE:
ROLE OF THE ASSESSMENT OF LIVER FUNCTION IMPAIRMENT BEFORE
TREATMENT
Marangoni R, Bellati G, Colombo A
Department of Medicine, St. Anna Hospital, Como, Italy
48
Poster Sessions
Hemodialysis II (PS9)
P84-P96
Chairmen:
Joanna STACHOWSKA-PIETKA, Warsaw, Poland,
Andrea REMUZZI, Milan, Italy
Posters: P88, P75, P89, P93, P81, P80, P92, P90, P91, P79, P78, P77, P76
assigned to Hemodialysis I and Hemodialysis II sessions will be
presented in a form of short oral presentations in Lecture Hall B starting
at 15:30.
P84
SERUM LEVELS OF SELENIUM (SE) IN PATIENTS ON HEMODIALYSIS (HD)
AND PERITONEAL DIALYSIS (PD)
Yonova D1, Georgieva I1, Vazelov E1, Trendafilov I1, Papazov V1,
Tsachev K2
1
Medical Faculty, Medical University, University Dialysis Center, Sofia,
Bulgaria; 2 Medical Faculty, Medical University, Clinical Department
of Laboratory and Immunology, Sofia, Bulgaria
P85
REDUCTION OF UREA AND INDOXYL SULPHATE CONCENTRATION
DURING DIFFERENT DIALYSIS TREATMENT MODALITIES
Holmar J1, Luman M2, Arund J1, Lauri K3, Tomson R1, Tanner R1, Kalle S1,
Fridolin I1
1
Department of Biomedical Engineering, Tallinn University
of Technology, Tallinn, Estonia; 2 Department of Nephrology, North
Estonian Medical Centre, Tallinn, Estonia; 3 Synlab Eesti OÜ,
Tallinn, Estonia
P86
AN EXPERIMENTAL STUDY TO INVESTIGATE THE STEAL PHENOMENON
DURING HEMODIALYSIS
Krueger U
Department of Vascular Surgery, Queen Elisabeth Hospital,
Berlin, Germany
P87
EFFECTS OF WHOLE BLOOD VISOCITY CHANGES THROUGHOUT
HEMODIALYSIS SESSION ON PULSE WAVE PROPAGATION:
MATHEMATICAL MODELLING
Poleszczuk J1, Dębowska M1, Wójcik-Załuska A2, Dąbrowski W3,
Książek A4, Załuska W4, Waniewski J1
1
Polish Academy of Sciences, Warsaw, Poland; 2 Department of Physical
Therapy and Rehabilitation, Medical University of Lublin, Lublin, Poland;
3
Department of Anesthesiology and Intensive Therapy, Medical
University of Lublin, Lublin, Poland; 4 Department of Nephrology,
Medical University of Lublin, Lublin, Poland
P88
PREDICTION OF SERUM POTASSIUM CONCENTRATION LEVELS DURING
A WEEK-LONG HAEMODIALYSIS CYCLE USING PSEUDO-ONE
COMPARTMENT MODELLING
Pietribiasi M1, Załuska A2, Załuska W3, Lindholm B4, Waniewski J1
1
Polish Academy of Sciences, Warsaw, Poland; 2 Department
of Rehabilitation and Physiotherapy, Medical University of Lublin,
Lublin,Poland; 3 Department of Nephrology, Medical University
of Lublin, Lublin, Poland; 4 Baxter Novum and Renal Medicine,
Karolinska Institutet, Stockholm, Sweden
P89
EFFECTS OF ELEVATED GLUCOSE LEVELS ON BLOOD-RHEOLOGICAL
PARAMETERS AND ITS REPERCUSSIONS ON DIALYSIS TREATMENT
Ndzengue S1, Müller M1, Vienken J2, Glasmacher B1
1
Institute for Multiphase Processes, Leibniz Universität Hannover,
Hannover Germany; 2 Nephro-Solutions AG, Hamburg, Germany
th
P90
HYDRODYNAMIC EVALUATION OF A CATHETER-BASED
INTRAVASCULAR ROTARY BLOOD PUMP FOR ASSISTING SELECTIVE
RENAL BLOOD CIRCULATION
Sumikura H1, Ohnuma K2, Hanada S3, Tsukiya T4, Mizuno T4, Homma A5,
Mukaibayashi H6, Kojima K6, Takewa Y4, Tatsumi E4
1
National Cerebral and Cardiovascular Center Research Institute, Osaka,
Japan; 2 Faculty of Biomedical Engineering, Toin University of Yokohama,
Osaka, Japan; 3 Taisei Clinic, Osaka, Japan; 4 Department of Artificial
organs, National Cerebral and Cardiovascular Center Research Institute,
Osaka, Japan; 5 School of Science and Engineering, Tokyo Denki
University, Tokyo, Japan; 6 IWAKI Co., Ltd., Tokyo, Japan
P91
WATER TRANSPORT PATHWAYS WITH THE PROLONGED PERITONEAL
EQUILIBRATION TEST (8HOURS), USING PERITONEAL SOLUTIONS WITH
LACTATE, BICARBONATE, ICODEXTRIN A
Teixido-Planas J, Troya-Saborido M, Del-Rio-Lafuente M, Rubio C, Bonet J
Nephrology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
P92
INTEGRATION OF A PATIENT-DEPENDENT KINETIC MODEL
AND STATISTICAL ALGORITHMS FOR THE PREVENTIVE
DETECTION OF INTRA–DIALYSIS HYPOTENSION
Bianchi C1, Vito D1, Casagrande G1, Minoretti C2, Pontoriero G3,
Rombolà G4, Schoenholzer C5, Costantino M1
1
Department of Chemistry, Materials and Chemical Engineering,
Politecnico di Milano, Milan, Italy; 2 Nefrologia e Dialisi, Azienda
Ospedaliera Sant'Anna, Como, Italy; 3 Nefrologia e Dialisi, Azienda
Ospedaliera di Lecco, Lecco, Italy; 4 Nefrologia e Dialisi, Ospedale
di Circolo e Fondazione Macchi di Varese, Varese, Italy; 5 Nefrologia
e Dialisi, Ospedale Regionale di Lugano (EOC), Lugano, Switzerland
P93
APPROACHING WEARABLE ARTIFICIAL KIDNEY
Bazaev N, Selishchev S
Biomedical systems, National Research University of Electronic
Technology, Moscow, Russian Federation
P94
DIALYSIS REGENERATION METHODS
Bazaev N, Grinval'd V, Pozhar K
Technology, Moscow, Russian Federation
P95
COMPARISON OF DIFFERENT EXPERIMENTAL SYSTEMS FOR
EXAMINATION OF THE DYNAMICS OF VITAMIN B12 RELEASE
FROM ALGINATE-POLYETHERSULFONE MICROCAPSULES
Grzeczkowicz M, Lewińska D
P96
PRELIMINARY RISK ANALYSIS ON AIR INFUSION IN EXTRACORPOREAL
BLOOD PURIFICATION DEVICES
Neri M1, De Rossi N1, Ferrari F2, Garzotto F3, Ronco C3, Trevisani A1
1
Department of Management and Engineering, Università degli Studi
di Padova, Vicenza, Italy; 2 Department of Intensive Care Unit, San
Bortolo Hospital, International Renal Research Institute of Vicenza
(IRRIV), Vicenza, Italy; 3 Department of Nephrology, Dialysis and
Transplantation, San Bortolo Hospital, International Renal Research
Institute of Vicenza (IRRIV), Vicenza, Italy
49
th
Poster Sessions
Biomaterials: Synthesis and Characterization (PS10)
P97-P102
Chairmen:
Dorota LEWINSKA, Warsaw, Poland
Jose Luis GOMEZ RIBELLES, Valencia, Spain
P97
IN VITRO DEGRADATION STUDY OF THE INNOVATIVE ELASTOMER
Zawidlak-Węgrzyńska B1, EL Fray M2, Piegat A2, Gonsior M1, Kustosz R1
1
Surgery Development, Zabrze, Poland; 2 Polymer Institute, Biomaterials
and Microbiology Technologies Dept., West Pomerania University
P98
SYNTHESIS OF A SUPRAMOLECULAR HEMA HYDROGEL
Maleki Esfandabadi S, Shokrolahi P, Barzin J
Biomaterials, Iran Polymer and Petrochemical Institute,
Tehran, Islamic Republic of Iran
P99
SYNTHESIS OF nZnHAp-UPy FOR BONE TISSUE ENGINEERING
APPLICATIONS
M.Moghadam M, Shokrollahi P, Barzin J
Biomaterials, Iran Polymer and Petrochemical Institute,
P100
POLY(ε-CAPROLACTONE)/BIOACTIVE GLASS COMPOSITE FILMS
ENRICHED WITH POLYPHENOLS EXTRACTED FROM SAGE
(SALVIA OFFICINALIS L.)
Dziadek M1, Dziadek K2, Ostrowska W1, Zagrajczuk B1, Menaszek E3,
Cholewa- Kowalska K1
1
Department of Glass Technology and Amorphous Coatings, AGH
University of Science and Technology, Cracow, Poland; 2 Department
of Human Nutrition, University of Agriculture in Cracow, Cracow, Poland;
3
Department of Cytobiology, Jagiellonian University,
Collegium Medicum, Cracow, Poland
P101
APPLICATION OF SYNTHETIC NANOSTRUCTURED ZEOLITE IN
FABRICATION OF POROUS TISSUE ENGINEERING SCAFFOLDS
Mohammadkhani B1, Tabesh H1, Houshmand B2, Mottaghy K3
1
Department of Life Sciences Engineering, Faculty of New Sciences
and Technologies, University of Tehran, Tehran, Islamic Republic of Iran;
2
Department of Periodontology, Faculty of Dentistry, Shahid Beheshti
University of Medical Sciences, Tehran, Islamic Republic of Iran;
3
Institute of Physiology, RWTH Aachen University, Aachen, Germany
P102
NANO-MODIFIED MEMBRANE AND ELECTRICAL STIMULATION FOR
TISSUE REPAIRING APPLICATIONS
Grzeczkowicz A, Grzeczkowicz M, Granicka L
Biomaterials: Biocompatibility (PS11)
P103-P108
Chairman:
Ludomira GRANICKA, Warsaw, Poland,
Andrzej CHWOJNOWSKI, Warsaw, Poland
P103
POLYURETHANE BIOACTIVE SURFACE – ACRYLIC ACID AND REDV
PEPTIDE IMMOBILIZATION
Kuźmińska A, Butruk–Raszeja B, Ciach T
Faculty of Chemical and Process Engineering, Warsaw University
P104
GUINEA PIG MAXIMIZATION TEST FOR A NEW ALIPHATIC-AROMATIC
POLYESTER
Zawidlak-Węgrzyńska B1, Gonsior M1, Kustosz R1, Ścigała P2, Janiczak K1,
Gawlikowski M1, Cieśla P1, El Fray M3, Piegat A1
1
Surgery Development, Zabrze, Poland; 2 Emergency and Specialty Animal
Medical Center, Piekary Śląskie, Poland; 3 Polymer Institute, Biomaterials
and Microbiology Technologies Dept., West Pomerania University
P105
POLY(L-LACTIC ACID) MEMBRANES FOR THE CONTROLLED RELEASE
OF PROTEINS TO IMPROVE THE HEALING OF SKIN DISEASES.
Gallego-Ferrer G, Delmote J, Gomez-Ribelles J
Centre for Biomaterials and Tissue Engineering, Universitat Politecnica
de Valencia, Valencia, Spain
P106
STUDY OF NANOSTRUCTURE AND ADHESION PROPERTIES
OF ALGINATE CELL MICROCARRIERS
Agapova O, Efimov A, Safonova L, Bobrova M, Agapov I
Laboratory of Bionanotechnology, V.I.Shumakov Federal Research
Center of transplantology and artificial organs of the Ministry
of Healthcare of the Russian Federation, Moscow, Russian Federation
P107
BIODEGRADABLE MEMBRANE AS A SCAFFOLD FOR ADHERENT
CELLS GROWTH - PRELIMINARY REPORT
Antosiak-Iwańska M, Godlewska E, Kinasiewicz J, Granicka L
P108
USE OF POLYETHYLENEIMINE AS AN ATTACHMENT FACTOR
IN HEPATIC CELLS CULTURE
Kowalska A, Zakrzewska K, Samluk A, Pijanowska D, Pluta K
Biomaterials for Bone Replacement (PS12)
P109-P114
Chairmen:
Gloria GALLEGO-FERRER , Valencia, Spain,
Gerardo CATAPANO, Rende, Italy
P109
COATINGS ON STAINLESS STEEL 316L FOR BIOMEDICAL APPLICATIONS
Poniatowska A1, Trzaskowska P1, Juśko E2, Ciach T1
1
of Technology, Warsaw, Poland; 2 Faculty of Chemistry,
Warsaw University of Technology, Warsaw, Poland
P110
EFFECT OF MATERIALS SURFACE AND CHEMICAL PROPERTIES ON CELLS
ACTIVITY AND ELASTICITY IN VITRO CHARACTERIZED WITH AFM
MICROSCOPY
Zagrajczuk B1, Dziadek M1, Menaszek E2, Orzechowska B3,
Cholewa-Kowalska K1, Laczka M1
1
Department of Glass Technology and Amorphous Coatings, Faculty
of Materials Science and Ceramics, AGH University of Science
and Technology, Cracow, Poland; 2 Department of Cytobiology,
Jagiellonian University, Collegium Medicum, Cracow, Poland;
3
Department of Biophysical Microstructures, Institute
of Nuclear Physics PAN, Cracow, Poland
50
th
Poster Sessions
P111
NEW TRANSPLANT OF KNEE-JOINT LIGAMENTS WITH COMPOSITE
NANOCOATING
Gerasimenko A1, Zhurbina N1, Kurilova U1, Suetina I2, Mezentseva M2,
Russu L2, Oshkukov S3, Zar V3
1
Technology, Moscow, Russian Federation; 2 Tissue culture, N.F. Gamaley
Federal Reseach Center of Epidemiology and Microbiology, Moscow,
Russian Federation; 3 Traumatology and orthopedics, M.F. Vladimirsky
Moscow Regional Research Clinical Institute, Moscow,
Russian Federation
P112
PROMOTION OF BONE REGENERATION BY UTILITZING OCTACALCIUM
PHOSPHATE AND COLLAGEN COMPOSITE IN CANINE FRONTAL
SINUS(Ⅲ)
Kaneko M, Wakatsuki M, Shigeno K, Nakada A, Nakamura T
Department of Bio-Artificial Organ, Institute for Frontier Medical
Sciences, Kyoto University, Kyoto, Japan
P113
IODINE APATITE - NEW OSTEOPLASTIC MATERIAL
Krylova E1, Krylov S1, Avvakumov I1, Agapova O2, Agapov I2
1
IRIS, Belgorod, Russian Federation; 2 Federal State Budgetary
Institution “Academician V.I.Shumakov Federal Research Center
of Transplantology and Artificial Organs”, Ministry of Health
of the Russian Federation, Moscow, Russian Federation
P114
POLY(ε-CAPROLACTONE)-BASED COMPOSITES CONTAINING BIOACTIVE
GLASS PARTICLES AND CARBON FIBERS FOR TISSUE ENGINEERING
APPLICATIONS
Dziadek M1, Martínez Comesana S2, Stodolak-Zych E3,
Cholewa-Kowalska K1, Zagrajczuk B1, Likus W4,
Los M4, Cieslar-Pobuda A4
1
Department of Glass Technology and Amorphous Coatings,
AGH University of Science and Technology, Cracow, Poland;
2
Department of Materials Engineering, University of Vigo, Pontevedra,
Spain; 3 Department of Biomaterials, AGH University of Science and
Technology, Cracow, Poland; 4 Department of Clinical and Experimental
Medicine, Linköping University, Linköping, Sweden
Biomaterials in Blood Contact (PS13)
P115-P122
Chairmen:
Birgit GLASMACHER, Hannover, Germany,
Bengt LINDHOLM, Stockholm, Sweden
P115
ELECTROPOLYMERIZED POLYMER COATINGS FOR STAINLESS STEEL
AND THEIR FEATURES TOWARDS BLOOD AND TISSUES
Trzaskowska P, Piechna M, Ciach T
P116
HEMOLYSIS ASSESSMENT OF AN INNOVATIVE BIOMATERIAL
FOR LONG TERM IMPLANTS
Janiczak K1, Zawidlak-Węgrzyńska B1, Cieśla P1, Gawlikowski M1,
EL Fray M2, Kustosz R1
1
Surgery Development, Zabrze, Poland; 2 Polymer Institute, West
Pomerania University of Technology, Szczecin, Poland
P117
IN VITRO HEMODYNAMICAL PERFORMANCE COMPARISON
IN ENDOVASCULAR DEVICES FOR TREATING INTRACRANIAL
ANEURYSMS: OUR MICROPOROUS COVERED STENT VS FLOW DIVER
Moriwaki T1, Hidaka R2, Tajikawa T3, Nakayama Y1
1
Division of Medical Engineering and Materials, National Cerebral
and Cardiovascular Center Research Institute, Osaka, Japan; 2 Graduate
School of Science and Engineering, Kansai University, Osaka, Japan;
3
Faculty of Engineering Science, Kansai University, Osaka, Japan
P118
IMMUNOLOGICALLY UNMODIFIED AND MODIFIED VASCULAR
XENOGRAFTS IN THE ONE-YEAR SURVIVAL ANIMALS
– MICROSCOPIC STUDY
Kim W
Department of Thoracic and Cardiovascular Surgery, Seoul National
University Hospital, Seoul, Republic of Korea
P119
EMERGING TREATMENTS USING AN IMPLANTABLE LARGE BORE
VASCULAR ACCESS SYSTEM
Khin N1, Murphy S2, Kyung C3, Avolio A1, Lane R1
1
Faculty of Medicine and Health Sciences, Macquarie University,
Sydney, Australia; 2 Aerospace, Mechanical and Mechatronic
Engineering, University of Sydney, Sydney, Australia; 3 AllVascular Pty
Ltd, Sydney, Australia
P120
WITHDRAWN
P121
EXPANDED PTFE MEMBRANE PREPARATION FOR VASCULAR
PROSTHESIS
Ranjbarzadeh-Dibazar A, Barzin J, Shokrolahi P
Biomaterial, Iran Polymer and Petrochemical Institute,
P122
WITHDRAWN
Biomeasurements, Robotics and Navigations (PS14)
P123-P132
Chairmen:
Anna KORZYNSKA, Warsaw, Poland,
Erik A. JOHANNESSEN, Borre, Norway
P123
THREE-DIMENSIONAL NANO- AND MICROSTRUCTURAL ANALYSIS OF
BIOLOGICAL OBJECTS BY SCANNING PTOBE NANOTOMOGRAPHY
Efimov A, Agapova O, Agapov I
Laboratory of Bionanotechnology, V.I.Shumakov Federal Research
Center of transplantology and artificial organs of the Ministry
of Healthcare of the Russian Federation, Moscow, Russian Federation
P124
NANOMATERIAL LAYERS AS STRAIN SENSORS
Blagov E1, Gerasimenko A2, Ichkitidze L2, Pavlov A1, Petuhov V2,
Podgaetsky V2, Selishchev S2, ShamanY1
1
Institute of Nanotachnology of Microelectronics of the RAS, Moscow,
Russian Federation; 2 Department of Biomedical Systems, National
Research University of Electronic Technology, MIET,
51
th
Poster Sessions
P125
STIMULATION OF THE CONDUCTIVITY OF LAYERS
Blagov E1, Gerasimenko A2, Ichkitidze L2, Kitsuk E1, Pavlov A1,
Podgaetsky V2, Selishchev S2, Shaman Y1
1
Institute of Nanotachnology of Microelectronics of the RAS, Moscow,
Russian Federation; 2 Department of Biomedical Systems, National
Research University of Electronic Technology, MIET,
P132
BIOMEASUREMENTS USING FRACTAL METHODS OF IMAGE ANALYSIS
Klonowski W, Stepien P
P126
DEVELOPMENT OF A NEW COMPACT DEVICE FOR PERSONAL
MONITORING OF INR, AND THE FIRST RESULTS OF ITS USE
IN PATIENTS RECEIVING ANTICOAGULANT THERAPY
Subbotovskaya A1, Seredina T2, Odintsova E3, Dolgushin S4, Tronin A2,
Lifshits G5
1
Laboratory of Genetic Diagnostics, Institute of Chemical Biology and
Fundamental Medicine of the Siberian Branch of the Russian Academy
of Sciences, Novosibirsk, Russian Federation; 2 MBU-Technology Ltd.,
Novosibirsk, Russian Federation; 3 Laboratory of Repair Enzymes,
Institute of Chemical Biology and Fundamental Medicine of the Siberian
Branch of the Russian Academy of Sciences, Novosibirsk, Russian
Federation; 4 Biomedical systems, National Research University
of Electronic Technology, Moscow, Russian Federation; 5 Laboratory for
Personalized Medicine, Institute of Chemical Biology and Fundamental
Medicine of the Siberian Branch of the Russian Academy of Sciences,
Novosibirsk, Russian Federation
Computer Modelling (PS15)
P133-P140
P127
FIBROBLAST MORPHOLOGY PARAMETERS PROPOSED TO COMPARE
INFLUENCE OF PROCESS OF VIRAL TRANSDUCTION TO LIVING CELL
MORPHOLOGY
Korzyńska A1, Orero G2, Roszkowiak Ł1, Zakrzewska K1, Samluk A1, Żak J1,
Pluta K1
1
Polish Academy of Sciences, Warsaw, Poland; 2 Molecular Biology
and Research Section, Hospital de Tortosa Verge de la Cinta, IISPV, URV,
Tortosa, Spain
P128
INNOVATIVE MAN-MACHINE INTERFACES FOR TELEMANIPULATION,
BASED ON FEATURE EXTRACTION OF OPERATOR BIOSIGNALS FROM
MEMS ACCELEROMETERS AND EMG SENSORS
Kostka P1, Nawrat Z2, Malota Z2
1
Faculty of Biomedical Engineering, Silesian University of Technology,
Gliwice, Poland; 2 Foundation for Development of Cardiac Surgery,
Zabrze, Poland
P129
NEW DESIGN OF SMART ACUATOR FOR COLONOSCOPE NAVIGATION
Rabie M, Yao W, Gourlay T
Biomedical Engineering Department, University of Strathclyde,
Glasgow, UK
P130
PROPERTIES OF MATERIALS USED FOR ARTIFICIAL ORGANS –
MOLECULAR CALCULATIONS
Klonowski W
P131
TOWARDS TEXTURE BASED SELECTIVE PROCESSING WITH REGIONS
OF INTEREST FOR TISSUE MICROARRAY IMAGES
Roszkowiak Ł, Korzyńska A, Pijanowska D
Chairmen:
Krzysztof JOZWIK, Lodz, Poland,
P133
SLEEP BRUXISM EPISODE DETECTION SYSTEM BASED ON ECG, EMG
AND HEART RATE VARIABILITY SIGNAL PROCESSING TOWARD
PREVENTING BIOSTIMULATOR DEVELOPMENT
Kostka P, Tkacz E
Faculty of Biomedical Engineering, Silesian University of Technology,
Gliwice, Poland
P134
MATHEMATICAL MODEL OF SHORT-TERM BLOOD PRESSURE
REGULATION
Pstras L1, Thomaseth K2, Waniewski J1, Balzani I3, Bellavere F4
1
Polish Academy of Sciences, Warsaw, Poland; 2 Institute of Electronics,
Computer and Telecommunication Engineering, National Research
Council, Padua, Italy; 3 Departament of Medicine, Sant’Antonio Hospital,
Padua, Italy; 4 Provincial Agency for Health Services (APSS), Trento, Italy
P135
IMPROVING HAEMOLYSIS PREDICTIONS IN VADS BY UTILISING
RECIRCULATING LAGRANGIAN PARTICLE TRACKING
Yousef H1, Molteni A2, Rolland S1, Low K1, Sienz J1, Foster G2
1
ASTUTE 2020, Swansea University, Swansea, UK; 2 Calon CardioTechnology Ltd, Swansea, UK
P136
ADDED COMPLIANCE AND RESISTANCE METHOD AS A TOOL
FOR LUNG FUNCTION TESTING
Pałko KJ, Gólczewski T, Darowski M
P137
OUR VIRTUAL PATIENT IN SIMULATIONS OF THE PHENOMENA
THAT OCCUR DURING THORACENTESIS
Gólczewski T, Michnikowski M, Stecka A
P138
THE RELATIONSHIP BETWEEN DEGRADATION TIME AND POROSITY
IN CUBIC CERAMIC SCAFFOLDS: MODELING AND SIMULATION
Tarkesh Esfahani M1, Tabesh H1, Gholami S1, Mohamadkhani B1,
Poorkhalil A2, Mottaghy K2
1
2
Institute of Physiology, University Hospital Aachen, RWTH Aachen
University, Aachen, Germany
52
Poster Sessions
P139
IN-SILICO PREDICTION OF ESTRADIOL RELEASE FROM AN
INTRAVAGINAL RING UTILIZING A MODIFIED FINITE ELEMENT METHOD
Ziyaee Sigaroudi A1, Tabesh H1, Jafari F1, Farzaneh F2, Mottaghy K3
1
2
Preventative Gynecology Research Center (PGRC), Shahid Beheshti
University of Medical Sciences, Tehran, Islamic Republic of Iran;
3
Institute of Physiology, University Hospital Aachen, RWTH Aachen
University, Aachen, Germany
th
P140
COLOUR RECOGNITION AND STANDARDIZATION ALGORITHM
FOR COLOUR CALIBRATION SLIDE USED
IN DIGITAL PATHOMORPHOLOGY
Żak J1, Korzyńska A1, Roszkowiak Ł1, Pijanowska D1, Dawgul M1,
Dudziński K1, Markiewicz T2
1
Polish Academy of Sciences, Warsaw, Poland; 2 Faculty of Electrical
Engineering, Warsaw University of Technology, Warsaw, Poland
53
AUTHORS INDEX
A
Abbasciano R, O53, O70
Abdel-Sayed S, P35
Abramov V, P65
Adorisio R, P20
Affeld K, O6, O26, O28
Agapov I, O97, P106, P113, P123
Agapova O, O97, P106, P113, P123
Aigner P, AL4, O3, O82
Akagawa E, P66
Al Halabi F, AL5, O111
Alessandro T, P64
Al-Khoury H, O109
Allal A, O74, P78
Altyntsev I, O4, O65, P5, P11, P24, P25
Amoabediny G, O127, O142
Amodeo A, O48, P18, P19, P20, P21, P23
Ando T, O21
Andrade A, P30
Andreas T, IL63 (O105)
Anissimov Y, IL62 (O104)
Anne H, O22
Antolinos Turpín CM, IL22 (O37)
Antona C, P14
Antonov S, O49
Antonowicz M, O65
Antosiak-Iwańska M, P107
Argiles A, IL19, IL36, IL70
Arsov S, O54
Arund J, P85
Asano T, O130
Asencio J, P37, P39
Ashley R, IL41
Avolio A, P119
Avvakumov I, P113
Becker M, O99
Bedou F, O22
Behr M, O55
Bellati G, P77
Bellavere F, P134
Belyaev L, P6, P13, P28
Benkowski R, O83
Bergmeister H, IL63 (O105)
Bernini F, O119
Białkowski J, P17
Biancari F, O70
Bianchi C, O51, P92
Blagov E, P124, P125
Bobrova M, O97, P106
Bode M, O111
Boës S, O5
Bolbasov E, IL60 (O102), IL62 (O104)
Bonet J, P91
Bonn F, O125
Borovkova N, P65
Boschetti-de-Fierro A, O123, P80, P81
Bozzetto M, O9
Brandl M, O113
Brown M, IL14
Brubert J, O16
Buesen M, P15
Bühler M, IL38 (O90)
Bujok W, O44, P9
Burchielli S, O119
Burmester M, O47
Busink E, CM3
Butruk–Raszeja B, P103
Buturović-Ponikvar J, IL65
Buzas E, KL7
Bużańska L, O62
B
C
Bach R, IL48
Bachamanda Somesh D, P43
Bader A, O100
Badria A, O81
Balzani I, P134
Baptista P, IL44 (O93)
Barzin J, P98, P99, P121
Baudequin T, AL3
Baurmeister U, IL26 (O43)
Bazaev N, P93, P94
Bazalytska S, P62
Beck W, P81
Cabiati M, P21
Campbell Ritchie A, P52
Canciglieri Junior O, P64, P67, P69
Carda C, O24, O63
Caruso M, O116
Casagrande G, O51, O58, O134, P92
Casanueva L, O47
Caselli C, P21
Casucci F, O9
Catapano G, IL32, O19, O20, P53
Cavalheiro A, P30
Ceelen W, O139
Chan C, O56, P27
54
Authors Index
Chan-Dominy A, O47
Chevtchik N, P49
Cholewa-Kowalska K, P100, P110, P114
Christensen D, IL30
Chuvieco S, P37, P39
Chwojnowski A, P45, P46, P47, P50, P59
Ciach T, O108, P103, P109, P115
Ciechanowska A, P45, P46, P47
Cieslar-Pobuda A, P114
Cieśla P, O18, O44, O80, O110, O112, P16, P104, P116
Claus P, O68
Colin S, P52
Colombo A, P77
Combs P, IL29
Congy-Jolivet N, O74
Constantino T, O72
Cools B, O68, O69
Cornelissen C, O141
Cornillie P, P38
Costantino M, O16, O45, O51, O58, O134, P92
Cusimano V, O132
Czak M, O66
Czerski A, P36
Czingon M, O44, P16
D
D'Alessandro C, O81
Damanik FFR, IL64 (O106)
Daniele C, P41
Danilov A, O137, P2
Darłak M, O4, O65, P5, P11, P24, P25
Darowski M, O86, O136, P23, P32, P136
D'Avenio G, P41
Dawgul M, P140
Dąbrowski W, O50, P87
De Gaetano F, O16, O45
De Rossi N, P96
De Schryver T, P38, P53
De Vos W, P38
de Zélicourt D, O5, O25
Debbaut C, O19, O20, O139, P38, P53
Debiol B, O74
Debiols B, P78
Dejanov P, O10
Del Bello A, P78
Del Cañizo J, IL42 (O92), IL44 (O93), P37, P39
Del Ry S, P21
Delas A, P78
Delcroix M, O69
Delmote J, P105
Del-Rio-Lafuente M, P91
Detrez J, P38
Dębowska M, O50, O124, P87
Di Molfetta A, IL77, O48, O117, P18, P19, P20, P21, P23
Dimitrov K, O118
Dmitrieva O, P4
Dobson G, O70
Dolata A, P45
Dolgushin S, P126
Domańska-Janik K, O62
Donato D, O19, O123
Doose C, O87
Doumerc N, O74, P78
Dreyer L, O14
Drohomirecka A, P36
Dubey I, P62
Dudziński K, O60, P140
Duijs JMGJ, IL64 (O106)
Dzekova P, O10, P83
Dzekova-Vidimliski P, P74
Dziadek K, P100
Dziadek M, P100, P110, P114
E
Efimov A, P106, P123
Eganova E, O78
Egles C, O22
Egron S, O87
Eichhorn T, IL58 (O94)
El Fray M, O18, O80, O110, P97, P104, P116
Elliott T, IL45
Eloot S, KL3, O76, O123
Enayati M, IL63 (O105)
Engel S, O57
Engels G, O54
Enmi J, O107, P44
Ensminger S, O87
Erben J, IL38 (O90)
Ernst L, P15
Esmaeilzadeh P, IL9 (O34)
Esposito L, O74, P78
Evertz F, O17
F
Faggian G, O53, O70
Falk V, O99, O100, P43
Falvo D'Urso Labate G, O19, O20, O139, P53
Famaey N, O46
Fanti D, O70
Farzaneh F, P139
Favre J, P35
Fedecostante M, P49
Fernandez I, P39
Fernandez-Lopez I, P37
Ferrari F, P96
Ferrari G, O48, O86, O117, O136, P18, P19, P20, P23
Figiel- Dąbrowska A, O62
55
Authors Index
Filatov I, P4
Filippelli S, O48, P18, P19, P20
Fiore G, P14
Fischer F, O101
Fischer M, IL59 (O95)
Fluger I, P34
Foltynski P, O129
Fonseca J, P30
Fontes P, IL43
Forriol F, O24
Foschinni G, O63
Foster G, O56, P135
Fragomeni G, O116
Fraisse A, O47
Franzese I, O53
Frei M, IL38 (O90)
Fresiello L, O117, O120, P18, P19, P23
Fridolin I, P85
Fu X, P29
Fujii Y, O13, P31
Fujita B, O87
G
Gaebler J, O26
Galán G, O63
Gallego-Ferrer G, IL7 (O32), O23, O79, P105
Gałecka K, P36
Game X, O74, P78
Gámiz-González MA, IL22 (O37)
Garcia Garcia A, AL5, O22
Garzotto F, P96
Garzón I, O63
Gautier S, O97
Gawlikowski M, O18, O27, O44, O66, O80, O110, O112, P11, P12,
P16, P104, P116
Gebert M, CM1, P80
Gelev S, O10, P83
Gelpi G, P14
Georgiev M, O49, P73
Georgieva I, P73, P84
Gerasimenko A, O78, P58, P111, P124, P125
Gerasimovska Kitanovska B, P82
Gerasimovska V, O10, P82, P83
Geremia I, O73
Gerosa G, O81
Gewillig M, O46, O68
Gföhler M, P7, P8
Ghez O, O47
Gholami S, P138
Giménez I, O61
Girndt M, IL18
Glasmacher B, O14, O17, O111, P60, P89
Glorieux G, O75
Głowacki M, O44, O112, P11, P16
Godlewska E, P107
Gojo S, P48
Golovkin A, IL60 (O102), IL62 (O104)
Gomez-Ribelles J, P105
Gonsior M, O18, O44, O65, O80, P9, P11, P16, P97, P104
Gossen M, P43
Gotier S, P4
Gottin L, O70
Gou Z, P29
Gough DA, KL5 (O88)
Gourlay T, P129
Gólczewski T, O135, O136, P136, P137
Gómez Ribelles JL, IL22 (O37), O72
Gómez-Estrada L, O23
Górczyńska K, O86, O136, P23
Graaff R, O54
Graefe R, AL2
Granegger M, CM2
Granicka L, P102, P107
Grasl C, IL63 (O105)
Grigioni M, P41
Grinval'd V, P94
Griselli M, O45
Gross C, O118, O121
Groß-Hardt S, O83, O84
Groth T, IL9 (O34)
Gryshkov O, P60
Grzeczkowicz A, P102
Grzeczkowicz M, O96, P50, P95, P102
Grzegorzewska A, O52, P76
Grzybowski A, P17
Guilbeau-Frugier C, O74
Guldris P, IL22 (O37)
Gullon L, P37, P39
Gutierrez-Gutierrez J, IL42 (O92), P37, P39
Gutowski P, O138
H
Hadimeri H, O54
Hage V, O74
Hahn A, O140
Hajek R, P34
Halbe M, IL47
Haller M, O121
Hallier S, O1
Hamming JF, IL64 (O106)
Han Q, P22
Hanada S, P90
Hanazaki K, O130
Harm S, O114, P75
Hartmann J, O113, O114, O115, P75
Hasan S, O77
Hashimoto S, P54, P55, P61
Haßler S, O55
56
Authors Index
Hawkins K, O56
Hazekamp M, O68
Heilmann A, O64, O77
Heine C, O77
Herbst C, O77
Hidaka R, P117
Hino H, P54, P55, P61
Hinteregger M, P7, P8
Hirano Y, O38
Hodler J, P80
Hoefer IE, IL64 (O106)
Holmar J, P85
Homma A, P90
Hornung M, P81
Hoser G, P45, P46, P47
Houshmand B, P101
Hovorka R, IL75
Hulko M, P80, P81
I
Iacobelli R, O48, P18, P19, P20
Ichihara Y, O29
Ichkitidze L, O78, P58, P70, P124, P125
Iida H, O107, P44
Iizuka K, O59, O67
Inada Y, P68
Inoue Y, P63
Ishii D, O107, P44
Itkin G, P4
Ivanković H, O23, O79
Ivanković M, O23, O79
Ivanov I, P57
J
Jacobs S, O30, O120
Jafari F, P139
Janeczek C, P7, P8
Janiczak K, O18, O44, O80, O110, O112, P16, P104, P116
Janiga G, O57
Janiszowski K, P1
Jankowski J, O75
Jankowski V, O75
Jaworek M, O27, P5, P14
Jockenhoevel S, O141
Jodko D, O7, P26
José María M, O72
Jost U, IL24 (O41)
Jóźwik K, O7, P26
Jung A, P40
Jungmann H, IL24 (O41)
Juśko E, P109
K
Kakinoki S, O38
Kalle S, P85
Kamar N, O74, P78
Kami D, P48
Kanda K, P48
Kaneko M, P68, P112
Kanemaru S, P68
Kapis A, O44, P9
Kappler B, O99
Karabegovic A, P7, P8
Karam B, O74
Kashefi A, O127, P33
Katagiri N, O59, O143, P31
Katsube T, O29
Kaufmann F, IL28
Kaufmann TAS, IL79, O83, O84
Kawasaki T, P48
Kawiak J, P45, P46, P47
Kazimierczak B, O60
Kellner K, O113
Kertzscher U, IL80, O6, O26, O28
Kerzenmacher S, IL38 (O90)
Khachab A, O140
Khakpour S, IL5
Khin N, P119
Khir AW, O85
Khubutia M, P65
Khvatov V, P65
Kim W, P118, P122
Kinasiewicz J, P107
Kinoshita Y, O130
Kitagawa H, O130
Kitsuk E, P125
Klammt S, IL25 (O42)
Kleinekofort W, O11
Klein-Nulend J, O142
Klonoff DC, PL4, IL71
Klonowski W, P130, P132
Klose K, P43
Knigge S, O14, O17
Kobayashi M, O21
Koewitsch A, IL9 (O34)
Kojima K, P90
Kokubo K, O12
Komagamine M, O29
Komorowska M, P36
Kong D, IL61 (O103)
Kordium V, P62
Korohoda P, P40
Korossis S, O81
Korzyńska A, P127, P131, P140
Kost J, O128
Kostka P, P128, P133
Kościelniak-Ziemniak M, O110
57
Authors Index
Koutsoukos P, O81
Kowalska A, O60, O98, P51, P108
Kozarski M, O86, O136, P23, P32
Krasheninnikov M, O97, P57
Krause B, IL35, O123, P80, P81
Kribben A, IL24 (O41)
Krieter D, O125, P81
Krisper P, P40
Krolitzki B, O14
Krueger U, P86
Kruk J, O60
Krupickova S, O47
Krylov S, P113, P57
Krylova E, P113, P57
Krzesiński G, O138
Książek A, O50, P87
Kubacki K, O44
Kunkel D, P43
Kupikowska-Stobba B, O96
Kürbitz T, O77
Kurilova U, P111
Kurisu K, O107, P44
Kurtcuoglu V, O5, O25
Kurtyka P, O4
Kusmic C, O119
Kustosz R, IL27, O4, O18, O44, O65, O66, O80, O110, O112, P5,
P9, P11, P16, P24, P25, P97, P104, P116
Kutkowska A, P50, P59
Kuźmińska A, P103
Kyung C, P119
L
L’Abbate A, O119
Laczka M, P110
Lalai RA, IL64 (O106)
Laleman W, P38
Lane R, P119
Lange F, O125
Lauri K, P85
Lavrijsen T, IL64 (O106)
Lech W, O62
Legallais C, IL3, IL40, O22
Lemke H, O125, P81
Lewandowski M, O27
Lewińska D, O96, P50, P95
Leypoldt K, O123
Li H, P22
Li S, P3
Liebsch G, IL37 (O89)
Lierath C, O15
Lifshits G, P126
Likus W, P114
Lin JT, KL5 (O88)
Lindholm B, O126, P88
Lodi M, O9
Lommel M, O28
Lomonte C, O9
Lonsky V, P34
Lopot F, O8
Los M, P114
Low K, P135
Lu C, P3
Lucarelli C, O53, O70
Lucherini F, P14
Lucisano JY, KL5 (O88)
Luman M, P85
Lyundup A, P57
Ładyżyński P, O129, O135, P45, P46, P47
Łukowska E, P59
M
M.Moghadam M, P99
Ma N, O99
Maderova K, P34
Maisano F, P35
Malashicheva A, IL60 (O102)
Malchikhina A, IL62 (O104)
Maleki Esfandabadi S, P98
Malota Z, P128
Mancini A, O53
Mano J, KL4 (O35)
Marangoni R, P77
Marijanović I, O23
Markiewicz T, P140
Martín de Llano J, O24
Martínez Comesana S, P114
Masereeuw R, P49
Mata M, O63
Matic I, O79
Matsuda K, IF3, O12
Mavrilas D, O81
Maw M, O3
Mazurczak K, O129
Mazzucco A, O70
Meboldt M, O5
Meier R, IL37 (O89)
Meisel H, O77
Menaszek E, P100, P110
Meng F, P3
Menon T, O53, O70
Menzel S, O141
Menzen C, O6
Meyns B, IL81, O30, O46, O68, O69, O117, O120
Mezentseva M, P111
Michielon G, O47
Michnikowski M, P137
Mihajlovic M, IL4, P49
Mikhalovsky S, IL34
58
Authors Index
Milián L, O24, O63
Milosevic J, O77
Mindubaev E, O137, P2
Mínguez M, O24
Minoretti C, P92
Mironov A, P65
Mishanin A, IL60 (O102)
Mitzner S, KL2, IL25 (O42), IL52, IL54
Miyamoto T, O29
Mizuno T, O67, O143, P90
Mnatsakanyan H, O39, P56
Moggridge G, O16
Mohammadkhani B, P101, P138
Moles M, P52
Molina-Mateo J, O72
Molteni A, P27, P135
Monbaliu D, P38
Morale W, O9
Moriarty C, O56
Moriguchi T, O12
Moriwaki T, P117
Moroni L, IL64 (O106)
Morozov V, P6, P13, P28
Moscato F, IL15, IL78, O3, O82, O118, O121
Motomura T, O83
Motta A, IL8 (O33)
Mottaghy K, O127, O140, O142, P33, P101, P138, P139
Mouzakis F, O127, P33
Mueller M, O14, O111
Mukaibayashi H, P90
Müller I, AL4
Müller J, O1
Müller M, P89
Munekage M, O130
Murphy S, P119
N
Naito N, O67
Nakada A, P68, P112
Nakajima H, P61
Nakamura T, P68, P112
Nakatani T, O13
Nakayama Y, O59, O107, P44, P117
Namikawa T, O130
Nawrat Z, P128
Nazari-Shafti T, O100
Ndzengue S, P89
Neidlin M, O83, O84
Neri M, P96
Neves NM, KL1 (O31)
Nevzorov A, P4
Niepolski L, P76
Nikitaiev S, P62
Nishinaka T, O29
Nishioka S, O38
Nix C, O68
Noda K, P55
Nurlidar F, O21
Nyberg S, IL10
O
Obidowski D, O7, P26
Obtułowicz P, O62
Ochsner G, O5
Odintsova E, P126
Oganesyan R, P57
Ohnuma K, P90
Okumura MLM, P67, P69
Onorati F, O53, O70
Oozawa S, O13
Orero G, P127
Orzechowska B, P110
Osaka D, O13
Oshkukov S, P111
Ostrowska W, P100
Ouwen C, P3
P
Pacholewicz J, IL17, O44
Palumbo P, O132
Pałko KJ, P23, P32, P136
Pankowska E, IL73, O129
Papazov V, P73, P84
Pauli L, O55
Pavlenko D, O71
Pavlov A, O78, P124, P125
Pawlak S, P17
Paziewska A, P50
Peeters G, P38
Pelosi G, O119
Perazzini C, O122
Peter N, O1
Petuhov V, P124
Pfeiffer D, O14
Piani D, O53
Pickup J, IL74
Piechna M, P115
Piegat A, O18, O80, P97, P104
Pieper I, O56
Piersigilli A, O119
Pietribiasi M, P88
Pijanowska D, O60, O98, P51, P108, P131, P140
Pirogov V, P62
Pitto L, P21
Pluta K, O98, P51, P108, P127
Podgaetsky V, O78, P58, P124, P125
Pokholenko I, P62
59
Authors Index
Polakovic V, O8
Poleszczuk J, O50, P87
Poniatowska A, P109
Ponikvar R, IL66
Ponkratova A, P65
Ponomarev I, P65
Pontoriero G, P92
Poorkhalil A, O127, P33, P138
Possenti L, O134
Pott D, O87
Pozhar K, P94
Preussiger M, IL24 (O41)
Pribolšan L, O23
Prikrylova K, P34
Protze S, P43
Przybylski R, P17
Pstras L, P134
Puzzuoli S, O119
Pydziński P, P12
Q
Qian W, P29
R
Rabelink TJ, IL64 (O106)
Rabie M, P129
Radley G, O56
Raes A, O76
Ragusa R, P21
Ramsauer B, O54
Ranjbarzadeh-Dibazar A, P121
Ratna Tuladhar S, O81
Ravagli E, O122
Redl H, IL63 (O105)
Rega F, O30, O46, O68, O69
Reis RL, PL3
Rekus M, O28
Remuzzi A, O9
Remuzzi G, O9
Renzulli A, O116
Reorowicz P, O7, P26
Repanas A, O14, O111
Ressler A, O79
Rico P, O39, P56
Rijnberg F, O68
Rimshan I, P58
Rivera A, P37
Rodriguez M, IL68
Rogina A, O23, O79
Rolland S, P135
Romanenko A, P62
Rombolà G, P92
Ronco C, P96
Rostaing L, O74, P78
Roszkowiak Ł, P127, P131, P140
Rota S, O9
Rothuizen TC, IL64 (O106)
Rotmans JI, IL64 (O106)
Routh TL, KL5 (O88)
Rozga J, IL13
Ródenas Rochina J, IL22 (O37)
Ruan X, P29
Rubio C, P91
Rudek M, P64, P69
Rudolph M, O64
Russu L, P111
Ruzickova J, P34
Ryabkin D, P58
S
Sabalińska S, P45, P46, P47
Sabater i Serra R, O72, P56
Safonova L, O97, P106
Saito S, O29
Salehi-Nik N, O142
Sallusto F, O74
Salmeron-Sanchez M, IL21 (O36), O39, P56
Salusto F, P78
Samluk A, O60, O98, P51, P108, P127
San Biagio L, O53, O70
Sanchez del Arco R, IL42 (O92), P37, P39
Sánchez-Romero N, O61
Sancho-Tello M, O24, O63
Sano S, O13
Santos Filho D, P30
Sauvant C, O125
Savelyev M, P58
Schettler V, IL51
Schima H, KL9, O3, O82, O118, O121
Schlatter G, O22
Schmid Daners M, O5
Schmidt C, P80
Schmidt H, IL12
Schneditz D, P40
Schneider K, IL63 (O105)
Schnurr K, IL23 (O40)
Schoenholzer C, P92
Schuele C, O6
Segers P, O19, O20, O123, O139, P38, P53
Selim G, O10, P83
Selishchev S, O2, O78, O137, P2, P58, P93, P124, P125
Senatore M, O9
Seredina T, P126
Serrani M, O16
Severi S, O122
Shagidulin M, O97
Shaman Y, P124, P125
60
Authors Index
Shaneh S, P71
Shesterikov E, IL62 (O104)
Shichkin N, P70
Shigeno K, P68, P112
Shionoya I, P68
Shiraishi Y, P63
Shokrolahi F, P71
Shokrollahi P, P71, P98, P99, P121
Shtyh D, P28
Sienz J, P135
Sierra A, P37
Siess T, O68
Siewnicka A, P1
Sikole A, O10, O54, P74, P82, P83
Simeonov R, P74
Sinev A, IL60 (O102)
Skagerlind M, P79
Snauwaert E, O76
Sonntag S, O83, O84
Soos P, O45
Soto-Gutierrez A, KL6
Sottile V, P52
Spasovski G, IL68
Speer O, O25
Spillner J, IL76
Spittler A, IL57
Stachowska-Pietka J, O126
Stadlbauer-Köllner V, P40
Stamatialis D, IL1, IL2, IL33, O71, O73, P49
Stamm C, O99, O100, P43
Stange J, IL11, IL25 (O42)
Stankiewicz B, P32
Stasiak J, O16
Stauber R, P40
Stecka A, O135, P137
Stegmayr B, IF2, IL49, IL50, O54, O75, P79
Steinseifer U, O83, O84, O87, P15
Stepien P, P132
Steuperaert M, O139
Stodolak-Zych E, P114
Storr M, O123, P81
Strobl K, O113, O115
Strusi V, IL6
Subbotovskaya A, P126
Suciu AM, O85
Suck M, O71
Suetina I, P111
Sugimoto K, P54
Sumikura H, O59, O67, P90
Suresh S, P60
Suwalski P, PL1
Suzuki S, O38
Svara F, O8
Sysoev A, P4
Szuber-Dynia A, P9
Szymanski J, IL46
Ścigała P, O18, O44, O80, P16, P104
Śliwka J, P17
Świątek M, P9
Świderska M, O52
T
Tabesh H, P33, P101, P138, P139
Taenaka Y, O143
Tajikawa T, P117
Takahashi Y, P54, P55, P61
Takeda T, P55
Takeshita D, O59
Takewa Y, IF1, O59, O67, O143, P31, P90
Tanihara M, O21
Tanner R, P85
Tarkesh Esfahani M, P138
Tateishi M, O29
Tateishi S, P31
Tatsumi E, O59, O67, O143, P31, P66, P90
Tazza L, O9
Teixido-Planas J, P91
Telyshev D, O2, O78, P70
ter Beek O, O71
Terada K, O21
Tessari M, O53, O70
Thamsen B, AL1, O26, O28
Thévenin D, O57
Thomaseth K, P134
Thormann A, O64
Thornton C, O56
Timmermans P, O120
Titova M, P57
Tkacz E, P133
Togo K, P31
Tolba R, P15
Tomson R, P85
Torbicz W, O60
Torchia F, O20
Torner B, O1
Tosim A, P69
Trajceska L, O10, P83
Trapp A, P64, P69
Trendafilov I, P73, P84
Trevisani A, P96
Tripisciano C, IL58 (O94)
Trivella M, O48, O119, P21
Trochanowska N, P36
Tronin A, P126
Troya-Saborido M, P91
Trzaskowska P, P109, P115
Tsachev K, P84
Tsukiya T, O67, O143, P90
Tverdohlebov S, IL60 (O102), IL62 (O104)
61
Authors Index
Tyczynski B, IL24 (O41)
U
Uchida H, O13
Umehara N, O29
V
Valenta R, IL56
Van Biesen W, O76
van Blitterswijk CA, IL64 (O106)
Van De Bruaene A, O69
Van Hoorebeke L, P53
Van Puyvelde J, O68
Van Raemdonck D, O69
van Zonneveld AJ, IL64 (O106)
Vande Walle J, O76
Vandecasteele T, P38
Vanholder R, IL69
Vazelov E, P73, P84
Verbelen T, O46, O69
Vermirovska J, O8
Vidaurrea A, IL22 (O37)
Vienken J, PL2, IL26 (O43), P89
Vigersky R, IL72
Vigo V, O9
Vismara R, P14
Visser MJT, IL64 (O106)
Vito D, O51, P92
Voigt M, P80, P81
Vollmer T, O75
von Segesser L, P35
Vozianov S, P62
W
Wakatsuki M, P68, P112
Walpoth BH, KL8
Walski T, P36
Walter I, IL63 (O105)
Wang I, O14
Waniewski J, IL20, O50, O124, O126, P87, P88, P134
Wanner C, O125
Warchoł W, O52, P76
Watanabe T, P48
Waterstradt K, IL23 (O40)
Wawro B, O60
Wądołowski P, O138
Wąż G, P36
Weber V, IL58 (O94), IL59 (O95)
Webster TJ, IL39 (O91)
Weiss R, IL58 (O94), IL59 (O95)
Wiecek A, IL67
Wiegmann L, O5, O25
Wierzchoń T, O65
Wilhelm M, P35
Willinger R, P7
Winiarska H, O62
Wisniewski A, O1
Witkiewicz W, P36
Witkowski D, P10, P26
Witt V, IL53, IL55
Włoczka G, P17
Wojasiński M, O108
Wojciechowski C, P45, P46, P47, P59
Wojta J, IL63 (O105)
Wójcik-Załuska A, O50, P87
Wrightson N, IL31
Wurm F, O1
X
Xu L, P3
Xu Z, O100, P3
Y
Yaku H, P48
Yamada A, P63
Yamamoto K, O12
Yamanami M, P48
Yamane K, O21
Yamane T, O12
Yamaoka T, O38
Yamazak K, O29
Yambe T, P63
Yang M, P3
Yang Y, IL9 (O34)
Yao W, P129
Yatabe T, O130
Yeganeh H, P71
Yonova D, O49, P73, P84
Yousef H, P135
Z
Zagrajczuk B, P100, P110, P114
Zakrzewska K, O60, O98, P51, P108, P127
Zalewski J, P9
Załuska A, P88
Załuska W, O50, P87, P88
Zandieh-Doulabi B, O142
Zar V, P111
Zawidlak-Węgrzyńska B, O18, O44, O80, O110, P9, P16, P97,
P104, P116
Zezula R, P34
Zhao M, IL9 (O34)
Zhao Q, IL61 (O103)
Zhdanov A, P6, P13, P28
Zhuang X, P3
Zhurbina N, P111
62
Authors Index
Zieliński K, O86, O135, O136, P23, P32
Zimpfer D, IL16, O118, O121
Ziyaee Sigaroudi A, P139
Zou J, P29
Zurriaga J, O24
Zuscich O, P34
Zweigart C, O123
Zychowicz M, O62
Żak J, P127, P140
63

congress information

Transcription

Similar documents

ALUMNI 2012 DRUK.indd - Poznan University of Medical Science

innsbruck austria - Unfallchirurgie Innsbruck

RAPORT 21 FKZ ang - Festiwal Kultury Żydowskiej

Lista expertilor care au participat la procesul de evaluare

manus - Igus

simpozion psihiatrie letterhead

here - 47th Annual Meeting of the Society for Invertebrate Pathology

Presentation of AGENCY SIGMA_June_2012 [tryb zgodności]

Diapositiva 1 - Piping Engineering Constructions

Programme

Curriculum Vitae and Track Record Leonardo Ricotti